{
    "testId": 390321267,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 59,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 34,
    "correctToIncorrect": 2,
    "incorrectToCorrect": 2,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 256,
    "averageTimeSpentInSeconds": 84,
    "otherAverageTimeSpentInSeconds": 71,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 2423,
            "questionIndex": 2423,
            "questionText": "<p>A 2-hour-old boy is in the newborn nursery with tachycardia.&nbsp; The patient was born at 40 weeks gestation to a 30-year-old woman with Graves disease that was previously treated with surgical resection.&nbsp; Weight is 2.08 kg (4 lb 9 oz) (&lt;5th percentile).&nbsp; Temperature is 37.2 C (99 F) and pulse is 190/min.&nbsp; Examination shows an irritable but consolable infant with warm, flushed skin.&nbsp; Appropriate pharmacotherapy is initiated.&nbsp; Which of the following is the most likely course of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t80896\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Neonatal Graves disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Transplacental passage of maternal TSH receptor&ndash;stimulating antibodies (due to maternal Graves disease)</li><li>Antibodies bind to infant&#39;s TSH receptors &amp; cause excessive thyroid hormone release &rarr; neonatal thyrotoxicosis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical&nbsp;features</strong></p></td><td><ul><li>Tachycardia &amp; irritability</li><li>Warm, moist skin</li><li>Low birth weight or preterm birth</li><li>&plusmn; Goiter, stare</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Maternal &amp; neonatal TSH receptor&ndash;stimulating antibodies</li><li>&darr; TSH, &uarr; free thyroxine</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment &amp;&nbsp;outcome</strong></p></td><td><ul><li>Methimazole plus &beta; blocker</li><li>Usually self-resolves within months (due to clearance of maternal antibodies)</li></ul></td></tr></tbody></table></div><p>This neonate with a <strong>maternal</strong> history of <strong>Graves disease</strong> has low birth weight, tachycardia, and irritability.&nbsp; These findings are consistent with <strong>neonatal Graves disease</strong> (thyrotoxicosis) due to <strong>transplacental</strong> passage of maternal <strong>TSH receptor&ndash;stimulating antibodies</strong>.&nbsp; The antibodies bind fetal TSH receptors and cause excessive thyroid hormone release.&nbsp; Although neonates born to women with active Graves disease during pregnancy are at greatest risk, elevated maternal antibody levels can occur despite prior treatment (eg, thyroidectomy) and lead to neonatal disease.</p><p>Presentation can occur at birth or within the first few weeks of life and commonly includes <strong>tachycardia</strong> with bounding pulses, <strong>irritability</strong>, and <strong>warm/moist skin</strong>, as seen in this patient.&nbsp; Prematurity and/or <strong>low birth weight</strong> with reduced subcutaneous fat is common, and microcephaly and craniosynostosis can occur.&nbsp; Neonatal goiter or staring gaze may be present, and these more specific findings often raise suspicion in infants born to mothers with unrecognized Graves disease.</p><p>Management includes short-term treatment with methimazole plus a beta blocker to prevent adverse effects of neonatal hyperthyroidism on the developing nervous system (eg, developmental/behavioral problems, poor growth).&nbsp; However, these medications can typically be rapidly tapered and discontinued because neonatal Graves disease usually <strong>self-resolves</strong> over weeks to months as maternal antibodies are metabolized and cleared from the infant&#39;s circulation <strong>(Choice C)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Infants with congenital hypothyroidism have a lifelong deficiency of thyroid hormone and require levothyroxine supplementation.&nbsp; Unlike this neonate, patients are asymptomatic in the immediate newborn period, and symptoms that develop over weeks to months include lethargy, poor feeding, and prolonged jaundice.&nbsp; This newborn has signs of hyperthyroidism (eg, tachycardia, irritability, flushed skin).</p><p><strong>(Choices B and D)</strong>&nbsp; Radioactive iodine therapy and thyroidectomy are treatment options for Graves disease due to the production and secretion of thyroid autoantibodies (ie, in older children and adults).&nbsp; Because neonatal Graves disease is due to transplacental antibody transfer, the condition self-resolves and does not require ablation or gland removal.</p><p><strong>Educational objective:</strong><br>Infants born to women with Graves disease are at risk for neonatal Graves disease due to the transplacental transfer of TSH receptor&ndash;stimulating antibodies.&nbsp; Manifestations (eg, tachycardia, irritability, flushed skin) are treated short term with antithyroid medication and beta blockers, and the condition spontaneously resolves within weeks to months due to the disappearance of maternal antibodies.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Lifelong deficiency requiring levothyroxine supplementation",
                    "choiceNumber": 1,
                    "correctTaken": 179,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progressive symptoms until radioactive iodine therapy",
                    "choiceNumber": 2,
                    "correctTaken": 43,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recurrent exacerbations requiring symptomatic control",
                    "choiceNumber": 3,
                    "correctTaken": 105,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Resolution of symptoms after thyroid gland removal",
                    "choiceNumber": 4,
                    "correctTaken": 91,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Self-resolution within months",
                    "choiceNumber": 5,
                    "correctTaken": 4581,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "506,610,true,-1,1*1885,2109,true,-1,1*365,379,true,-1,1*406,461,true,-1,1*960,1177,true,-1,1*1365,1489,true,-1,1*1492,1654,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "786",
                    "mediaDataId": 0,
                    "title": "Graves disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29406005",
                    "mediaDataId": 0,
                    "title": "Neonatal thyrotoxicosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29406005",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26980880",
                    "mediaDataId": 0,
                    "title": "Management of neonates born to mothers with Graves&#39; disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26980880",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 41,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 5081,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 90,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1071,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 2220,
            "questionIndex": 2220,
            "questionText": "<p>A 58-year-old man comes to the physician with a one-year history of diarrhea.&nbsp; The stools are watery and accompanied by abdominal cramps.&nbsp; He has no fever, blood from the rectum, or foul-smelling stools.&nbsp; He has also experienced frequent episodes of dizziness, flushing, wheezing, and a feeling of warmth.&nbsp; The patient has taken herbal medicines, which failed to relieve his symptoms.&nbsp; He is depressed about his illness and feels hopeless about diagnosis and treatment.&nbsp; He appears ill.&nbsp; Cardiac auscultation shows a 2/6 systolic murmur over the left lower sternal border that increases with inspiration.&nbsp; Abdominal examination shows hepatomegaly 3 cm below the right costal margin and no abdominal tenderness.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"375\"><tbody><tr><td>Hemoglobin</td><td>14.0 g/dL</td></tr><tr><td>Mean corpuscular volume</td><td>90 fL</td></tr><tr><td>Platelets</td><td>200,000/&micro;L</td></tr><tr><td>Leukocytes</td><td>6,100/&micro;L</td></tr><tr><td>Alkaline phosphatase</td><td>400 U/L</td></tr><tr><td>Aspartate aminotransferase (SGOT)</td><td>101 U/L</td></tr><tr><td>Alanine aminotransferase (SGPT)</td><td>99 U/L</td></tr></tbody></table></blockquote><p>This patient is at risk of developing a deficiency of which of the following vitamins or minerals?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t79878\"><table class=\"table-default-style\" style=\"width:479px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Features of carcinoid syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li>Skin: flushing, telangiectasias, cyanosis</li><li>Gastrointestinal: diarrhea, cramping</li><li>Cardiac: valvular lesions (right &gt; left side)</li><li>Pulmonary: bronchospasm</li><li>Miscellaneous: niacin deficiency (dermatitis, diarrhea, dementia)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Elevated 24-hr urinary excretion of 5-HIAA</li><li>CT scan/MRI of abdomen &amp; pelvis to localize tumor</li><li>OctreoScan to detect metastases</li><li>Echocardiogram (if symptoms of carcinoid heart disease are present)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Octreotide for symptomatic patients &amp; prior to surgery/anesthesia</li><li>Surgery for liver metastases</li></ul></td></tr></tbody></table></div></p><p>The patient&#39;s clinical features - episodic flushing and wheezing, diarrhea, and valvular heart disease with tricuspid regurgitation - are consistent with <strong>carcinoid syndrome</strong>.&nbsp; Carcinoids are slow-growing tumors found most commonly in the distal small intestine, proximal colon, and lung.&nbsp; These tumors can secrete several products, including histamine, serotonin, and vasoactive intestinal peptide, that are metabolized in the liver.&nbsp; Gastrointestinal carcinoid tumors often metastasize to the liver.&nbsp; In such cases, the liver is unable to metabolize these hormones before they are released into the systemic circulation, leading to the carcinoid syndrome.&nbsp; Other clinical features include cutaneous telangiectasias and tricuspid regurgitation.</p><p>Serotonin is synthesized in carcinoid cells from tryptophan, which is also used in the production of niacin or nicotinic acid.&nbsp; Advanced disease results in increased tryptophan conversion to serotonin and its metabolite 5-hydroxyindoleacetic acid.&nbsp; This may result in tryptophan and niacin deficiency causing pellagra (with diarrhea, dermatitis, glossitis, angular stomatitis, and dementia).</p><p><strong>(Choices A and E)</strong>&nbsp; Neither calcium nor vitamin C deficiency is associated with carcinoid syndrome.</p><p><strong>(Choice B)</strong>&nbsp; Iron deficiency is typically not seen in patients with carcinoid syndrome.&nbsp; In addition, this patient&#39;s serum hemoglobin and mean corpuscular volume are within normal limits, making iron deficiency even less likely.</p><p><strong>(Choice D)</strong>&nbsp; Vitamin A deficiency is not seen in association with carcinoid syndrome.&nbsp; It occurs most commonly due to dietary deficiency or in association with fat malabsorption (eg, celiac disease, small-bowel Crohn&#39;s disease, pancreatic insufficiency).&nbsp; Fatty diarrhea or steatorrhea typically causes pale, greasy, and malodorous stools, unlike the watery diarrhea seen in patients with carcinoid syndrome.</p><p><strong>Educational objective:</strong><br>Carcinoid tumors are rare neuroendocrine tumors that cause episodic flushing, secretory diarrhea, bronchospasm, and cardiac valvular abnormalities.&nbsp; Carcinoid cells cause increased production of serotonin from tryptophan (required for niacin synthesis), resulting in niacin deficiency (ie, pellagra, with dermatitis, diarrhea, and dementia).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 5825,
            "topic": "Carcinoid tumors",
            "titleId": 5825,
            "title": "Carcinoid tumors",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Calcium",
                    "choiceNumber": 1,
                    "correctTaken": 13124,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iron",
                    "choiceNumber": 2,
                    "correctTaken": 7932,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Niacin",
                    "choiceNumber": 3,
                    "correctTaken": 61011,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin A",
                    "choiceNumber": 4,
                    "correctTaken": 38277,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin C",
                    "choiceNumber": 5,
                    "correctTaken": 2117,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "846,895,true,-1,1*1042,1264,true,-1,1*404,435,true,-1,1*311,353,true,-1,1*514,608,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "361",
                    "mediaDataId": 0,
                    "title": "Carcinoid syndrome and well-differentiated neuroendocrine tumors",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16444370",
                    "mediaDataId": 0,
                    "title": "Carcinoid syndrome: diagnosis and medical management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16444370",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 150,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 122461,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 878,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 2188,
            "questionIndex": 2188,
            "questionText": "<p>A 30-year-old Hispanic male presents to the office with complaints of palpitations, tremor, nervousness and headache.&nbsp; His past history is insignificant.&nbsp; His mother has type 2 diabetes, which is well-controlled with medications.&nbsp; His temperature is 37.0&#xB0; C (98.6&#xB0; F), pulse is 100/min, blood pressure is 150/80 mm Hg, and respirations are 16/min.&nbsp; He appears anxious, sweaty and shaky.&nbsp; His neurological examination is non-focal, and examination of other systems is unremarkable.&nbsp; His fingerstick blood glucose level is 38 mg/dL.&nbsp; Intravenous administration of a bolus of 50% dextrose leads to the improvement of his symptoms.&nbsp; He is then subjected to supervised prolonged fasting.&nbsp; After an overnight fast, laboratory studies reveal:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"650\"><tbody><tr><td width=\"24%\">Blood glucose</td><td width=\"76%\">40 mg/dL</td></tr><tr><td width=\"24%\">Serum insulin</td><td width=\"76%\">15 microU/L (normal value is &lt; 6 microU/L with hypoglycemia)</td></tr><tr><td width=\"24%\">Serum pro-insulin</td><td width=\"76%\">9 microU/L (normal value is &lt; 20% of total immunoreactive insulin)</td></tr><tr><td width=\"24%\">C-peptide level</td><td width=\"76%\">0.8 nmol/L&nbsp;&nbsp; (normal value is less than 0.2 nmol/L)</td></tr><tr><td width=\"24%\">Sulfonylurea</td><td width=\"76%\">Negative</td></tr><tr><td width=\"24%\">IGF-II</td><td width=\"76%\">Negative</td></tr></tbody></table></blockquote><p>Based on the above information, what is the most likely cause of this patient&#39;s hypoglycemia?</p>",
            "questionHeader": "",
            "explanationText": "<p>In normal individuals, a blood glucose level below 60 mg/dL results in near-complete suppression of insulin secretion.&nbsp; The patient in this vignette thus presents with&nbsp;hypoglycemia and&nbsp;inappropriately elevated serum insulin levels.&nbsp;</p><p>There are two important causes of hypoglycemia in non-diabetic patients&nbsp;with elevated insulin levels:&nbsp;&nbsp;</p><ol><li>insulinoma (beta cell tumor)</li><li>surreptitious use of insulin or sulfonylurea&nbsp;</li></ol><p>Elevated&nbsp;C-peptide levels and proinsulin levels&nbsp;greater than 5 pmol/L are seen in patients with beta cell tumors; therefore, this is the most likely diagnosis.</p><p><strong>(Choice B)</strong> Non-beta cell tumors, typically large mesenchymal tumors, can lead to hypoglycemia independent of insulin.&nbsp; Such tumors produce insulin-like growth factor II (IGF II), which has an insulinomimetic action after binding to&nbsp;insulin receptors.&nbsp; In patients with suspected non-beta cell tumors, the serum IGF II level can be measured.&nbsp; Patients with this condition&nbsp;characteristically&nbsp;have suppressed insulin and c-peptide levels.</p><p><strong>(Choice C) </strong>Sulfonylurea causes an increased output of endogenous insulin from the beta cells.&nbsp; Patients with sulfonylurea-induced hypoglycemia are sometimes difficult to differentiate from those with insulinoma because increased insulin and c-peptide levels are&nbsp;seen in both groups. &nbsp;Nonetheless, the proinsulin level is sometimes lower than 20% of the total insulin immunoreactivity.&nbsp; The diagnosis is confirmed by measuring the plasma sulfonylurea level.</p><p><strong>(Choice D) </strong>Exogenous insulin-induced hypoglycemia is associated with very high serum insulin levels combined with low c-peptide levels.&nbsp; The low c-peptide levels result from the&nbsp;suppression of endogenous insulin production.&nbsp;</p><p><strong>(Choice E) </strong>Glucagonoma produces a characteristic skin rash (necrotic migratory erythema) with elevated blood glucose levels (not hypoglycemia).</p><p><strong>Educational Objective:</strong><br>Hypoglycemia is associated with multiple differential diagnoses.&nbsp; Helpful tests used in the evaluation of hypoglycemic patients are measurements of&nbsp;c-peptide, proinsulin and sulfonylurea levels.&nbsp; Hypoglycemia secondary to insulinoma is associated with elevated insulin, c-peptide and proinsulin levels.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2740,
            "topic": "Hypoglycemia",
            "titleId": 2740,
            "title": "Hypoglycemia",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Beta cell tumor",
                    "choiceNumber": 1,
                    "correctTaken": 287805,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Non-beta cell tumor",
                    "choiceNumber": 2,
                    "correctTaken": 8751,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sulfonylurea agents",
                    "choiceNumber": 3,
                    "correctTaken": 6460,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exogenous insulin",
                    "choiceNumber": 4,
                    "correctTaken": 26521,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucagonoma",
                    "choiceNumber": 5,
                    "correctTaken": 5757,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "442,554,true,-1,1*854,1037,true,-1,1*1424,1494,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "736",
                    "mediaDataId": 0,
                    "title": "Hypoglycemia in adults",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 72,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 335294,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 86,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 959,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 2645,
            "questionIndex": 2645,
            "questionText": "<p>A 64-year-old woman comes to the office due to a progressive rash.&nbsp; The patient initially had painful, itchy red spots on her right leg 2 months ago, which gradually enlarged and began to crust.&nbsp; Similar spots later appeared on her abdomen and chin.&nbsp; She has used several over-the-counter corticosteroid and antibiotic creams with no improvement.&nbsp; The patient has had no palpitations, abdominal pain, or vomiting, but has had occasional watery stools.&nbsp; She was diagnosed with type 2 diabetes mellitus 6 months ago, and lifestyle modification was advised.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 110/70 mm Hg, pulse is 78/min, and respirations are 14/min.&nbsp; Weight is 10 kg (22 lb) lower than 6 months ago; BMI is 21 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows erythematous plaques with central clearing and eroded borders on the right thigh.&nbsp; There are scattered papules with crusting over the lower abdomen and in the perioral skin.&nbsp; The remainder of the examination shows no abnormalities.&nbsp; Laboratory studies are significant for a hemoglobin level of 10.2 g/dL and glucose level of 176 mg/dL.&nbsp; Which of the following would be most helpful in establishing the diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t51039\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Features of glucagonoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Weight loss</li><li><strong>Necrolytic migratory erythema</strong>: erythematous papules that coalesce to form large, indurated plaques with central clearing</li><li>Diabetes mellitus/hyperglycemia</li><li>Gastrointestinal symptoms (eg, diarrhea, anorexia, abdominal pain)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Markedly elevated glucagon level</li><li>Abdominal imaging (MRI or CT scan)</li></ul></td></tr></tbody></table></div><p>This patient with diabetes mellitus, weight loss, diarrhea, and a painful, pruritic rash likely has a <strong>glucagonoma</strong>, a pancreatic neuroendocrine tumor characterized by the unregulated release of glucagon.&nbsp; Manifestations reflect the effects of glucagon, which increases amino acid oxidation and has catabolic actions.</p><p>Glucagonoma is often diagnosed late in the disease course due to nonspecific early features; <strong>necrolytic migratory erythema (NME)</strong> is the presenting feature in ~70% of patients.&nbsp; NME, likely due to amino acid deficiency, is characterized by <strong>painful/pruritic papules</strong> that coalesce to form large, indurated plaques with scaling and <strong>central clearing</strong> on the face, groin, and extremities.&nbsp; The excess glucagon also causes hyperglycemia/<strong>diabetes mellitus</strong>, although this is usually mild and rarely requires insulin.&nbsp; Other common features include <strong>weight loss</strong>&nbsp;(catabolic action of glucagon), <strong>diarrhea</strong>&nbsp;(secretion of glucagon and other molecules [eg, secretin]), venous thromboembolism, and neuropsychiatric symptoms (eg, depression, psychosis).</p><p>Laboratory evaluation typically shows <strong>normocytic, normochromic anemia</strong>, which may be due to anemia of chronic disease or a direct effect of glucagon on erythropoiesis.&nbsp; A markedly elevated <strong>serum glucagon</strong> level (&gt;500 pg/mL) confirms the diagnosis.&nbsp; Although glucagon is increased in other conditions (eg, hypoglycemia, Cushing syndrome, pancreatitis), the elevations are typically mild to moderate.&nbsp; Abdominal imaging (CT scan or MRI) can localize the tumor and evaluate for metastases.</p><p><strong>(Choice A)</strong>&nbsp; Antimitochondrial antibodies are associated with primary biliary cholangitis, which presents with diffuse pruritis, jaundice, hepatomegaly, and abnormal liver markers (eg, alkaline phosphatase, aminotransferases).&nbsp; Skin manifestations include xanthomas and hyperpigmentation.</p><p><strong>(Choice C)</strong>&nbsp; Porphyria cutanea tarda causes skin fragility and chronic, scarring blisters and bullae in sun-exposed areas.&nbsp; It is commonly associated with hepatitis C; hepatic aminotransferases are often mildly elevated.&nbsp; Blood counts are typically normal.</p><p><strong>(Choice D)</strong>&nbsp; Vitamin A deficiency most commonly presents with impaired night vision.&nbsp; Skin findings (eg, hyperkeratosis) are usually nonspecific.</p><p><strong>(Choice E)</strong>&nbsp; Tissue transglutaminase IgA antibodies are seen in dermatitis herpetiformis, typically associated with celiac disease.&nbsp; Skin manifestations include grouped, intensely pruritic papules and vesicles on the extensor surfaces of the elbows, knees, back, and buttocks.</p><p><strong>(Choice F)</strong>&nbsp; Niacin deficiency is characterized by photosensitive, pigmented dermatitis (primarily in sun-exposed areas); diarrhea; and neuropsychiatric symptoms (eg, dementia, psychosis).</p><p><strong>Educational objective:</strong><br>Glucagonomas frequently cause necrolytic migratory erythema, characterized by painful/pruritic papules that coalesce to form large plaques on the face, groin, and extremities.&nbsp; Other manifestations include diabetes mellitus, weight loss, diarrhea, and anemia.&nbsp; A serum glucagon level &gt;500 pg/mL confirms the diagnosis, and abdominal imaging can localize the tumor and evaluate for metastases.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 18295,
            "topic": "Glucagonoma",
            "titleId": 18295,
            "title": "Glucagonoma",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antimitochondrial antibody test",
                    "choiceNumber": 1,
                    "correctTaken": 817,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucagon level",
                    "choiceNumber": 2,
                    "correctTaken": 7510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma total porphyrins level",
                    "choiceNumber": 3,
                    "correctTaken": 1896,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum retinol level",
                    "choiceNumber": 4,
                    "correctTaken": 498,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tissue transglutaminase IgA antibody test",
                    "choiceNumber": 5,
                    "correctTaken": 4425,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinary N-methylnicotinamide level",
                    "choiceNumber": 6,
                    "correctTaken": 836,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "589,701,true,-1,1*187,208,true,-1,1*1115,1205,true,-1,1*877,920,true,-1,1*1284,1434,true,-1,1*1472,1604,true,-1,1*1681,1832,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "466",
                    "mediaDataId": 0,
                    "title": "Pancreatic neuroendocrine tumors (PanNETs)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27422767",
                    "mediaDataId": 0,
                    "title": "Glucagonoma syndrome: a review and update on treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27422767",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 62,
            "othersAvgTimeSpent": 83,
            "notes": null,
            "peopleTaken": 15982,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1521,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 2179,
            "questionIndex": 2179,
            "questionText": "<p>A 75-year-old woman comes to the office due to 2 months of heat intolerance, sweating, and palpitation.&nbsp; The patient has lost significant weight recently despite increasing her food intake.&nbsp; Medical history is notable for hypertension and heart failure with preserved ejection fraction.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 146/80 mm Hg, pulse is 116/min and regular, and respirations are 18/min.&nbsp; Physical examination shows a mildly enlarged and nontender thyroid.&nbsp; There is no proptosis or pretibial myxedema.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">normal</td></tr><tr><td style=\"vertical-align:middle;\">Serum creatinine</td><td style=\"vertical-align:middle;\">1.0 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">&lt;0.001 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">T3</td><td style=\"vertical-align:middle;\">500 ng/dL</td></tr><tr><td style=\"vertical-align:middle;\">Free thyroxine (T4)</td><td style=\"vertical-align:middle;\">4.7 ng/dL (normal: 0.9-1.7 ng/dL)</td></tr></tbody></table><p>Radioactive iodine uptake at 24 hours is significantly increased and homogeneously distributed throughout the thyroid gland.&nbsp; Atenolol is prescribed to control the patient&#39;s symptoms and tachycardia.&nbsp; Which of the following is the most appropriate next step in management of this patient&#39;s thyroid disorder?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t97600\"><table class=\"table-default-style\" style=\"width:610px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Treatment of Graves disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>&beta;-Blockers</strong></p></td><td><ul><li>Initiated at diagnosis to mitigate hyperadrenergic complications</li></ul></td></tr><tr><td><p align=\"center\"><strong>Antithyroid<br />drugs</strong></p></td><td><ul><li>Can induce remission in many patients</li><li>May be used as pretreatment prior to radioactive iodine or thyroidectomy (eg, high-risk patient, severe hyperthyroidism)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Radioactive<br />iodine</strong></p></td><td><ul><li>Acceptable option for moderate hyperthyroidism</li><li>May initially worsen ophthalmopathy&nbsp;and hyperthyroid symptoms</li><li>Leads to permanent hypothyroidism over time</li></ul></td></tr><tr><td><p align=\"center\"><strong>Thyroidectomy</strong></p></td><td><ul><li>Preferred in patients with very large goiter, obstructive symptoms, or ophthalmopathy</li></ul></td></tr></tbody></table></div><p>This patient has <strong>Graves disease</strong> (GD), presenting with primary hyperthyroidism (ie, elevated thyroid hormone levels, suppressed TSH), a diffuse goiter, and homogeneously increased radioiodine uptake.&nbsp; Initial management of hyperthyroidism (from any cause) includes a <strong>beta blocker</strong> (eg, propranolol, atenolol) to control hyperadrenergic symptoms (eg, palpitation, tachycardia).</p><p>The hyperthyroid state in GD can be corrected with thionamide <strong>antithyroid drugs</strong> (ATDs) (eg, <strong>methimazole</strong>), radioactive iodine (RAI), or thyroidectomy.&nbsp; In <strong>older patients</strong> (eg, age &gt;65), especially those with <strong>cardiac comorbidities</strong> (eg, congestive heart failure, as in this patient), <strong>ATDs</strong> are favored for initial treatment because RAI can transiently worsen hyperthyroid symptoms and may be poorly tolerated <strong>(Choice A)</strong>.&nbsp; Once the patient returns to a euthyroid state, RAI can be considered, or the ATD may be continued for long-term management.</p><p><strong>(Choice B)</strong>&nbsp; Potassium iodide has a transient inhibitory effect on thyroid hormone synthesis and release.&nbsp; It is used mainly in short courses (eg, 1-2 weeks) in preparation for thyroidectomy and for the treatment of thyroid storm but is not used when longer-term therapy is anticipated; thionamide ATDs are preferred.</p><p><strong>(Choice C)</strong>&nbsp; Systemic glucocorticoids (eg, prednisone) are used for thyroid storm, type 2 amiodarone-induced thyrotoxicosis, and severe cases of subacute (de Quervain) thyroiditis.</p><p><strong>(Choice D)</strong>&nbsp; Beta blockers alone are used for painless (silent) thyroiditis, which causes self-limited hyperthyroidism due to the release of preformed thyroid hormone.&nbsp; However, GD is characterized by increased thyroid hormone synthesis, and an ATD is needed.</p><p><strong>(Choice F)</strong>&nbsp; Thyroidectomy is preferred for patients with large goiters causing obstructive symptoms and those with moderate or severe ophthalmopathy, which can worsen during RAI therapy.&nbsp; However, it may not be preferred in older patients with increased surgical risk and would not be performed until the patient was in a euthyroid state on ATDs.</p><p><strong>Educational objective:</strong><br>Graves disease can be treated with thionamide antithyroid drugs, radioactive iodine, or thyroidectomy.&nbsp; Antithyroid drugs are preferred for older patients and those with cardiac comorbidities (eg, heart failure) who may not tolerate surgery or the transient exacerbation of hyperthyroid symptoms from radioactive iodine.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer radioactive iodine therapy",
                    "choiceNumber": 1,
                    "correctTaken": 798,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Begin potassium iodide now",
                    "choiceNumber": 2,
                    "correctTaken": 169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Begin prednisone with a slow taper",
                    "choiceNumber": 3,
                    "correctTaken": 185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observe and follow up in 6 weeks",
                    "choiceNumber": 4,
                    "correctTaken": 291,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe methimazole therapy",
                    "choiceNumber": 5,
                    "correctTaken": 3236,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer for subtotal thyroidectomy",
                    "choiceNumber": 6,
                    "correctTaken": 301,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2266,2600,true,-1,1*1604,1815,true,-1,1*1375,1496,true,-1,1*190,310,true,-1,1*377,482,true,-1,1*497,582,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "487",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25905220",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism in aging.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25905220",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 138,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 5049,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1065,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 27039,
            "questionIndex": 115143,
            "questionText": "<p>A 16-year-old girl is brought to the clinic due to behavioral changes over the school year.&nbsp; The patient has had difficulty concentrating, and her academic performance has declined.&nbsp; She also has been uninterested in participating in her regular extracurricular activities or spending time with her boyfriend.&nbsp; She sleeps approximately 9 hours a night, has no difficulty falling or staying asleep, and naps after school.&nbsp; The patient typically eats 3 meals a day, but her appetite has recently decreased, which she attributes to intermittent constipation.&nbsp; Medications include oral contraceptive pills.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 110/70 mm Hg, pulse is 50/min, and respirations are 16/min.&nbsp; BMI is at the 85th percentile.&nbsp; The patient appears well, and the physical examination is unremarkable.&nbsp; Which of the following is the best next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T80427\" style=\"overflow-x:auto;\" tid=\"51561\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of hypothyroidism</strong></p></td></tr><tr><td><p align=\"center\"><strong>Mood symptoms</strong></p></td><td><ul><li>Depression</li><li>Apathy</li><li>Social withdrawal</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cognitive symptoms</strong></p></td><td><ul><li>Impaired concentration &amp; memory</li><li>Psychomotor slowing</li><li>Executive dysfunction</li></ul></td></tr><tr><td><p align=\"center\"><strong>Severe symptoms</strong></p></td><td><ul><li>Delirium</li><li>Psychosis (myxedema madness)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physical symptoms</strong></p></td><td><ul><li>Bradycardia</li><li>Cold intolerance</li><li>Fatigue</li><li>Muscle weakness &amp; myalgia</li><li>Hyporeflexia</li></ul></td></tr></tbody></table></div><p>This teenaged patient has <strong>difficulty concentrating</strong> as well as <strong>loss of interest</strong> in activities and relationships, symptoms that often suggest a mood disorder (eg, depression).&nbsp; However, depressive symptoms are nonspecific and warrant a thorough history and physical examination to assess for an underlying medical condition (eg, hypothyroidism, vitamin B<font size=\"2\"><sub>12</sub></font> deficiency).&nbsp; In this case, the patient also has <strong>constipation</strong> and <strong>bradycardia</strong>, raising concern for <strong>acquired hypothyroidism</strong>.</p><p>The most common cause of hypothyroidism in adolescents is autoimmune thyroiditis, in which immune-mediated thyroid gland destruction impairs thyroxine synthesis.&nbsp; Hypothyroidism leads to a generalized hypometabolic state in children (similarly in adults), often marked by fatigue, constipation, bradycardia, and/or cold intolerance.&nbsp; Mood and cognitive symptoms are common and in adolescents often include <strong>declining school performance</strong>, as seen here.&nbsp; Features of hypothyroidism that are unique to children include declining growth velocity or short stature and delayed puberty.</p><p>Thyroid function tests show <strong>increased TSH</strong> and <strong>decreased free thyroxine</strong> levels, and most patients have elevated antithyroid antibodies (eg, antithyroglobulin, antithyroid peroxidase).&nbsp; Treatment with levothyroxine typically results in improved depressive symptoms.</p><p><strong>(Choice A)</strong>&nbsp; Selective serotonin reuptake inhibitors (eg, fluoxetine) are first-line medications for depression and can be considered in an adolescent with typical manifestations (eg, difficulty concentrating, loss of interests) and an otherwise unrevealing history and physical examination.&nbsp; However, the priority in this patient who also has bradycardia and constipation is evaluation for an underlying medical condition (ie, hypothyroidism).</p><p><strong>(Choice B)</strong>&nbsp; Oral contraceptive pills do not significantly affect mood and do not explain this patient&#39;s social withdrawal or difficulty concentrating, making medication discontinuation unnecessary.</p><p><strong>(Choice C)</strong>&nbsp; Sleep studies are indicated for fatigue and difficulty concentrating in the setting of snoring or frequent awakenings that are concerning for obstructive sleep apnea (OSA).&nbsp; This patient sleeps 9 hours without difficulty falling or staying asleep.&nbsp; In addition, bradycardia and constipation are not features of OSA.</p><p><strong>(Choice E)</strong>&nbsp; Stimulant medications are first-line agents for attention deficit hyperactivity disorder.&nbsp; Although difficulty concentrating is common, symptoms are typically present before age 12, and this patient&#39;s new onset of symptoms, along with bradycardia, suggests a different cause.&nbsp; In addition, standardized ratings from multiple sources (eg, parents, teachers) are typically obtained before initiating pharmacotherapy.</p><p><strong>Educational objective:</strong><br>Depressive symptoms (eg, declining school performance, loss of interest) may indicate an underlying medical condition, and acquired hypothyroidism should be considered in those who also have hypometabolic symptoms (eg, bradycardia, constipation).&nbsp; Thyroid function tests show increased TSH and decreased free thyroxine levels.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 12124,
            "topic": "Hypothyroidism",
            "titleId": 12124,
            "title": "Hypothyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Begin selective serotonin reuptake inhibitor",
                    "choiceNumber": 1,
                    "correctTaken": 541,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue oral contraceptive pills",
                    "choiceNumber": 2,
                    "correctTaken": 72,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a sleep study",
                    "choiceNumber": 3,
                    "correctTaken": 175,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain thyroid function tests",
                    "choiceNumber": 4,
                    "correctTaken": 4266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe a trial of stimulant medication",
                    "choiceNumber": 5,
                    "correctTaken": 16,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "135,208,true,-1,1*225,262,true,-1,1*1524,1598,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "486",
                    "mediaDataId": 0,
                    "title": "Hypothyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30137821",
                    "mediaDataId": 0,
                    "title": "Hypothyroidism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30137821",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 42,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 5070,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 84,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 749,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 11243,
            "questionIndex": 12398,
            "questionText": "<p>A 26-year-old woman comes to the office for a routine visit 6 months after the birth of her first child.&nbsp; Her pregnancy and vaginal delivery were uneventful and her infant is healthy; she breastfed for the first 5 months.&nbsp; The patient reports that during the first 2-3 months after childbirth she had excessive anxiety and worried frequently about her newborn daughter.&nbsp; She also felt unusually fatigued and irritable, which has worsened over the last several weeks.&nbsp; The patient has also experienced constipation, but her appetite is normal and she has gained 2.5 kg (5.5 lb) in the last 3 months.&nbsp; Blood pressure is 130/90 mm Hg and pulse is 60/min.&nbsp; Heart and lung sounds are normal.&nbsp; Mild bilateral lower extremity edema is present.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hemoglobin</td><td>12 g/dL</td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>130 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>4.2 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>1.1 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>100 mg/dL</td></tr><tr><td>Total cholesterol</td><td>280 mg/dL</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31172\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\" style=\"width:32.0%\"><p align=\"center\"><strong>Thyroiditis</strong></p></td></tr><tr><td style=\"width:33.0%\"></td><td style=\"width:35.0%\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:32.0%\"><p align=\"center\"><strong>Diagnostic testing</strong></p></td></tr><tr><td style=\"width:33.0%\"><p align=\"center\"><strong>Chronic autoimmune thyroiditis</strong><br />(Hashimoto thyroiditis)</p></td><td style=\"width:35.0%\"><ul><li>Predominant hypothyroid features</li><li>Diffuse goiter</li></ul></td><td style=\"width:32.0%\"><ul><li>Positive TPO antibody</li><li>Variable radioiodine uptake</li></ul></td></tr><tr><td style=\"width:33.0%\"><p align=\"center\"><strong>Painless thyroiditis</strong><br />(silent thyroiditis)</p></td><td style=\"width:35.0%\"><ul><li>Variant of chronic autoimmune thyroiditis</li><li>Mild, brief hyperthyroid phase</li><li>Small, nontender goiter</li><li>Spontaneous recovery</li></ul></td><td style=\"width:32.0%\"><ul><li>Positive TPO antibody</li><li>Low radioiodine uptake</li></ul></td></tr><tr><td style=\"width:33.0%\"><p align=\"center\"><strong>Subacute </strong><strong>(granulomatous) </strong><strong>thyroiditis</strong><br />(de Quervain thyroiditis)</p></td><td style=\"width:35.0%\"><ul><li>Likely postviral inflammatory process</li><li>Prominent fever &amp; hyperthyroid symptoms</li><li>Painful/tender goiter</li></ul></td><td style=\"width:32.0%\"><ul><li>Elevated ESR &amp; CRP</li><li>Low radioiodine uptake</li></ul></td></tr><tr><td colspan=\"3\" style=\"width:32.0%\"><p style=\"margin-left:.05in;\"><strong>CRP</strong> = C-reactive protein; <strong>ESR</strong> = erythrocyte sedimentation rate; <strong>TPO</strong> = thyroid peroxidase.</p></td></tr></tbody></table></div><p><strong>Postpartum thyroiditis</strong> occurs in 7%-8% of women after childbirth, usually in the first 6 months.&nbsp; Patients can have a <strong>brief hyperthyroid phase</strong> due to release of preformed thyroid hormone but frequently have only mild, nonspecific symptoms (eg, anxiety [as seen in this patient], palpitations).&nbsp; The subsequent <strong>hypothyroid phase</strong> (eg, fatigue, weight gain despite normal appetite, constipation) often brings patients to medical attention.&nbsp; Examination typically shows a nontender goiter, bradycardia, diastolic hypertension, lower extremity edema, and other findings (eg, coarse facies, delayed deep tendon reflex relaxation).&nbsp; In the hypothyroid phase, <strong>TSH</strong> will be elevated and <strong>free T4</strong> levels will be low.&nbsp; Other laboratory findings associated with hypothyroidism include hypercholesterolemia (due to thyroid effects on lipid metabolism) and hyponatremia.</p><p>Postpartum thyroiditis is similar to painless (silent) thyroiditis, but by convention the latter is not diagnosed within a year of childbirth.&nbsp; Both may be considered variants of chronic lymphocytic (Hashimoto) thyroiditis and are associated with elevated titers of <strong>anti-thyroid peroxidase autoantibodies</strong>.&nbsp; However, whereas Hashimoto thyroiditis frequently leads to permanent hypothyroidism, postpartum and painless thyroiditis are usually self-limited, and patients return to a euthyroid state over several months.</p><p><strong>(Choice A)</strong>&nbsp; Postpartum thyroiditis and postpartum depression cause overlapping symptoms.&nbsp; Hypothyroidism should be excluded first as it is a reversible cause of depression.&nbsp; In general, postpartum depression is more often associated with weight loss and additional depressive symptoms (eg, anhedonia, feelings of inappropriate guilt).&nbsp; If thyroid function is normal, depression would be more likely.</p><p><strong>(Choice B)</strong>&nbsp; Peripartum cardiomyopathy is characterized by systolic heart failure and occurs in the last month of pregnancy or up to 5 months after delivery.&nbsp; It can lead to edema and hyponatremia but would not occur 6 months after pregnancy and would present with respiratory features (eg, dyspnea, orthopnea, lung crackles) and tachycardia (rather than borderline bradycardia).&nbsp; Hypothyroidism can cause lower extremity edema.</p><p><strong>(Choice C)</strong>&nbsp; Weight gain and hypercholesterolemia in postpartum hypothyroidism usually resolve with restoration of the euthyroid state.&nbsp; Directed lifestyle and pharmacologic interventions are not usually needed.</p><p><strong>(Choice D)</strong>&nbsp; Hypothyroidism and adrenal insufficiency can both cause hyponatremia.&nbsp; However, adrenal insufficiency is unlikely in this patient in light of the associated edema, weight gain, and normal blood pressure.</p><p><strong>Educational objective:</strong><br>Postpartum thyroiditis is an autoimmune disorder characterized by a possible brief hyperthyroid phase, a self-limited hypothyroid phase, and an ultimate return to a euthyroid state.&nbsp; It is associated with anti-thyroid peroxidase autoantibodies.&nbsp; Painless (silent) thyroiditis is a similar disorder, but by convention is not diagnosed within a year of childbirth.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 12124,
            "topic": "Hypothyroidism",
            "titleId": 12124,
            "title": "Hypothyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cognitive-behavioral therapy",
                    "choiceNumber": 1,
                    "correctTaken": 166,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiography",
                    "choiceNumber": 2,
                    "correctTaken": 118,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exercise and dietary modification",
                    "choiceNumber": 3,
                    "correctTaken": 184,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Morning serum cortisol",
                    "choiceNumber": 4,
                    "correctTaken": 353,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid function studies",
                    "choiceNumber": 5,
                    "correctTaken": 4136,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2514,2659,true,-1,1*1893,2103,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "488",
                    "mediaDataId": 0,
                    "title": "Thyroiditis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22312089",
                    "mediaDataId": 0,
                    "title": "Approach to the patient with postpartum thyroiditis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22312089",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 41,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 5026,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1004,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 3492,
            "questionIndex": 3492,
            "questionText": "<p>A 37-year-old woman comes to the office with a 7-month history of galactorrhea and amenorrhea.&nbsp; She has also had worsening vaginal dryness, but no headaches or visual symptoms.&nbsp; The patient&#39;s medical history is unremarkable, and she does not use tobacco, alcohol, or illicit drugs.&nbsp; She is married, has 2 children, and remarks that her family is &#x22;complete.&#x22;&nbsp; The patient&#39;s husband has undergone vasectomy.&nbsp; Her temperature is 36.7 C (98 F), blood pressure is 120/80 mm Hg, pulse is 72/min, and respirations are 14/min.&nbsp; Visual field testing is normal.&nbsp; Pregnancy test is negative, serum prolactin level is 150 ng/mL (154 ng/mL on repeat measurement), and thyrotropin (TSH) and serum creatinine are normal.&nbsp; MRI of the pituitary gland reveals a 6-mm hypointense lesion, as shown in the image below, which is consistent with a pituitary adenoma.</p><p><img id=\"4350\"  src=\"https://www.uworld.com/media/L19004.png\" draggable=\"false\" ></p><p>Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"4351\"  src=\"https://www.uworld.com/media/L28485.png\" draggable=\"false\" ></p><p>This patient has a <strong>pituitary microadenoma</strong> (&lt;10 mm) associated with <strong>galactorrhea</strong> and symptoms of low estrogen (eg, amenorrhea, vaginal dryness).&nbsp; Any mass lesion in the pituitary gland can cause a mild elevation in prolactin due to disruption of the normal inhibitory dopaminergic regulation of prolactin secretion.&nbsp; However, significant elevations in the prolactin level (eg, serum prolactin level &gt;200 ng/mL or repeat level &gt;100 ng/mL) suggest a prolactin-secreting tumor (<strong>prolactinoma</strong>).&nbsp; Elevated prolactin levels suppress gonadotropin-releasing hormone, LH, and estradiol, leading to oligo-amenorrhea in premenopausal females.&nbsp; Men and postmenopausal women often have minimal early symptoms and are more likely to seek evaluation when a large tumor (&gt;1 cm, macroadenoma) causes mass-effect symptoms (eg, headache, visual field defects).</p><p>Asymptomatic patients with an incidental finding of a microprolactinoma may be observed over time <strong>(Choice A)</strong>.&nbsp; Patients with <strong>macroprolactinomas</strong> or <strong>symptomatic tumors</strong> of any size (as with this patient) should be treated with <strong>dopaminergic agonists</strong> (eg, cabergoline, bromocriptine), which can <strong>normalize prolactin levels</strong> and <strong>reduce tumor size</strong>.&nbsp; Patients who fail to respond or who have very large tumors (&gt;3 cm) should be referred for transsphenoidal resection <strong>(Choice C)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Patients with residual prolactinoma tissue following resection can be considered for radiotherapy.&nbsp; However, the response to radiotherapy is generally delayed, and radiotherapy may lead to panhypopituitarism.</p><p><strong>(Choice E)</strong>&nbsp; Estrogen replacement therapy may be given to reduce the risk of osteoporosis in hypoestrogenic women with microprolactinoma who do not tolerate dopamine agonists.&nbsp; However, estrogen does not reduce tumor size.</p><p><strong>Educational objective:</strong><br>Patients with a macroprolactinoma (&gt;1 cm) or a symptomatic prolactinoma should be treated with dopaminergic agonists (eg, cabergoline, bromocriptine), which can lower prolactin levels and reduce tumor size.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11896,
            "topic": "Hyperprolactinemia",
            "titleId": 11896,
            "title": "Hyperprolactinemia",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Monitoring by periodic serum prolactin and MRI",
                    "choiceNumber": 1,
                    "correctTaken": 2326,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Radiotherapy",
                    "choiceNumber": 2,
                    "correctTaken": 745,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transsphenoidal surgery",
                    "choiceNumber": 3,
                    "correctTaken": 9938,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Treatment with cabergoline",
                    "choiceNumber": 4,
                    "correctTaken": 25006,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Treatment with estrogen",
                    "choiceNumber": 5,
                    "correctTaken": 662,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1353,1561,true,-1,1*872,1329,true,-1,1*1574,1783,true,-1,1*176,347,true,-1,1*357,518,true,-1,1*661,871,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "734",
                    "mediaDataId": 0,
                    "title": "Hyperprolactinemia, including prolactinoma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21296991",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21296991",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 38677,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1030,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 5249,
            "questionIndex": 8888,
            "questionText": "<p>A 26-year-old woman calls the office with a question about management of hypothyroidism during pregnancy.&nbsp; The patient is not pregnant but wishes to become pregnant soon.&nbsp; She has a history of hypothyroidism for several years and has been on a stable dose of levothyroxine.&nbsp; TSH checked 3 months ago was 2.0 &micro;U/mL.&nbsp; The patient currently has mild fatigue but is otherwise asymptomatic.&nbsp; Family history is notable for primary hypothyroidism in her mother, who is doing well on a regimen of liothyronine (T<font size=\"2\"><sub>3</sub></font>) and levothyroxine (T<font size=\"2\"><sub>4</sub></font>).&nbsp; Which of the following is the most appropriate recommendation for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t81698\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\" style=\"width:50.0%;\"><p align=\"center\"><strong>Maternal thyroid testing in pregnancy, 1st trimester</strong></p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Hormone</strong></p></td><td style=\"width:25.0%;\"><p align=\"center\"><strong>Change</strong></p></td><td style=\"width:50.0%;\"><p align=\"center\"><strong>Mechanism</strong></p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Total T4</strong></p></td><td style=\"width:25.0%;\"><p align=\"center\">Increased</p></td><td rowspan=\"2\" style=\"width:50.0%;\"><ul><li>&beta;-hCG stimulates thyroid hormone production in 1st trimester</li><li>Estrogen stimulates TBG; thyroid increases hormone production to maintain steady free T4 level</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Free T4</strong></p></td><td style=\"width:25.0%;\"><p align=\"center\">Unchanged or mildly increased</p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>TSH</strong></p></td><td style=\"width:25.0%;\"><p align=\"center\">Decreased</p></td><td style=\"width:50.0%;\"><ul><li>Increased &beta;-hCG &amp; thyroid hormone suppress TSH secretion</li></ul></td></tr><tr><td colspan=\"3\" style=\"width:50.0%;\"><p><strong>TBG</strong> = thyroxine-binding globulin.</p></td></tr></tbody></table></div></p><p>During pregnancy, estrogen induces an increase in serum <strong>thyroxine-binding globulin</strong> levels, requiring an increase in the amount of thyroid hormone needed to saturate the binding sites.&nbsp; Thyroxine production is also increased due to the stimulatory effects of hCG on TSH receptors (as hCG and TSH have a similar alpha subunit).&nbsp; These changes lead to an increase in <strong>total thyroid hormone</strong> levels, with a minimal increase in free hormone levels and a decrease in TSH.&nbsp; However, patients with pre-existing hypothyroidism are unable to increase thyroxine production appropriately and are at risk for a worsening hypothyroid state and adverse fetal and maternal effects (eg, gestational hypertension, preeclampsia, premature delivery, postpartum hemorrhage).</p><p>Individuals such as this patient on a stable dose of thyroid replacement should have their dose <strong>increased</strong> by approximately 30% at the time the pregnancy is detected <strong>(Choices A and B)</strong>.&nbsp; The dose should be adjusted subsequently (typically in 4-week increments) based on TSH using <strong>pregnancy-specific norms</strong>.&nbsp; Total T<font size=\"2\"><sub>4</sub></font> should also be followed and maintained within pregnancy-specific norms.</p><p><strong>(Choice C)</strong>&nbsp; This patient has been on a stable dose of levothyroxine and has a TSH in the low-normal range (&lt;2.5 &micro;U/mL).&nbsp; She does not require dosing adjustments at this time.</p><p><strong>(Choice E)</strong>&nbsp; T<font size=\"2\"><sub>3</sub></font> is the active form of thyroid hormone and is produced predominantly by conversion from T<font size=\"2\"><sub>4</sub></font> in peripheral tissues.&nbsp; However, T<font size=\"2\"><sub>3</sub></font> has a short half-life, and supplementation with liothyronine (oral T<font size=\"2\"><sub>3</sub></font>) is associated with wide fluctuations in blood levels.&nbsp; T<font size=\"2\"><sub>3</sub></font> supplementation is not recommended for most patients with primary hypothyroidism, and those who are taking T<font size=\"2\"><sub>3</sub></font> should be changed to levothyroxine alone if considering pregnancy.</p><p><strong>Educational objective:</strong><br>Levothyroxine requirements increase during pregnancy.&nbsp; Patients with hypothyroidism should increase their levothyroxine dose at the time pregnancy is detected, with subsequent dose adjustments based on TSH and total T<font size=\"2\"><sub>4</sub></font> using pregnancy-specific norms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 12124,
            "topic": "Hypothyroidism",
            "titleId": 12124,
            "title": "Hypothyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Continue the current levothyroxine dose through pregnancy",
                    "choiceNumber": 1,
                    "correctTaken": 7309,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decrease the levothyroxine dose when the patient becomes pregnant",
                    "choiceNumber": 2,
                    "correctTaken": 3421,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase the levothyroxine dose prior to pregnancy",
                    "choiceNumber": 3,
                    "correctTaken": 2551,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase the levothyroxine dose when the patient becomes pregnant",
                    "choiceNumber": 4,
                    "correctTaken": 24413,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Switch to combination treatment with liothyronine and levothyroxine",
                    "choiceNumber": 5,
                    "correctTaken": 282,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1276,1307,true,-1,1*1384,1439,true,-1,1*2007,2187,true,-1,1*902,1178,true,-1,1*613,754,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22869843",
                    "mediaDataId": 0,
                    "title": "Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22869843",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 53,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 37976,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 941,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 3662,
            "questionIndex": 3662,
            "questionText": "<p>A 4-month-old girl is brought to the clinic for a well-child check.&nbsp; The mother is concerned that the girl is less active than other children at day care.&nbsp; The patient is exclusively formula-fed and must be awakened for most feeds; she has also been having less frequent bowel movements for the past month.&nbsp; She was born to a 30-year-old woman at term via spontaneous vaginal delivery at home.&nbsp; The mother is healthy but had limited prenatal care.&nbsp; Height and weight were at the 50th percentile at birth; weight is at the 25th percentile today.&nbsp; The patient is afebrile with mild bradycardia.&nbsp; The anterior and posterior fontanelles are enlarged, and the patient has a large, protruding tongue without fasciculations.&nbsp; The abdomen is protuberant with a large, reducible umbilical hernia.&nbsp; She is unable to lift her head when prone.&nbsp; Which of the following is the most likely cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T48535\" style=\"overflow-x:auto;\" tid=\"3634\"><div align=\"center\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Congenital hypothyroidism</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Thyroid dysgenesis most common (eg, agenesis, hypoplasia, ectopy)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>manifestations</strong></p></td><td><ul><li>Asymptomatic at birth*</li><li>Symptomatic weeks to months after birth (as maternal T4 wanes)<ul style=\"list-style-type:circle;\"><li>Hypometabolism: &#8595; HR &amp; temperature, lethargy/poor feeding, hypotonia, constipation, jaundice</li><li>Mucopolysaccharide accumulation: macroglossia, umbilical hernia</li><li>Delayed bone maturation: enlarged fontanelles</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Newborn screening</li><li>&#8593; TSH &amp; &#8595; T4</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Levothyroxine</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prognosis</strong></p></td><td><ul><li>No deficits if treatment started in neonatal period</li><li>Untreated disease leads to intellectual disability, developmental delay &amp; poor growth</li></ul></td></tr><tr><td colspan=\"2\"><p>*Can rarely present with delayed passage of meconium.</p><p><strong>HR</strong> = heart rate.</p></td></tr></tbody></table></div></div><p>This 4-month-old patient who is unable to lift her head has <strong>hypotonia</strong>, a worrisome finding in young infants that may be suggestive of a neuromuscular or genetic disorder but is more commonly due to an infectious or metabolic condition.&nbsp; This patient also has bradycardia, enlarged fontanelles, and constipation, characteristic findings of <strong>congenital hypothyroidism</strong>.&nbsp; Patients are typically asymptomatic at birth due to the transplacental transfer of maternal T4, and they develop symptoms as levels wane over weeks to months.</p><p>Congenital hypothyroidism is usually due to thyroid dysgenesis and leads to a hypometabolic state characterized by <strong>lethargy</strong> (eg, less activity, <strong>feeding problems</strong>/poor weight gain), <strong>constipation</strong>, and <strong>bradycardia</strong>, as in this patient.&nbsp; Because skeletal muscle is a highly metabolic tissue that requires thyroid hormone signaling for contractile functioning, patients develop diffuse myopathy with hypotonia and weakness.&nbsp; T4 also regulates the degradation of mucopolysaccharides, which accumulate in subcutaneous tissue in hypothyroidism, causing myxedematous skin changes (eg, <strong>macroglossia, protuberant abdomen, umbilical hernia</strong>).&nbsp; Finally, <strong>enlarged fontanelles</strong> with delayed closure are typical because thyroid hormone promotes bone growth and maturation.</p><p>Laboratory evaluation shows increased TSH and decreased T4.&nbsp; Prompt treatment with levothyroxine reduces the risk for neurologic deficits and developmental delay.</p><p><strong>(Choice A)</strong>&nbsp; Beckwith-Wiedemann syndrome is an overgrowth disorder often associated with macroglossia and umbilical hernia.&nbsp; Unlike in this patient, hypotonia is not seen, and macrosomia (weight &gt;97th percentile) would be expected.</p><p><strong>(Choice C)</strong>&nbsp; Congenital myotonic dystrophy causes severe hypotonia and weakness.&nbsp; However, symptoms are present at birth, not beginning at age 4 months.&nbsp; Patients typically require mechanical ventilation in the neonatal period due to respiratory failure.</p><p><strong>(Choice D)</strong>&nbsp; Infant botulism most commonly occurs due to the ingestion of environmental <em>Clostridium botulinum</em> spores.&nbsp; Patients have hypotonia with constipation, poor feeding, and autonomic signs (eg, fluctuating heart rate).&nbsp; In contrast to the symptoms in this patient, however, symptoms in infant botulism progress rapidly (&lt;1 week) to bulbar weakness and respiratory compromise.</p><p><strong>(Choice E)</strong>&nbsp; Spinal muscular atrophy type I is characterized by progressive hypotonia and symmetric paralysis, and bulbar muscle involvement typically leads to poor feeding and growth.&nbsp; However, tongue fasciculations are a classic finding and are not seen in this patient whose enlarged fontanelles and bradycardia would not be expected in spinal muscular atrophy type I.</p><p><strong>Educational objective:</strong><br>Hypotonia in young infants should raise concern for congenital hypothyroidism in the setting of hypometabolic symptoms (eg, constipation, bradycardia, poor feeding/weight gain), as well as enlarged fontanelles and macroglossia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 12124,
            "topic": "Hypothyroidism",
            "titleId": 12124,
            "title": "Hypothyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Beckwith-Wiedemann syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 809,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congenital hypothyroidism",
                    "choiceNumber": 2,
                    "correctTaken": 3934,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congenital myotonic dystrophy",
                    "choiceNumber": 3,
                    "correctTaken": 104,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Infant botulism",
                    "choiceNumber": 4,
                    "correctTaken": 147,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Spinal muscular atrophy type I",
                    "choiceNumber": 5,
                    "correctTaken": 122,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "185,247,true,-1,1*341,450,true,-1,1*665,717,true,-1,1*1492,1888,true,-1,1*2325,2407,true,-1,1*2420,2450,true,-1,1*2580,2661,true,-1,1*2779,2886,true,-1,1*3055,3087,true,-1,1*3238,3259,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "467",
                    "mediaDataId": 0,
                    "title": "Congenital hypothyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32644339",
                    "mediaDataId": 0,
                    "title": "Congenital hypothyroidism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32644339",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 58,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 5116,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 77,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1543,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 3488,
            "questionIndex": 3488,
            "questionText": "<p>A 35-year-old man comes to the office due to a 2-day history of jitteriness, chills, and malaise.&nbsp; The patient has also had anterior neck pain that radiates to his jaw and ears.&nbsp; He recovered from an upper respiratory tract illness a week before the onset of his current symptoms but previously had felt well.&nbsp; The patient was seen in the clinic occasionally in the remote past for sexually transmitted infections, but his medical history is otherwise unremarkable.&nbsp; He lives alone and is sexually active with both men and women.&nbsp; Temperature is 38 C (100.4 F), blood pressure is 150/70 mm Hg, and pulse is 110/min.&nbsp; The thyroid gland is diffusely enlarged and tender.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Hemoglobin</td><td style=\"vertical-align:middle;\">13.9 g/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Hematocrit</td><td style=\"vertical-align:middle;\">44%</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Platelets</td><td style=\"vertical-align:middle;\">200,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Leukocytes</td><td style=\"vertical-align:middle;\">10,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">&lt;0.001 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">Free T4</td><td style=\"vertical-align:middle;\">4.6 ng/dL (normal: 0.9-2.4)</td></tr><tr><td style=\"vertical-align:middle;\">Erythrocyte sedimentation rate</td><td style=\"vertical-align:middle;\">100 mm/hr</td></tr></tbody></table><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T81559\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\" style=\"width:30.0%\"><p align=\"center\"><strong>Thyroiditis</strong></p></td></tr><tr><td style=\"width:30.0%\"></td><td style=\"width:40.0%\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:30.0%\"><p align=\"center\"><strong>Diagnostic testing</strong></p></td></tr><tr><td style=\"width:30.0%\"><p align=\"center\"><strong>Chronic autoimmune thyroiditis<br>(Hashimoto thyroiditis)</strong></p></td><td style=\"width:40.0%\"><ul><li>Predominant hypothyroid features</li><li>Diffuse goiter</li></ul></td><td style=\"width:30.0%\"><ul><li>Positive TPO antibody</li><li>Variable radioiodine uptake</li></ul></td></tr><tr><td style=\"width:30.0%\"><p align=\"center\"><strong>Painless thyroiditis<br>(silent thyroiditis)</strong></p></td><td style=\"width:40.0%\"><ul><li>Variant of chronic autoimmune thyroiditis</li><li>Mild, brief hyperthyroid phase</li><li>Small, nontender goiter</li><li>Spontaneous recovery</li></ul></td><td style=\"width:30.0%\"><ul><li>Positive TPO antibody</li><li>Low radioiodine uptake</li></ul></td></tr><tr><td style=\"width:30.0%\"><p align=\"center\"><strong>Subacute thyroiditis<br>(de Quervain thyroiditis)</strong></p></td><td style=\"width:40.0%\"><ul><li>Neck pain with painful/tender goiter</li><li>Transient hyperthyroid phase</li><li>Often follows viral upper respiratory tract infection</li></ul></td><td style=\"width:30.0%\"><ul><li>Elevated ESR &amp; CRP</li><li>Low radioiodine uptake</li></ul></td></tr><tr><td colspan=\"3\" style=\"width:30.0%\"><p style=\"margin-left:.05in;\"><strong>CRP</strong> = C-reactive protein; <strong>ESR</strong> = erythrocyte sedimentation rate; <strong>TPO</strong> = thyroid peroxidase.</p></td></tr></tbody></table></div><p>This patient has <strong>subacute thyroiditis</strong> presenting with <strong>primary hyperthyroidism</strong> (elevated free T4, suppressed TSH), low-grade fever, and a <strong>painful, tender goiter</strong>.&nbsp; Subacute (de Quervain, subacute granulomatous) thyroiditis is thought to be due to a <strong>postviral inflammatory process</strong> and is often preceded by an upper respiratory tract illness.&nbsp; The diagnosis is based primarily on clinical features; additional supportive findings include elevated inflammatory markers (eg, erythrocyte sedimentation rate, C-reactive protein) and <strong>low radioiodine uptake</strong> (because the hyperthyroidism is due to release of preformed thyroid hormone rather than new hormone synthesis).</p><p>Thyrotoxicosis in subacute thyroiditis resolves spontaneously within a few weeks and may be followed by a hypothyroid phase lasting a few months.&nbsp; Most patients eventually recover to a euthyroid state.&nbsp; Treatment includes <strong>beta blockers</strong> to control thyrotoxic symptoms and <strong>nonsteroidal anti-inflammatory drugs</strong> (NSAIDs) for pain relief.&nbsp; Glucocorticoids are used for severe thyroid pain not responding to NSAIDs.</p><p><strong>(Choices A, B, and E)</strong>&nbsp; Acute HIV infection can cause fever, pharyngitis, and lymphadenopathy, often with a generalized rash and gastrointestinal symptoms (ie, antiretroviral syndrome).&nbsp; Acute gonococcal infection also can present with pharyngitis and fever.&nbsp; Retropharyngeal space infections in adults commonly present as neck pain and fever, often with dysphagia.&nbsp; However, none of these disorders is associated with a goiter or hyperthyroid state.</p><p><strong>(Choices C and D)</strong>&nbsp; Graves disease typically presents with thyrotoxicosis and goiter, often with proptosis.&nbsp; Chronic lymphocytic (Hashimoto) thyroiditis typically presents with hypothyroidism, although patients may develop a brief hyperthyroid phase.&nbsp; However, the goiter seen in both of these conditions is nontender, and fever is uncommon.</p><p><strong>(Choice G)</strong>&nbsp; Suppurative infection of the thyroid gland (infectious thyroiditis) is a rare condition that most commonly occurs in children.&nbsp; It presents with high-grade fever and pain at the thyroid gland, which may be palpably enlarged due to abscess formation.&nbsp; However, the pain is typically unilateral, and patients are usually euthyroid due to focal (rather than diffuse) thyroid involvement.</p><p><strong>Educational objective:</strong><br>Subacute (de Quervain) thyroiditis is characterized by fever, neck pain, and a tender goiter following an upper respiratory tract illness.&nbsp; Patients have a self-limited thyrotoxic phase followed by hypothyroidism and eventual recovery of thyroid function.&nbsp; Treatment is directed at symptom relief and includes beta blockers and nonsteroidal anti-inflammatory drugs.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute retroviral syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 84,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gonococcal pharyngitis",
                    "choiceNumber": 2,
                    "correctTaken": 14,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Graves disease",
                    "choiceNumber": 3,
                    "correctTaken": 191,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hashimoto thyroiditis",
                    "choiceNumber": 4,
                    "correctTaken": 127,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retropharyngeal abscess",
                    "choiceNumber": 5,
                    "correctTaken": 22,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subacute thyroiditis",
                    "choiceNumber": 6,
                    "correctTaken": 3744,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Suppurative thyroiditis",
                    "choiceNumber": 7,
                    "correctTaken": 851,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "348,371,true,-1,1*897,945,true,-1,1*1830,2063,true,-1,1*2608,2631,true,-1,1*2869,2993,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "488",
                    "mediaDataId": 0,
                    "title": "Thyroiditis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34913664",
                    "mediaDataId": 0,
                    "title": "Thyroiditis: evaluation and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34913664",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 58,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 5033,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 492,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 3483,
            "questionIndex": 3483,
            "questionText": "<p>A 30-year-old man comes to the office for a preventive medical evaluation.&nbsp; The patient has not seen a physician for many years and has no prior significant medical conditions.&nbsp; He has gained 4.5 kg (9.9 lb) over the past year despite exercising regularly and having a healthy diet.&nbsp; The patient does not smoke and has moderate alcohol intake.&nbsp; Blood pressure is 130/92 mm Hg and pulse is 60/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is normal.&nbsp; Fasting serum lipid results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Total cholesterol</td><td style=\"vertical-align:middle;\">280 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">HDL</td><td style=\"vertical-align:middle;\">40 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">LDL</td><td style=\"vertical-align:middle;\">180 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Triglycerides</td><td style=\"vertical-align:middle;\">300 mg/dL</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient&#39;s dyslipidemia?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T99527\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:9.0pt;\"><strong>Indications to test for hypothyroidism in asymptomatic patients</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical findings<br>&amp; history</strong></p></td><td><ul><li>Bradycardia, diastolic hypertension</li><li>Pleural/pericardial effusion</li><li>Autoimmune disease (eg, vitiligo, type 1 diabetes mellitus)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br>abnormalities</strong></p></td><td><ul><li>Hyperlipidemia</li><li>Hyponatremia</li><li>Macrocytic anemia</li><li>Hyperprolactinemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pituitary/hypothalamic<br>disorders</strong></p></td><td><ul><li>Sellar/parasellar mass</li><li>Pituitary surgery or radiation</li><li>Acute or chronic hypopituitarism</li></ul></td></tr></tbody></table></div><p>This young patient has <strong>dyslipidemia</strong> (eg, high triglycerides and LDL) despite maintaining a healthy weight and lifestyle.&nbsp; Given his associated constitutional symptoms (eg, weight gain), he should be tested for <strong>hypothyroidism</strong> with a <strong>serum TSH</strong> level.&nbsp; Hypothyroidism causes decreased LDL clearance largely due to decreased expression and activity of hepatic LDL receptors and is associated with <strong>elevated total cholesterol and LDL levels</strong> and increased risk for coronary artery disease.&nbsp; It also causes decreased activity of lipoprotein lipase, leading to <strong>hypertriglyceridemia</strong>.</p><p>In patients with hypothyroidism-associated dyslipidemia, treatment with <strong>levothyroxine</strong> often improves lipid levels and may obviate the need for specific lipid-lowering therapy, especially in young, low-risk patients.&nbsp; If not already checked, TSH levels should also be considered prior to the initiation of statin medications (eg, atorvastatin) because untreated hypothyroidism can increase the risk for <strong>statin myopathy (Choice A)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Anabolic steroid use is associated with elevated total cholesterol and LDL and decreased HDL.&nbsp; It is not associated with hypertriglyceridemia.</p><p><strong>(Choices D and E)</strong>&nbsp; Adding ezetimibe to a statin may lower the risk for cardiovascular events in patients with established atherosclerosis; benefits in primary prevention are less clear.&nbsp; Fibrates (eg, gemfibrozil) can reduce the risk for pancreatitis due to very high triglyceride levels (eg, &gt;1,000 mg/dL), but lifestyle interventions are preferred as initial therapy for mild hypertriglyceridemia.</p><p><strong>(Choice F)</strong>&nbsp; LDL receptor mutations are seen in some patients with familial hypercholesterolemia.&nbsp; This disorder is characterized by LDL levels of &gt;190 mg/dL, often with cutaneous xanthomas and a strong family history of premature atherosclerosis, findings not seen in this patient.</p><p><strong>Educational objective:</strong><br>Hypothyroidism can cause elevated levels of total cholesterol, LDL, and triglycerides and is associated with an increased risk for coronary atherosclerosis.&nbsp; Treatment with levothyroxine can improve lipid levels.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 12124,
            "topic": "Hypothyroidism",
            "titleId": 12124,
            "title": "Hypothyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Begin atorvastatin therapy",
                    "choiceNumber": 1,
                    "correctTaken": 1337,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inquire about anabolic steroid use",
                    "choiceNumber": 2,
                    "correctTaken": 651,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain thyroid function studies",
                    "choiceNumber": 3,
                    "correctTaken": 2222,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe ezetimibe therapy",
                    "choiceNumber": 4,
                    "correctTaken": 63,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start gemfibrozil therapy",
                    "choiceNumber": 5,
                    "correctTaken": 287,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Test for LDL receptor mutation",
                    "choiceNumber": 6,
                    "correctTaken": 466,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "158,186,true,-1,1*287,336,true,-1,1*370,456,true,-1,1*767,827,true,-1,1*956,1030,true,-1,1*1381,1449,true,-1,1*1573,1614,true,-1,1*1635,1754,true,-1,1*1801,1921,true,-1,1*2027,2261,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "213",
                    "mediaDataId": 0,
                    "title": "Management of dyslipidemias",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29472712",
                    "mediaDataId": 0,
                    "title": "Direct effects of thyroid hormones on hepatic lipid metabolism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29472712",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28342184",
                    "mediaDataId": 0,
                    "title": "The lipid-lowering effect of levothyroxine in patients with subclinical hypothyroidism: a systematic review and meta-analysis of randomized controlled trials.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28342184",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 53,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 5026,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 668,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 4124,
            "questionIndex": 4124,
            "questionText": "<p>A 24-year-old primigravida comes to the office for her first prenatal visit.&nbsp; Her last menstrual period was 8 weeks ago and 2 home pregnancy tests have been positive.&nbsp; The patient feels generally well, although she has experienced mild intermittent nausea and anxiety during the pregnancy.&nbsp; Medical history is unremarkable, and her only medication is an over-the-counter prenatal vitamin.&nbsp; Thyroid function tests were normal on evaluation for fatigue and mild palpitations 6 months ago.&nbsp; The patient stopped drinking alcohol after finding out she was pregnant, and she does not use tobacco or illicit drugs.&nbsp; Blood pressure is 120/80 mm Hg and pulse is 82/min.&nbsp; Physical examination findings are normal.&nbsp; Pelvic ultrasound shows a gestational sac containing a fetal pole and a yolk sac.&nbsp; Thyroid function study results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"5\" cellspacing=\"0\" width=\"450\"><tbody><tr><td></td><td><strong>Today</strong></td><td><strong>Six months ago</strong></td></tr><tr><td>TSH</td><td>0.3 &micro;U/mL</td><td>2.0 &micro;U/mL</td></tr><tr><td>Total thyroxine (T4)</td><td>15 &micro;g/dL</td><td>8 &micro;g/dL</td></tr><tr><td>Total triiodothyronine (T3)</td><td>220 ng/dL</td><td>130 ng/dL</td></tr></tbody></table></blockquote><p>Which of the following is the most likely cause of this patient&#39;s current laboratory findings?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t81698\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\" style=\"width:50.0%;\"><p align=\"center\"><strong>Maternal thyroid testing in pregnancy, 1st trimester</strong></p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Hormone</strong></p></td><td style=\"width:25.0%;\"><p align=\"center\"><strong>Change</strong></p></td><td style=\"width:50.0%;\"><p align=\"center\"><strong>Mechanism</strong></p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Total T4</strong></p></td><td style=\"width:25.0%;\"><p align=\"center\">Increased</p></td><td rowspan=\"2\" style=\"width:50.0%;\"><ul><li>&beta;-hCG stimulates thyroid hormone production in 1st trimester</li><li>Estrogen stimulates TBG; thyroid increases hormone production to maintain steady free T4 level</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Free T4</strong></p></td><td style=\"width:25.0%;\"><p align=\"center\">Unchanged or mildly increased</p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>TSH</strong></p></td><td style=\"width:25.0%;\"><p align=\"center\">Decreased</p></td><td style=\"width:50.0%;\"><ul><li>Increased &beta;-hCG &amp; thyroid hormone suppress TSH secretion</li></ul></td></tr><tr><td colspan=\"3\" style=\"width:50.0%;\"><p><strong>TBG</strong> = thyroxine-binding globulin.</p></td></tr></tbody></table></div></p><p>Thyroid hormone production increases during pregnancy to cope with metabolic demands.&nbsp; This is accomplished by 2 mechanisms:</p><ul><li><strong>Estrogen</strong> stimulates synthesis of <strong>thyroxine-binding globulin</strong> (TBG) and decreases TBG clearance, leading to an increased pool of bound thyroid hormone.&nbsp; Patients with normal thyroid reserve subsequently increase thyroid hormone production to maintain free hormone levels.</li><li><strong>hCG</strong> (which shares a common alpha subunit with TSH and a very similar beta subunit) directly stimulates <strong>TSH receptors</strong>.&nbsp; This results in increased hormone production with feedback suppression of pituitary TSH release.</li></ul><p>In patients with normal thyroid function, the net effect (as seen in this patient) can resemble subclinical hyperthyroidism with <strong>increased</strong> circulating <strong>total T3 and T4</strong>, <strong>normal</strong> (or mildly elevated) <strong>free T4</strong>, and <strong>suppressed TSH</strong>, although the patient remains clinically euthyroid.&nbsp; However, patients with impaired thyroid function (eg, chronic lymphocytic [Hashimoto] thyroiditis) cannot increase thyroid hormone production, resulting in a relative hypothyroid state <strong>(Choice C)</strong>.&nbsp; For this reason, patients with baseline hypothyroidism who become pregnant should have their replacement thyroxine dose increased.</p><p><strong>(Choice A)</strong>&nbsp; Euthyroid sick syndrome is an alteration in biochemical thyroid function tests in the setting of severe nonthyroid illness.&nbsp; Common findings include a low total and free T3 with a normal T4 and TSH.</p><p><strong>(Choice B)</strong>&nbsp; Graves disease causes an increase in total and free thyroid hormone levels.&nbsp; However, most patients will have additional manifestations, such as proptosis, diffuse goiter, hypertension, and tachycardia.</p><p><strong>(Choice D)</strong>&nbsp; Iodine requirements increase during pregnancy, and inadequate iodine intake can cause maternal and fetal hypothyroidism.&nbsp; Such patients would have an elevated TSH with decreased thyroid hormone levels.</p><p><strong>(Choice F)</strong>&nbsp; Subacute (granulomatous or De Quervain) thyroiditis can cause hyperthyroidism with a suppressed TSH.&nbsp; However, it most commonly follows an acute viral illness and is associated with a painful, tender goiter.</p><p><strong>Educational objective:</strong><br>Thyroid hormone production increases during pregnancy to cope with metabolic demands.&nbsp; Estrogen causes an increase in thyroxine-binding globulin, leading to increased total (but not free) thyroid hormone levels.&nbsp; hCG directly stimulates TSH receptors, causing increased production of thyroid hormones.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 8749,
            "topic": "Thyroid disorder in pregnancy",
            "titleId": 8749,
            "title": "Thyroid disorder in pregnancy",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Euthyroid sick syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 539,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Graves disease",
                    "choiceNumber": 2,
                    "correctTaken": 2056,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hashimoto disease",
                    "choiceNumber": 3,
                    "correctTaken": 462,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iodine deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 135,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal physiologic changes",
                    "choiceNumber": 5,
                    "correctTaken": 12005,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subacute thyroiditis",
                    "choiceNumber": 6,
                    "correctTaken": 1656,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "336,392,true,-1,1*941,1038,true,-1,1*1323,1644,true,-1,1*1782,1855,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "484",
                    "mediaDataId": 0,
                    "title": "Thyroid physiology and diagnostic testing",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21787128",
                    "mediaDataId": 0,
                    "title": "Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21787128",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24002560",
                    "mediaDataId": 0,
                    "title": "Thyroid disease in pregnancy: (Women&#39;s Health Series).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24002560",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25798985",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 148: thyroid disease in pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25798985",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 205,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16853,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1207,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 3721,
            "questionIndex": 3721,
            "questionText": "<p>A 1-month-old boy is brought to the clinic for a well-child check.&nbsp; He was born at home to a 24-year-old primigravid woman who consumed a well-balanced diet and took prenatal vitamins throughout the pregnancy.&nbsp; Family history is unremarkable.&nbsp; The patient is exclusively formula-fed but has a weak suck and rarely finishes the bottle.&nbsp; On examination, the patient has scleral icterus; jaundice of the face and chest; a large, protruding tongue; and a hoarse cry.&nbsp; His tone is normal, but his activity level has decreased.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Total bilirubin</td><td style=\"vertical-align:middle;\">8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Direct bilirubin</td><td style=\"vertical-align:middle;\">0.7 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">110 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">T4, serum</td><td style=\"vertical-align:middle;\">0.6 &micro;g/dL</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T48535\" style=\"overflow-x:auto;\" tid=\"3634\"><div align=\"center\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Congenital hypothyroidism</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Thyroid dysgenesis most common (eg, agenesis, hypoplasia, ectopy)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>manifestations</strong></p></td><td><ul><li>Asymptomatic at birth*</li><li>Symptomatic weeks to months after birth (as maternal T4 wanes)<ul style=\"list-style-type:circle;\"><li>Hypometabolism: &#8595; HR &amp; temperature, lethargy/poor feeding, hypotonia, constipation, jaundice</li><li>Mucopolysaccharide accumulation: macroglossia, umbilical hernia</li><li>Delayed bone maturation: enlarged fontanelles</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Newborn screening</li><li>&#8593; TSH &amp; &#8595; T4</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Levothyroxine</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prognosis</strong></p></td><td><ul><li>No deficits if treatment started in neonatal period</li><li>Untreated disease leads to intellectual disability, developmental delay &amp; poor growth</li></ul></td></tr><tr><td colspan=\"2\"><p>*Can rarely present with delayed passage of meconium.</p><p><strong>HR</strong> = heart rate.</p></td></tr></tbody></table></div></div><p>This 1-month-old infant has clinical features and laboratory studies&mdash;increased TSH and decreased T4&mdash;consistent with <strong>congenital hypothyroidism</strong>.&nbsp; The most common cause of this condition is <strong>thyroid dysgenesis</strong> (eg, agenesis, hypoplasia, ectopy).</p><p>During early gestation, the thyroid diverticulum forms in the primitive pharynx and descends to the anterior neck, remaining attached to the tongue by the thyroglossal duct.&nbsp; Any disruption in this process can cause thyroid dysgenesis, leading to <strong>impaired thyroid hormone synthesis</strong>.&nbsp; Most patients with congenital hypothyroidism&nbsp;are identified via newborn screening while asymptomatic;&nbsp;those who were not screened at birth (as may have occurred in this infant who was born at home)&nbsp;are diagnosed after developing <strong>symptoms</strong>, typically <strong>weeks to months</strong> after birth due to waning levels of maternally derived T4</p><p>Generalized <strong>hypometabolism</strong> leads to <strong>poor feeding</strong> and <strong>decreased activity</strong>, as well as <strong>prolonged jaundice</strong> (ie, age &gt;2 weeks), which is due to decreased gastrointestinal motility and diminished activity of hepatic enzymes involved in bilirubin metabolism.&nbsp; Other findings are due to mucopolysaccharide accumulation in soft tissues and include a&nbsp;<strong>large, protruding tongue</strong> and&nbsp;a&nbsp;<strong>hoarse voice</strong> (laryngeal involvement), as seen in this patient.</p><p><strong>(Choice A)</strong>&nbsp; Inborn errors of thyroid hormone (eg, thyroid peroxidase) production are uncommon causes of congenital hypothyroidism (&lt;15% of cases) and are usually associated with a goiter on examination, making this cause less likely than thyroid dysgenesis in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Maternal iodine deficiency can cause congenital hypothyroidism; however, this patient&#39;s mother consumed a well-balanced diet and took prenatal vitamins throughout the pregnancy.&nbsp; Furthermore, this patient is exclusively formula-fed, and all infant formulas contain iodine.</p><p><strong>(Choice C)</strong>&nbsp; Panhypopituitarism causes hypothyroidism due to decreased pituitary production of TSH, in contrast to this patient&#39;s increased TSH.&nbsp; Moreover, patients often have midline defects (eg, cleft lip/palate) and/or evidence of other pituitary hormone deficiencies (eg, micropenis due to gonadotropin deficiency), a finding not seen in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Maternal Graves disease can lead to transplacental transfer of TSH receptor&ndash;stimulating antibodies causing congenital hyperthyroidism (neonatal Graves disease).&nbsp; Unlike the symptoms in this patient, symptoms include hyperphagia and hyperactivity (eg, restlessness), and laboratory evaluation would show decreased TSH and increased T4.</p><p><strong>Educational objective:</strong><br>Thyroid dysgenesis is the most common cause of congenital hypothyroidism (elevated TSH, low T4).&nbsp; Patients become symptomatic weeks to months after birth with signs of hypometabolism (eg, prolonged jaundice, poor feeding) and mucopolysaccharide accumulation (eg, macroglossia, hoarse cry).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 12124,
            "topic": "Hypothyroidism",
            "titleId": 12124,
            "title": "Hypothyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Defective thyroid peroxidase activity",
                    "choiceNumber": 1,
                    "correctTaken": 597,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iodine deficiency (endemic goiter)",
                    "choiceNumber": 2,
                    "correctTaken": 218,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panhypopituitarism",
                    "choiceNumber": 3,
                    "correctTaken": 64,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid dysgenesis",
                    "choiceNumber": 4,
                    "correctTaken": 3839,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transplacental TSH receptor&ndash;stimulating antibody",
                    "choiceNumber": 5,
                    "correctTaken": 297,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "226,246,true,-1,1*333,340,true,-1,1*388,404,true,-1,1*405,450,true,-1,1*977,1260,true,-1,1*1667,1707,true,-1,1*1969,1991,true,-1,1*2031,2099,true,-1,1*2173,2204,true,-1,1*2589,2608,true,-1,1*2731,2895,true,-1,1*3144,3208,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "467",
                    "mediaDataId": 0,
                    "title": "Congenital hypothyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32644339",
                    "mediaDataId": 0,
                    "title": "Congenital hypothyroidism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32644339",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 88,
            "othersAvgTimeSpent": 91,
            "notes": null,
            "peopleTaken": 5015,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 77,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2265,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 3976,
            "questionIndex": 3976,
            "questionText": "<p>A 46-year-old man undergoes an elective inguinal hernia repair.&nbsp; After induction of general anesthesia, he is noted to be pale and tachycardic.&nbsp; The patient&#39;s medical history is significant for frequent headaches, hypertension, and an anxiety disorder.&nbsp; His outpatient medications include lisinopril, alprazolam, and as-needed naproxen.&nbsp; The patient regularly drinks a 6-pack of beer on weekends but does not use tobacco or illicit drugs.&nbsp; Family history is unremarkable.&nbsp; His temperature is 36.9 C (98.4 F), blood pressure is now 250/140 mm Hg (it was 144/90 mm Hg before induction), and pulse is 125/min.&nbsp; ECG shows sinus tachycardia with no ischemic changes.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>In light of this patient&#39;s history of hypertension and frequent headaches, his presentation with severe hypertension, pallor, and sinus tachycardia is concerning for an occult <strong>pheochromocytoma</strong> with a <strong>catecholamine surge</strong> due to anesthesia.&nbsp; Pheochromocytomas and paraganglionomas are catecholamine-producing tumors arising from chromaffin cells of the adrenal medulla or extra-adrenal paraganglia, respectively.</p><p>Hypertension in pheochromocytoma can be intermittent or sustained.&nbsp; <strong>Paroxysms</strong> of severe <strong>hypertension</strong> can be precipitated by increases in intra-abdominal pressure (eg, tumor palpation, positional changes), surgical procedures, and a number of medications, particularly <strong>anesthetic</strong> agents.&nbsp; In addition, nonselective <strong>beta blockers</strong> can cause a state of unopposed alpha adrenergic stimulation leading to vasoconstriction and paradoxical hypertension.&nbsp; For this reason, alpha adrenergic blockers (eg, phenoxybenzamine) should be administered prior to beta blockers in patients with pheochromocytoma.</p><p><strong>(Choices A, C, and F)</strong>&nbsp; Alcohol withdrawal and panic disorder can mimic pheochromocytoma paroxysms but are unlikely to manifest when the patient is under anesthesia.&nbsp; Thyroid storm can be precipitated by surgery in patients with preexisting thyrotoxicosis, but the presentation is usually less acute, and almost all patients will have pyrexia.&nbsp; Severely elevated blood pressure and pallor (from catecholamine-induced vasoconstriction) are more likely due to catecholamine surge from pheochromocytoma.</p><p><strong>(Choice B)</strong>&nbsp; Anaphylaxis is a severe type 1 hypersensitivity reaction to a drug, environmental agent, or food.&nbsp; Anaphylaxis typically causes hives, angioedema, respiratory compromise, and acute hypotension rather than hypertension.</p><p><strong>(Choice E)</strong>&nbsp; Serotonin syndrome is characterized by abnormal mental status, autonomic hyperactivity, and muscular rigidity with hyperreflexia.&nbsp; It is typically triggered by initiation or titration of selective serotonin reuptake inhibitors.</p><p><strong>Educational objective:</strong><br>Pheochromocytomas are catecholamine-producing tumors arising from chromaffin cells of the adrenal medulla.&nbsp; Paroxysms of severe hypertension in patients with pheochromocytoma can be precipitated by surgical procedures, induction of anesthesia, and a number of medications.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 8195,
            "topic": "Pheochromocytoma",
            "titleId": 8195,
            "title": "Pheochromocytoma",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "4",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol withdrawal",
                    "choiceNumber": 1,
                    "correctTaken": 1908,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anaphylaxis",
                    "choiceNumber": 2,
                    "correctTaken": 1960,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder",
                    "choiceNumber": 3,
                    "correctTaken": 882,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pheochromocytoma",
                    "choiceNumber": 4,
                    "correctTaken": 19645,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serotonin syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 3829,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid storm",
                    "choiceNumber": 6,
                    "correctTaken": 7523,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "267,440,true,-1,1*548,1034,true,-1,1*1201,1214,true,-1,1*1416,1469,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "508",
                    "mediaDataId": 0,
                    "title": "Pheochromocytoma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24893135",
                    "mediaDataId": 0,
                    "title": "Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24893135",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 141,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 35747,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 609,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 3878,
            "questionIndex": 3878,
            "questionText": "<p>A 45-year-old woman comes to the office due to progressive fatigue, myalgias, and muscle weakness in both lower extremities for the past month.&nbsp; She has slight difficulty getting up from a chair, and has weakness and cramping in the legs after walking a short distance.&nbsp; The patient&#39;s other medical problems include hypertension, which is treated with lisinopril.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 140/80 mm Hg, pulse is 64/min, and respirations are 14/min.&nbsp; Examination shows mildly decreased strength in the proximal muscles of the lower extremities with sluggish ankle jerks bilaterally.&nbsp; Laboratory tests show a normal erythrocyte sedimentation rate and an elevated serum creatine kinase level.&nbsp; Serum sodium, glucose, potassium, and creatinine are normal.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31134\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Common causes of myopathy </strong></p></td></tr><tr><td><p align=\"center\"><strong>Connective tissue diseases </strong></p></td><td><ul><li>Polymyositis/dermatomyositis</li><li>Inclusion body myositis</li><li>Vasculitis</li><li>Overlap syndrome (mixed connective tissue disease)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Endocrine/</strong></p><p align=\"center\"><strong>metabolic </strong></p></td><td><ul><li>Hypothyroidism, thyrotoxicosis</li><li>Cushing syndrome</li><li>Electrolytes (&#8595; potassium, calcium, phosphorus)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Drugs/toxins </strong></p></td><td><ul><li>Corticosteroids, statins</li><li>Zidovudine, colchicine</li><li>Alcohol, cocaine, heroin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Miscellaneous </strong></p></td><td><ul><li>Infections, trauma, hyperthermia</li></ul></td></tr></tbody></table></div><p>This patient has <strong>myalgias</strong> and proximal muscle <strong>weakness</strong> with an elevated serum creatine kinase (CK) level.&nbsp; In a relatively young, otherwise healthy woman with fatigue and delayed deep tendon reflexes, this presentation is most consistent with <strong>hypothyroid myopathy</strong>.&nbsp; Myopathy occurs in over one third of patients with hypothyroidism, and can range from an asymptomatic elevation in CK to myalgias, muscle hypertrophy, proximal myopathy, and rhabdomyolysis.&nbsp; Serum CK can be elevated for years before a patient develops clinical symptoms of hypothyroidism, and there is no clear correlation between the degree of CK elevation and severity of muscle disease.&nbsp; Inflammatory markers (eg, erythrocyte sedimentation rate, C-reactive protein) may be normal or mildly elevated.</p><p>Initial testing should include <strong>TSH and free T4</strong>.&nbsp; If thyroid studies are normal, additional testing, including serologic markers (eg, antinuclear antibodies, anti-Jo-1 antibodies) and muscle biopsy, may be needed to rule out other causes of myositis <strong>(Choice A)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Myopathy with elevated CK concentration usually is not a manifestation of lisinopril toxicity.&nbsp; The most common drugs associated with myopathy are corticosteroids, statins, and colchicine.</p><p><strong>(Choice C)</strong>&nbsp; Electromyogram in patients with hypothyroid myopathy can be normal or show nonspecific changes.&nbsp; It is more helpful in evaluating patients with polymyositis and can be considered if thyroid studies are normal.</p><p><strong>(Choice D)</strong>&nbsp; Polymyositis is characterized by symmetric proximal muscle weakness.&nbsp; Sedimentation rate and CK are elevated in approximately half of patients, and the diagnosis can be confirmed with muscle biopsy.&nbsp; However, myalgias are typically absent or mild and deep tendon reflexes are normal.</p><p><strong>Educational objective:</strong><br>Hypothyroid myopathy is characterized by myalgias, proximal muscle weakness, and an elevated serum creatine kinase level.&nbsp; Patients often have additional features of hypothyroidism (eg, fatigue, delayed reflexes).&nbsp; Initial diagnostic testing includes TSH and free T4 levels.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 12124,
            "topic": "Hypothyroidism",
            "titleId": 12124,
            "title": "Hypothyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibody test",
                    "choiceNumber": 1,
                    "correctTaken": 2232,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinuation of lisinopril",
                    "choiceNumber": 2,
                    "correctTaken": 948,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Electromyogram",
                    "choiceNumber": 3,
                    "correctTaken": 3322,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Muscle biopsy",
                    "choiceNumber": 4,
                    "correctTaken": 6183,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum TSH and free T4 tests",
                    "choiceNumber": 5,
                    "correctTaken": 8021,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "114,198,true,-1,1*284,316,true,-1,1*357,368,true,-1,1*388,404,true,-1,1*440,452,true,-1,1*1269,1471,true,-1,1*1987,2028,true,-1,1*2127,2200,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 37,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 20706,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 39,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 720,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 4382,
            "questionIndex": 4382,
            "questionText": "<p>A 44-year-old woman comes to the office due to fatigue for the last several months.&nbsp; She becomes tired easily after walking short distances.&nbsp; She also has difficulty combing her hair due to problems holding her hands over her head for long periods.&nbsp; The patient reports an unintentional weight loss of 3.6 kg (7.9 lb) over the last 2 months despite no loss of appetite.&nbsp; The patient does not use tobacco or alcohol.&nbsp; Medical history is notable for hyperlipidemia, for which she takes pravastatin.&nbsp; Her father died of a stroke at age 54, and her mother has diabetes mellitus.&nbsp; Vital signs are normal except for a pulse of 115/min.&nbsp; Cardiac examination shows regular tachycardia with no murmur.&nbsp; The lungs are clear to auscultation.&nbsp; The patient&#39;s gait is normal, but she awkwardly drops into the chair when asked to slowly sit.&nbsp; There is no muscle tenderness to palpation.&nbsp; Deep tendon reflexes are brisk and symmetric.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t97320\"><table class=\"table-default-style table-header-footer-style\" style=\"width:630px\"><tbody><tr><td colspan=\"6\"><p align=\"center\"><strong>Differential diagnosis of myopathy</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Weakness</strong></p></td><td><p align=\"center\"><strong>Pain &amp;<br />tenderness</strong></p></td><td><p align=\"center\"><strong>ESR</strong></p></td><td><p align=\"center\"><strong>Creatine<br />kinase</strong></p></td><td><p align=\"center\"><strong>Other features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Glucocorticoid-<br />induced myopathy</strong></p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">No</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">Normal</p></td><td><ul><li>Prominent atrophy</li><li>Lower extremities most affected</li></ul></td></tr><tr><td><p align=\"center\"><strong>Polymyositis &amp;<br />dermatomyositis</strong></p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Less&nbsp;common</p></td><td><p align=\"center\">Normal or&nbsp;&uarr;</p></td><td><p align=\"center\">&uarr;</p></td><td><ul><li>Multisystem involvement (arthritis, rash, ILD)</li><li>&uarr; Malignancy risk</li></ul></td></tr><tr><td><p align=\"center\"><strong>Statin-induced<br />myopathy</strong></p></td><td><p align=\"center\">Variable</p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">Normal or&nbsp;&uarr;</p></td><td><ul><li>Additive risk with fibrates</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hypothyroid<br />myopathy</strong></p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">&uarr;</p></td><td><ul><li>Delayed DTRs; myoedema</li><li>Hypothyroid symptoms &amp; abnormal thyroid test results</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hyperthyroid<br />myopathy</strong></p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Uncommon</p></td><td><p align=\"center\">Variable</p></td><td><p align=\"center\">Normal or&nbsp;&uarr;</p></td><td><ul><li>Brisk DTRs</li><li>&uarr;&nbsp;T4, &darr;&nbsp;TSH</li></ul></td></tr><tr><td colspan=\"6\"><p><strong>DTRs</strong>&nbsp;=&nbsp;deep tendon reflexes; <strong>ESR</strong>&nbsp;=&nbsp;erythrocyte sedimentation rate;&nbsp;<strong>ILD</strong>&nbsp;=&nbsp;interstitial lung disease.</p></td></tr></tbody></table></div><p>This patient has proximal muscle weakness (eg, difficulty working with arms overhead, difficulty getting into or out of a chair) consistent with myopathy, which can be due to multiple causes (eg, drugs, endocrine, autoimmune).&nbsp;&nbsp;Given this the&nbsp;multiple findings consistent with hyperthyroidism (ie, tachycardia, weight loss, brisk reflexes), she most likely has <strong>hyperthyroid (thyrotoxic) myopathy</strong>.</p><p>Myopathy can occur in both hyperthyroidism and hypothyroidism, likely due to changes in cellular metabolism and catabolism.&nbsp; Hyperthyroid myopathy can have acute or chronic presentations:</p><ul><li>Chronic: slowly progressive <strong>proximal muscle weakness</strong>; involvement of distal extremity and bulbar and respiratory muscles is uncommon.</li><li>Acute: severe proximal and distal weakness; rhabdomyolysis can occur.</li></ul><p>In hyperthyroid myopathy, myalgias are uncommon and muscle atrophy is rare.&nbsp; In contrast, hypothyroid myopathy typically causes pronounced muscle tenderness and myalgias; muscle swelling and edema may also be present.</p><p>The diagnosis of hyperthyroid myopathy is based primarily on clinical findings and thyroid function tests (ie, <strong>elevated thyroxine, suppressed TSH</strong>).&nbsp; Creatine kinase levels are usually normal.&nbsp; Symptoms generally resolve with treatment of the underlying thyroid condition.</p><p><strong>(Choice A)</strong>&nbsp; Myopathy due to statins (eg, pravastatin) can cause proximal muscle weakness.&nbsp; However, muscle pain and tenderness are often present, and this patient&#39;s tachycardia and brisk reflexes are more consistent with hyperthyroidism.</p><p><strong>(Choice B)</strong>&nbsp; Polymyositis, a rare inflammatory myopathy, can cause symmetric proximal muscle weakness.&nbsp; However, this patient&#39;s weight loss, tachycardia, and brisk reflexes are not typical and make thyroid myopathy more likely.</p><p><strong>(Choice C)</strong>&nbsp; Myasthenia gravis is caused by autoantibodies to acetylcholine receptors on the postsynaptic membrane of the neuromuscular junction and presents with fatigable weakness (ie, weakness increases with repeated stimulation).&nbsp; Lambert-Eaton syndrome is due to autoantibodies against calcium channels on the presynaptic membrane and causes weakness that improves with repeated stimulation.&nbsp; Neither is associated with tachycardia or brisk reflexes.</p><p><strong>(Choice D)</strong>&nbsp; Although polyneuropathy can occur in thyrotoxicosis, it typically manifests with distal muscle weakness accompanied by sensory symptoms and decreased reflexes.&nbsp; This patient&#39;s proximal weakness and brisk reflexes are more consistent with hyperthyroid myopathy.</p><p><strong>(Choice F)</strong>&nbsp; Upper motor neuron disease (eg, primary lateral sclerosis) typically causes slowness, stiffness, and clumsiness of movement, often with spasticity and hyperreflexia.&nbsp; Although this patient has brisk reflexes, her tachycardia and weight loss are not typical.</p><p><strong>Educational objective:</strong><br>Chronic hyperthyroid myopathy is characterized by proximal muscle weakness associated with clinical features of hyperthyroidism.&nbsp; The diagnosis is based primarily on clinical findings and thyroid function tests.&nbsp; Symptoms resolve with treatment of the underlying thyroid condition.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Drug reaction",
                    "choiceNumber": 1,
                    "correctTaken": 218,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inflammatory muscle disease",
                    "choiceNumber": 2,
                    "correctTaken": 604,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neuromuscular junction disorder",
                    "choiceNumber": 3,
                    "correctTaken": 3565,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polyneuropathy",
                    "choiceNumber": 4,
                    "correctTaken": 2177,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid disease",
                    "choiceNumber": 5,
                    "correctTaken": 6263,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Upper motor neuron disease",
                    "choiceNumber": 6,
                    "correctTaken": 392,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "200,231,true,-1,1*340,357,true,-1,1*1461,1498,true,-1,1*1524,1741,true,-1,1*2945,3104,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 60,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 13219,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 794,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 13707,
            "questionIndex": 15097,
            "questionText": "<p>A 51-year-old woman comes to the office for a follow-up.&nbsp; The patient has hypertension treated with lisinopril, hydrochlorothiazide, and amlodipine.&nbsp; She also takes paroxetine for hot flashes ever since her menopause at age 50 and says she continues to experience occasional episodes of &#x22;hot flashes and anxiety.&#x22;&nbsp; The patient has been monitoring her blood pressure at home and brings a report with highly variable blood pressure readings.&nbsp; She reports no weight changes, fatigue, chest pain, myalgias, or polyuria.&nbsp; She has been taking her medications as prescribed.&nbsp; The patient does not smoke cigarettes or drink alcohol.&nbsp; Her father died at age 65 from hemorrhagic stroke.&nbsp; Blood pressure is 170/100 in the right arm and 166/94 in the left arm, and pulse is 88/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is normal.&nbsp; Complete blood count, serum electrolytes, glucose, creatinine, and TSH level are within normal limits.&nbsp; What is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t56582\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pheochromocytoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Indications for testing</strong></p></td><td><ul><li>Classic triad: episodic headache, sweating &amp; tachycardia</li><li>Resistant HTN or HTN accompanied by unexplained &uarr; glucose</li><li>Family history or familial syndrome (eg, MEN2, NF1, VHL)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic approach</strong></p></td><td><ul><li>Urine or plasma metanephrine levels</li><li>Confirmatory abdominal imaging for &uarr; metanephrines</li></ul></td></tr><tr><td><p align=\"center\"><strong>Notable features</strong></p></td><td><ul><li>10% bilateral, 10% extraadrenal, 10% malignant</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Preoperative alpha blockade prior to beta blockade</li><li>Laparoscopic or open surgical resection</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HTN</strong> = hypertension; <strong>MEN2</strong> = multiple endocrine neoplasia type 2; <strong>NF1</strong> = neurofibromatosis type 1; <strong>VHL</strong> = von Hippel-Lindau syndrome.</p></td></tr></tbody></table></div><p>This patient has <strong>resistant hypertension</strong>, which is defined as hypertension that persists despite treatment with antihypertensive agents from 3 different classes, one being a diuretic.&nbsp; Resistant hypertension should raise suspicion for a <strong>secondary cause</strong>.</p><p>Although rare, <strong>pheochromocytoma</strong> is a potential cause of secondary hypertension that should be considered.&nbsp; Pheochromocytomas release an excess of <strong>catecholamines</strong> (ie, dopamine, epinephrine, norepinephrine) into the bloodstream, resulting in characteristic clinical manifestations.&nbsp; <strong>Paroxysmal hypertension</strong> (eg, highly variable blood pressure readings) is present in about half of patients and a clue to diagnosis in this patient.&nbsp; Her accompanying episodes of <strong>anxiety</strong> and &#x22;hot flashes&#x22; (eg, <strong>sweating</strong>) despite paroxetine therapy could also be manifestations of pheochromocytoma.&nbsp; The classic symptomatic triad, consisting of episodic headache, sweating, and tachycardia, is present in less than half of patients.</p><p>The initial evaluation for pheochromocytoma involves the measurement of <strong>urine or plasma metanephrines</strong>, which are breakdown products of epinephrine and norepinephrine.&nbsp; Elevated metanephrine levels have high sensitivity for pheochromocytoma; therefore, normal levels usually rule out the disease.&nbsp; The specificity of elevated metanephrine levels is poor, however.&nbsp; Therefore, elevated levels warrant additional testing in the form of abdominal CT scan or MRI and/or positron emission tomography to confirm the presence and location of a pheochromocytoma.</p><p><strong>(Choice A)</strong>&nbsp; Many psychoactive agents, including tricyclic antidepressants and antipsychotics, can increase serum catecholamine levels and, when appropriate, should be tapered and discontinued prior to testing.&nbsp; However, selective serotonin reuptake inhibitors (eg, paroxetine) do not affect testing.</p><p><strong>(Choice B)</strong>&nbsp; Due to their addictive potential, benzodiazepines should generally be avoided in the treatment of anxiety.&nbsp; In addition, an underlying cause of this patient&#39;s intermittent anxiety should be ruled out.</p><p><strong>(Choice C)</strong>&nbsp; 24-hour urinary free cortisol is used to test for Cushing disease, which can cause secondary hypertension.&nbsp; However, the hypertension is typically constant rather than sporadic and is often accompanied by weight gain and characteristic physical features (ie, central obesity, purple abdominal striae).</p><p><strong>(Choice E)</strong>&nbsp; Renal duplex imaging allows for evaluation for renal artery stenosis (RAS), which is a potential cause of secondary hypertension.&nbsp; However,&nbsp;pheochromocytoma is a better explanation of this patient&#39;s labile&nbsp;blood pressure readings and episodes of anxiety and sweating.&nbsp; Labile blood pressure is not common with RAS.</p><p><strong>(Choice F)</strong>&nbsp; Obstructive sleep apnea is a common cause of secondary hypertension, but it is unlikely in this patient with normal BMI.</p><p><strong>Educational objective:</strong><br>Pheochromocytoma should be suspected in patients with resistant hypertension, especially in the presence of other suggestive features (eg, episodic anxiety, headaches, sweating, tachycardia).&nbsp; Measurement of urine or plasma metanephrine levels is the initial step in evaluation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 8195,
            "topic": "Pheochromocytoma",
            "titleId": 8195,
            "title": "Pheochromocytoma",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discontinue paroxetine",
                    "choiceNumber": 1,
                    "correctTaken": 2304,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate benzodiazepine therapy",
                    "choiceNumber": 2,
                    "correctTaken": 95,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain 24-hour urinary free cortisol level",
                    "choiceNumber": 3,
                    "correctTaken": 1143,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain plasma metanephrines",
                    "choiceNumber": 4,
                    "correctTaken": 11193,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain renal duplex imaging",
                    "choiceNumber": 5,
                    "correctTaken": 5154,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain sleep study",
                    "choiceNumber": 6,
                    "correctTaken": 232,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "144,185,true,-1,1*225,242,true,-1,1*299,349,true,-1,1*367,413,true,-1,1*437,475,true,-1,1*757,828,true,-1,1*1481,1568,true,-1,1*1985,2163,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "508",
                    "mediaDataId": 0,
                    "title": "Pheochromocytoma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "6453259",
                    "mediaDataId": 0,
                    "title": "Prevalence of clinically unsuspected pheochromocytoma.  Review of a 50-year autopsy series.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/6453259",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 76,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 20121,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 465,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 3498,
            "questionIndex": 3498,
            "questionText": "<p>A 33-year-old woman comes to the office for follow-up of a thyroid nodule that was discovered incidentally on a routine physical examination 3 weeks ago.&nbsp; The patient feels well and has experienced no weight changes, temperature intolerance, or menstrual irregularities.&nbsp; Medical history is notable for primary hypothyroidism treated with levothyroxine.&nbsp; Family history is notable for hypertension and hypothyroidism in her mother, but the patient has no relatives with a history of thyroid cancer.&nbsp; TSH is normal.&nbsp; Neck ultrasound reveals a 2.0-cm hypoechoic nodule in the right lobe of her thyroid without any enlarged lymph nodes.&nbsp; Fine-needle aspiration biopsy reveals large cells with ground glass cytoplasm, and pale nuclei containing inclusion bodies and central grooving consistent with papillary thyroid cancer.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Surgical resection</strong> is the primary treatment for <strong>papillary thyroid cancer</strong>.&nbsp; The extent of surgery depends on the tumor size, extrathyroidal invasion, patient age, and lymph node involvement.&nbsp; Small tumors (&lt;1-2 cm) without evidence of lymph node involvement or contralateral thyroid abnormalities can usually be managed with partial thyroidectomy/lobectomy, whereas larger tumors usually warrant total thyroidectomy.&nbsp; In addition, regional lymph node or central compartment lymph node dissection is usually performed for papillary cancer with lymph node metastasis or extrathyroidal invasion.</p><p>Following surgery, adjuvant therapy with <strong>radioiodine</strong> ablation is warranted for patients with increased risk of tumor recurrence (eg, large tumors, extrathyroidal invasion, lymph node metastasis, incomplete resection) <strong>(Choice D)</strong>.&nbsp; TSH can stimulate growth of occult residual or metastatic disease.&nbsp; For this reason, patients at increased risk of recurrence should also receive adequate doses of <strong>thyroid replacement</strong> to <strong>suppress TSH</strong> secretion.</p><p><strong>(Choice A)</strong>&nbsp; Thyroid peroxidase (TPO) antibodies are a marker for chronic lymphocytic (Hashimoto) thyroiditis.&nbsp; TPO antibodies are useful in the initial evaluation of hypothyroidism and diffuse goiter but have no utility in evaluation of papillary thyroid cancer.</p><p><strong>(Choice B)</strong>&nbsp; Mutations of several genes (eg, BRAF, RET) are common in papillary thyroid cancer.&nbsp; Genetic mutation profiling may be performed when the cytology results from fine-needle aspiration biopsy are indeterminate but are not needed if cytology confirms papillary cancer.</p><p><strong>(Choice C)</strong>&nbsp; Calcitonin is a marker for medullary thyroid cancer, which arises from the parafollicular C cells of the thyroid gland.&nbsp; Papillary and follicular cancers arise from thyroid epithelial cells.</p><p><strong>(Choice F)</strong>&nbsp; Thyroid scintigraphy is performed in the initial evaluation of thyroid nodules in patients with subnormal TSH levels.&nbsp; A hyperfunctioning (&#x22;hot&#x22;) nodule with increased uptake of the radiomarker is less likely to be malignant than a hypofunctioning (&#x22;cold&#x22;) nodule.</p><p><strong>Educational objective:</strong><br>Surgical resection is the primary treatment modality for papillary thyroid carcinoma.&nbsp; Postoperative adjuvant therapies for patients at increased risk of recurrence include radioiodine ablation and suppressive doses of thyroid hormone.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 8742,
            "topic": "Thyroid cancer",
            "titleId": 8742,
            "title": "Thyroid cancer",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antithyroid peroxidase antibody assay",
                    "choiceNumber": 1,
                    "correctTaken": 62,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Genetic mutation analysis in fine-needle aspiration biopsy sample",
                    "choiceNumber": 2,
                    "correctTaken": 455,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measurement of serum calcitonin",
                    "choiceNumber": 3,
                    "correctTaken": 458,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Radioactive iodine ablation",
                    "choiceNumber": 4,
                    "correctTaken": 1205,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Surgical resection",
                    "choiceNumber": 5,
                    "correctTaken": 13811,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid scintigraphy",
                    "choiceNumber": 6,
                    "correctTaken": 720,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "220,445,true,-1,1*850,1062,true,-1,1*1174,1263,true,-1,1*1338,1421,true,-1,1*1818,1935,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "489",
                    "mediaDataId": 0,
                    "title": "Thyroid malignancies",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26462967",
                    "mediaDataId": 0,
                    "title": "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:  the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26462967",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 74,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 16711,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 510,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 2630,
            "questionIndex": 2630,
            "questionText": "<p>A 31-year-old woman comes to the office after 3 months of continuous burning upper abdominal pain that is only partially relieved by over-the-counter famotidine or antacids.&nbsp; She also has experienced recent-onset constipation and excess urination.&nbsp; The patient reports no weight loss or decreased appetite.&nbsp; Her menstrual periods are regular.&nbsp; The patient&#39;s father has a history of &#x22;many stomach ulcers and multiple kidney stones.&#x22;&nbsp; Her temperature is 37.1 C (98.8 F), blood pressure is 130/85 mm Hg, pulse is 78/min, and respirations are 14/min.&nbsp; Abdominal examination shows normal bowel sounds, tenderness in the epigastric region, and no palpable masses.&nbsp; Her stools are positive for occult blood.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"300\"><tbody><tr><td>Sodium</td><td>137 mEq/L</td></tr><tr><td>Potassium</td><td>4.2 mEq/L</td></tr><tr><td>Chloride</td><td>104 mEq/L</td></tr><tr><td>Bicarbonate</td><td>24 mEq/L</td></tr><tr><td>Calcium</td><td>11.4 mg/dL</td></tr><tr><td>Phosphorus</td><td>2.9 mg/dL</td></tr><tr><td>Blood urea nitrogen</td><td>21 mg/dL</td></tr><tr><td>Creatinine</td><td>1.0 mg/dL</td></tr></tbody></table></blockquote><p>Additional evaluation is most likely to reveal which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32261\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\" style=\"width:65.0%;\"><p align=\"center\"><strong>Multiple endocrine neoplasia syndrome type 1</strong></p></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Manifestation</strong></p></td><td style=\"width:65.0%;\"><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Pituitary adenomas<br />(10%-20%)</strong></p></td><td style=\"width:65.0%;\"><ul><li>Secretion of prolactin, growth hormone, ACTH (or nonfunctioning tumors)</li><li>Mass effects (eg, headache, visual field defects)</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Primary hyperparathyroidism<br />(&gt;90%)</strong></p></td><td style=\"width:65.0%;\"><ul><li>Multiple parathyroid adenomas or parathyroid hyperplasia</li><li>Hypercalcemia (eg, polyuria, kidney stones, decreased bone density)</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Pancreatic/gastrointestinal neuroendocrine tumors<br />(60%-70%)</strong></p></td><td style=\"width:65.0%;\"><ul><li>Gastrinoma: recurrent peptic ulcers</li><li>Insulinoma: hypoglycemia</li><li>VIPoma: secretory diarrhea, hypokalemia, hypochlorhydria</li><li>Glucagonoma: weight loss, necrolytic migratory erythema, hyperglycemia</li></ul></td></tr></tbody></table></div><p>This patient most likely has <strong>type 1 multiple endocrine neoplasia syndrome (MEN1)</strong>, an autosomal dominant condition characterized by 3 primary tumor types (&#x22;the 3 Ps&#x22;):</p><ul><li><p><strong>Parathyroid</strong> adenomas/hyperplasia.&nbsp; Constipation, polyuria, and possibly abdominal pain in the setting of a calcium level of 11.4 mg/dL suggest <strong>symptomatic hypercalcemia</strong>, likely from <strong>primary hyperparathyroidism (PHPT)</strong>.&nbsp; Phosphorus may be low or low-normal.&nbsp; PHPT is present in &gt;90% of patients with MEN1, usually occurs by age 40, and results from multiglandular parathyroid adenomas or parathyroid hyperplasia.</p></li><li><p>Gastrointestinal/<strong>pancreatic</strong> endocrine tumors (eg, gastrinomas).&nbsp; Burning upper abdominal pain that is only partially responsive to famotidine and antacids and associated with occult gastrointestinal bleeding is concerning for <strong>Zollinger-Ellison syndrome</strong>, characterized by severe and refractory peptic ulcer disease due to gastrin-producing tumors (<strong>gastrinomas</strong>).</p></li><li><p><strong>Pituitary</strong> adenomas.</p></li></ul><p>The patient&#39;s father probably also had MEN1 given his history of kidney stones (likely due to hypercalcemia) and recurrent peptic ulcers.</p><p><strong>(Choice A)</strong>&nbsp; Primary adrenal insufficiency presents with fatigue and weight loss.&nbsp; Typical clinical findings include hypotension, hyperpigmentation, and hyperkalemia.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"1302\">Glucagonoma</a> is a less common tumor in MEN1 and is characterized by hyperglycemia, necrolytic migratory erythema, weight loss, and anemia.</p><p><strong>(Choice C)</strong>&nbsp; Medullary thyroid cancer is a component of MEN2 and typically presents as a thyroid nodule.</p><p><strong>(Choice D)</strong>&nbsp; Gastric cancer can cause abdominal pain with gastrointestinal ulceration and bleeding.&nbsp; However, it is commonly associated with weight loss, early satiety, and dysphagia; would be rare at this patient&#39;s age; and is less likely to explain hypercalcemia.</p><p><strong>(Choice E)</strong>&nbsp; Milk-alkali syndrome is characterized by hypercalcemia, renal insufficiency, and metabolic alkalosis.&nbsp; This patient has a normal serum creatinine and bicarbonate.</p><p><strong>(Choice G)</strong>&nbsp; Sarcoidosis causes hypercalcemia due to increased conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D.&nbsp; However, whereas pulmonary symptoms are common, gastrointestinal manifestations (eg, epigastric pain) are rare.&nbsp; Sarcoidosis also would not explain this patient&#39;s family history of recurrent kidney stones and peptic ulcers.</p><p><strong>(Choice H)</strong>&nbsp; A toxic thyroid adenoma could cause hypercalcemia due to increased bone turnover.&nbsp; However, this patient has no other manifestations of thyrotoxicosis (eg, weight loss, tachycardia).</p><p><strong>Educational objective:</strong><br>Type 1 multiple endocrine neoplasia is characterized by primary hyperparathyroidism, pituitary tumors, and gastrointestinal/pancreatic endocrine tumors (eg, gastrinomas).&nbsp; Common complications include symptomatic hypercalcemia and recurrent peptic ulcers.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23524,
            "topic": "Multiple endocrine neoplasia",
            "titleId": 23524,
            "title": "Multiple endocrine neoplasia",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adrenal insufficiency",
                    "choiceNumber": 1,
                    "correctTaken": 115,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucagonoma",
                    "choiceNumber": 2,
                    "correctTaken": 813,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medullary thyroid cancer",
                    "choiceNumber": 3,
                    "correctTaken": 1562,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Metastatic gastric carcinoma",
                    "choiceNumber": 4,
                    "correctTaken": 929,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Milk-alkali syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 2413,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary hyperparathyroidism",
                    "choiceNumber": 6,
                    "correctTaken": 9768,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sarcoidosis",
                    "choiceNumber": 7,
                    "correctTaken": 320,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid adenoma",
                    "choiceNumber": 8,
                    "correctTaken": 107,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "393,417,true,-1,1*539,595,true,-1,1*899,921,true,-1,1*1310,1500,true,-1,1*2987,3070,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "496",
                    "mediaDataId": 0,
                    "title": "Multiple endocrine neoplasia (MEN)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17014705",
                    "mediaDataId": 0,
                    "title": "Multiple endocrine neoplasia type 1.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17014705",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 200,
            "othersAvgTimeSpent": 94,
            "notes": null,
            "peopleTaken": 16027,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 728,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 3520,
            "questionIndex": 3520,
            "questionText": "<p>A 24-year-old woman is evaluated for a lump in her neck.&nbsp; She discovered the lump a week ago while showering.&nbsp; The patient feels well and has no associated pain, fever, night sweats, or weight changes.&nbsp; Her medical history is unremarkable, although she has had irregular menses for a year since insertion of an intrauterine device.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Her mother died during surgery for thyroid cancer.&nbsp; Blood pressure is 133/80 mm Hg and pulse is 78/min.&nbsp; On examination, there is a palpable 2-cm nodule in the right thyroid lobe.&nbsp; The remainder of the examination, including chest, abdomen, extremities, and skin, is normal.&nbsp; Serum TSH and calcium levels are normal and calcitonin is elevated.&nbsp; Ultrasound-guided aspiration biopsy reveals malignant cells.&nbsp; Which of the following tests is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t40973\"><table class=\"table-default-style\" style=\"width:516px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Classification of multiple endocrine neoplasia</strong></p></td></tr><tr><td style=\"width: 15%;\"><p align=\"center\"><strong>Type 1</strong></p></td><td style=\"width: 85%;\"><ul><li><strong>Primary hyperparathyroidism</strong> (parathyroid adenomas or hyperplasia)</li><li>Pituitary tumors (prolactin, visual defects)</li><li>Pancreatic tumors (especially gastrinomas)</li></ul></td></tr><tr><td style=\"width: 15%;\"><p align=\"center\"><strong>Type 2A</strong></p></td><td style=\"width: 85%;\"><ul><li><strong>Medullary thyroid cancer</strong> (calcitonin)</li><li>Pheochromocytoma</li><li>Primary hyperparathyroidism (parathyroid hyperplasia)</li></ul></td></tr><tr><td style=\"width: 15%;\"><p align=\"center\"><strong>Type 2B</strong></p></td><td style=\"width: 85%;\"><ul><li><strong>Medullary thyroid cancer</strong> (calcitonin)</li><li>Pheochromocytoma</li><li>Mucosal neuromas/marfanoid habitus</li></ul></td></tr></tbody></table></div></p><p>This patient with a malignant thyroid mass, elevated serum calcitonin level, and family history of thyroid malignancy likely has an inherited form of <strong>medullary thyroid cancer</strong> (MTC).&nbsp; MTC is a calcitonin-producing tumor arising from neuroendocrine parafollicular C cells of the thyroid gland.&nbsp; Although most MTC is sporadic, approximately one third of MTC is inherited as a component of <strong>multiple endocrine neoplasia (MEN) types 2A and 2B</strong>.</p><p>MEN 2A and 2B (usually due to <em>RET</em> proto-oncogene mutations) are also associated with <strong>pheochromocytoma</strong>, which can be asymptomatic at the time of diagnosis but cause life-threatening <strong>hypertensive crisis</strong> during surgical procedures (eg, thyroidectomy).&nbsp; In light of this risk, most patients with MTC should undergo <em>RET</em> mutation testing and screening for pheochromocytoma with a <strong>plasma fractionated metanephrine</strong> assay.&nbsp; If found, pheochromocytoma should be resected prior to thyroidectomy.</p><p><strong>(Choices A, B, and C)</strong>&nbsp; The aldosterone-renin activity ratio can help evaluate hyperaldosteronism (eg, hypertension, hypernatremia, hypokalemia).&nbsp; The low-dose dexamethasone suppression test and the salivary cortisol test are helpful in screening for Cushing syndrome (eg, obesity, facial plethora, easy bruising).&nbsp; This patient has no manifestations of these conditions.&nbsp; In addition, adrenocortical tumors are uncommon in MEN syndromes, with biochemical testing recommended only in patients with manifestations of excessive hormonal production.</p><p><strong>(Choices E and F)</strong>&nbsp; Serum prolactin and insulin-like growth factor-1 are screening tests for prolactin and growth hormone-secreting pituitary tumors.&nbsp; Pituitary tumors occur in MEN1 but are not a feature of MEN2.</p><p><strong>Educational objective:</strong><br>Medullary thyroid cancer (MTC) is a calcitonin-producing tumor of the thyroid parafollicular C cells.&nbsp; It often occurs as a component of multiple endocrine neoplasia types 2A and 2B, which are also associated with pheochromocytoma.&nbsp; Patients with MTC should be screened for pheochromocytoma prior to thyroidectomy with a plasma fractionated metanephrine assay.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23524,
            "topic": "Multiple endocrine neoplasia",
            "titleId": 23524,
            "title": "Multiple endocrine neoplasia",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aldosterone-renin activity ratio",
                    "choiceNumber": 1,
                    "correctTaken": 892,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Late-night salivary cortisol",
                    "choiceNumber": 2,
                    "correctTaken": 448,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low-dose dexamethasone suppression test",
                    "choiceNumber": 3,
                    "correctTaken": 1380,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma fractionated metanephrine assay",
                    "choiceNumber": 4,
                    "correctTaken": 17552,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma insulin-like growth factor-1",
                    "choiceNumber": 5,
                    "correctTaken": 1912,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum prolactin assay",
                    "choiceNumber": 6,
                    "correctTaken": 4340,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "215,238,true,-1,1*748,892,true,-1,1*893,951,true,-1,1*978,1141,true,-1,1*1165,1377,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "496",
                    "mediaDataId": 0,
                    "title": "Multiple endocrine neoplasia (MEN)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24449662",
                    "mediaDataId": 0,
                    "title": "Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24449662",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 104,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 26524,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 998,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 4324,
            "questionIndex": 4324,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 36 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> office</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> headaches and amenorrhea<br><strong>History of Present Illness:</strong><br>&#8226; 2 months of symptoms<br>&#8226; frequent headaches occurring at various times during the day<br>&#8226; amenorrhea (menarche at age 12; regular monthly menstrual cycles until 2 months ago)<br>&#8226; 7-kg (15-lb) weight loss<br>&#8226; intermittent palpitations<br>&#8226; vague visual symptoms<br><strong>Past Medical History:</strong><br>&#8226; none<br><strong>Medications</strong>:<br>&#8226; none<br><strong>Allergies:</strong><br>&#8226; no known drug allergies<br><strong>Family History:</strong><br>&#8226; noncontributory<br><strong>Psychosocial History:</strong><br>&#8226; accountant<br>&#8226; does not use tobacco, alcohol, or recreational substances</p><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr style=\"text-align:center;\"><td><strong>Temp</strong></td><td><strong>Pulse</strong></td><td><strong>Resp</strong></td><td><strong>BP</strong></td><td><strong>O</strong><font size=\"2\"><sub><strong>2</strong></sub></font>&nbsp;<strong>Sat</strong></td><td><strong>Ht</strong></td><td><strong>Wt</strong></td><td><strong>BMI</strong></td></tr><tr style=\"text-align:center; vertical-align:top;\"><td>37.1 C<br>(98.8 F)</td><td>103/min</td><td>16/min</td><td>130/60<br>mm Hg</td><td>98%<br>on room air</td><td>173 cm<br>(5 ft 8 in)</td><td>69 kg<br>(152.1 lb)</td><td>23 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table><p>&#8226; Appearance: awake and oriented<br>&#8226; Pulmonary: clear lung fields<br>&#8226; Cardiac: regular rhythm; tachycardia; S1 and S2<br>&#8226; Abdominal: soft and nontender<br>&#8226; Neurologic: fine hand tremor</p><p><u><strong>Diagnostic Studies</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Serum total T3</td><td style=\"vertical-align:middle;\">222 ng/dL&nbsp; (normal: 80-200)</td></tr><tr><td style=\"vertical-align:middle;\">Serum free T4</td><td style=\"vertical-align:middle;\">2.5 ng/dL (normal: 0.9-1.7)</td></tr><tr><td style=\"vertical-align:middle;\">Serum TSH</td><td style=\"vertical-align:middle;\">6 &micro;U/mL (normal: 0.5-5)</td></tr></tbody></table><p><u><strong>Question:</strong></u> Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T97417\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Primary vs secondary (central) hyperthyroidism</strong></p></td></tr><tr><td></td><td style=\"width: 40%;\"><p align=\"center\"><strong>Primary</strong></p></td><td><p align=\"center\"><strong>Central</strong></p></td></tr><tr><td><p align=\"center\"><strong>TSH<br>T3, T4</strong></p></td><td><p align=\"center\">&#8595;<br>&#8593;</p></td><td><p align=\"center\">&#8593;<br>&#8593;</p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Ophthalmopathy (Graves)</li><li>Tender goiter (eg, SGT) or painless goiter (eg, silent/postpartum thyroiditis)</li></ul></td><td><ul><li>Headache, visual disturbances</li><li>Amenorrhea (hyperprolactinemia)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Autoimmune<br>markers</strong></p></td><td><ul><li>TRAb/TSI (Graves)</li><li>TPO (Hashimoto, silent/postpartum)</li></ul></td><td><p align=\"center\">Absent</p></td></tr><tr><td><p align=\"center\"><strong>Radioiodine<br>uptake</strong></p></td><td><ul><li>&#8593; (eg, Graves, toxic adenoma)</li><li>&#8595; (eg, silent/postpartum)</li></ul></td><td><p align=\"center\">&#8593;</p></td></tr><tr><td colspan=\"3\"><p><strong>SGT</strong> = subacute granulomatous (de Quervain) thyroiditis; <strong>TPO</strong> = thyroid peroxidase antibody; <strong>TRAb</strong> = thyrotropin receptor antibody; <strong>TSI</strong> = thyroid-stimulating immunoglobulin.</p></td></tr></tbody></table></div><p>This patient has <strong>hyperthyroidism</strong> presenting with tachycardia, weight loss, and elevated thyroid hormone (ie, T3, T4) levels, with an inappropriately <strong>elevated TSH</strong>&nbsp;indicating <strong>secondary (central) hyperthyroidism</strong>.&nbsp; Given her <strong>CNS symptoms</strong> (ie, headache, visual disturbances), <strong>TSH-secreting pituitary adenoma</strong> is the most likely cause.&nbsp; Thyrotroph adenomas are most commonly macroadenomas and can generate symptoms related to mass effects (eg, optic chiasm or pituitary stalk compression); they may also cosecrete other pituitary hormones (eg, growth hormone, prolactin).</p><p>The following additional findings are often seen in thyrotroph adenomas:</p><ul><li><p>Diffuse, nontender goiter (due to stimulation of thyroid follicles by TSH)</p></li><li><p>Menstrual symptoms (eg, due to ovulatory dysfunction from excess thyroid hormone)</p></li><li><p>Galactorrhea (eg, prolactin cosecretion or disrupted <a href=\"3419\">prolactin regulation</a> due to pituitary stalk compression)</p></li></ul><p>Additional laboratory tests supporting the diagnosis include an elevated serum alpha subunit (found in glycoprotein hormones such as TSH); levels of insulin-like growth factor 1 and prolactin should also be assessed.&nbsp; <strong>Radioiodine uptake</strong> is <strong>diffusely increased</strong> due to increased thyroid hormone synthesis; <strong>MRI of the pituitary</strong> confirms the diagnosis.&nbsp; Management includes beta blockers (eg, propranolol) for symptom control, somatostatin analogues (eg, octreotide) to reduce TSH secretion, and transsphenoidal resection of the tumor.</p><p><strong>(Choice A)</strong>&nbsp; Generalized resistance to thyroid hormone is an uncommon autosomal dominant condition due to mutations in the thyroid hormone receptor.&nbsp; Patients have elevated T3 and T4 and normal to elevated TSH levels, often with an associated goiter.&nbsp; However, most patients are clinically hypothyroid, not hyperthyroid.</p><p><strong>(Choice B)</strong>&nbsp; Graves disease typically presents with hyperthyroidism and diffuse goiter.&nbsp; However, TSH is suppressed, and patients often have infiltrative ophthalmopathy and pretibial myxedema.</p><p><strong>(Choice C)</strong>&nbsp; Chronic lymphocytic (Hashimoto) thyroiditis occasionally presents with a transient hyperthyroid phase due to inflammatory destruction of thyroid follicles and release of thyroid hormone.&nbsp; However, TSH is suppressed.</p><p><strong>(Choice D)</strong>&nbsp; Normal pregnancy is associated with the upregulation of thyroid hormone production due to increased thyroid-binding globulin and stimulation of TSH receptors by hCG; TSH levels typically decrease due to feedback inhibition of TSH secretion.</p><p><strong>(Choice E)</strong>&nbsp; Surreptitious intake of thyroid hormone is occasionally seen in patients attempting to lose weight.&nbsp; In such cases, TSH is suppressed and the thyroid would not be enlarged.</p><p><strong>Educational objective:</strong><br>TSH-secreting pituitary adenomas cause hyperthyroidism with elevated thyroid hormone and TSH levels.&nbsp; Most TSH-secreting tumors are macroadenomas and can be associated with mass effect symptoms, including headache, visual field defects, and impaired function of surrounding pituitary tissue.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Generalized resistance to thyroid hormone",
                    "choiceNumber": 1,
                    "correctTaken": 387,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Graves disease",
                    "choiceNumber": 2,
                    "correctTaken": 970,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hashimoto thyroiditis",
                    "choiceNumber": 3,
                    "correctTaken": 257,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal pregnancy",
                    "choiceNumber": 4,
                    "correctTaken": 301,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Surreptitious thyroid hormone intake",
                    "choiceNumber": 5,
                    "correctTaken": 412,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "TSH-secreting pituitary adenoma",
                    "choiceNumber": 6,
                    "correctTaken": 11632,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "264,295,true,-1,1*450,451,true,-1,1*953,1186,true,-1,1*1362,1419,true,-1,1*1594,1748,true,-1,1*1881,2062,true,-1,1*2074,2117,true,-1,1*2340,2382,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "487",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26792794",
                    "mediaDataId": 0,
                    "title": "Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26792794",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 131,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 13959,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1671,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 18276,
            "questionIndex": 19744,
            "questionText": "<p>A 68-year-old woman is hospitalized for right lower lobe pneumonia and treated with ceftriaxone and azithromycin.&nbsp; On the third hospital day, she develops acute shortness of breath and palpitation.&nbsp; ECG reveals atrial fibrillation with a heart rate of 150/min.&nbsp; Temperature is 39 C (102.2 F) and blood pressure is 100/60 mm Hg.&nbsp; The patient&#39;s heart rate improves following intravenous administration of diltiazem.&nbsp; Subsequent laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">22,000/mm<font size=\"2\"><sup>3</sup></font> (20% bands)</td></tr><tr><td style=\"vertical-align:middle;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">35 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">1.7 mg/dL (baseline: 1 mg/dL)</td></tr><tr><td style=\"vertical-align:middle;\">Serum cortisol (random)</td><td style=\"vertical-align:middle;\">26 &micro;g/dL (normal: 5-23 &micro;g/dL)</td></tr><tr><td style=\"vertical-align:middle;\">Thyroid-stimulating hormone</td><td style=\"vertical-align:middle;\">0.31 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">Thyroxine (T4) (total)</td><td style=\"vertical-align:middle;\">5 &micro;g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Triiodothyronine (T3) (total)</td><td style=\"vertical-align:middle;\">70 ng/dL (normal: 115-190 ng/dL)&nbsp;</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s abnormal thyroid function tests?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t61752\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Euthyroid sick syndrome</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Early/mild</strong></p></td><td><p align=\"center\"><strong>Prolonged/severe</strong></p></td></tr><tr><td><p align=\"center\"><strong>T3</strong></p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">&darr;</p></td></tr><tr><td><p align=\"center\"><strong>T4</strong></p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">&darr;</p></td></tr><tr><td><p align=\"center\"><strong>TSH</strong></p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">&darr;</p></td></tr></tbody></table></div><p>Thyroid function tests often are abnormal in patients with severe, acute illness.&nbsp; <strong>Euthyroid sick syndrome</strong> (ESS) is a common pattern of thyroid function markers often seen in hospitalized patients.&nbsp; A characteristic feature of ESS is decreased peripheral conversion of T4 to T3 by 5&#39;-monodeiodinase.&nbsp; Factors that suppress conversion of T4 to T3 include:</p><ul><li>Caloric deprivation</li><li>Increased glucocorticoid and inflammatory cytokine (eg, tumor necrosis factor, interferon alpha) levels</li><li>Elevated free fatty acid levels</li></ul><p>Just as inflammation leads to low T3 levels, it also suppresses TSH (but not to the levels seen with hyperthyroidism).&nbsp; Although a <strong>low T3 level</strong> initially may be the only indication of ESS (as in this patient), <strong>T4</strong> and <strong>TSH</strong> levels may also <a href=\"7695\">decrease</a> as the underlying illness continues.&nbsp; Many experts believe that ESS represents a mild, transient <strong>central hypothyroid state</strong> that functions to <strong>minimize maladaptive catabolism</strong> in severe illness.</p><p>In general, thyroid testing should be avoided in hospitalized patients unless a clear indication is present, as in this patient with acute atrial fibrillation (possibly precipitated by pneumonia).&nbsp; Treatment of ESS with exogenous thyroid hormone (ie, levothyroxine) does not improve clinical outcomes and is not indicated.&nbsp; During recovery, patients may experience a modest, transient increase in TSH levels, which may be misinterpreted as subclinical hypothyroidism.&nbsp; Therefore, follow-up testing should be delayed until the patient has returned to baseline health.</p><p><strong>(Choice B)</strong>&nbsp; Amiodarone and high-dose beta blockers (primarily propranolol), which are sometimes given for atrial fibrillation, can suppress deiodination of T4.&nbsp; However, diltiazem does not have a prominent effect on thyroid metabolism.</p><p><strong>(Choice C)</strong>&nbsp; Hypotensive pituitary infarction is unlikely in this patient because it typically is seen in the setting of significant (ie, requiring multiple transfusions) postpartum hemorrhage due to the increased vascularity of the pituitary during pregnancy.&nbsp; Pituitary (or hypothalamic) injury can cause central hypothyroidism (ie, low T4, low TSH) that in some cases may be difficult to differentiate from ESS due to overlapping laboratory features.&nbsp; In such cases, serum cortisol should be obtained; a normal level (as in this patient) makes overt central hypopituitarism unlikely.</p><p><strong>(Choice D)</strong>&nbsp; Thyroid gland inflammation (ie, thyroiditis) can cause destruction of thyroid follicles and release of preformed thyroid hormone.&nbsp; TSH would be suppressed, but serum levels of T4 would be elevated.</p><p><strong>Educational objective:</strong><br>Euthyroid sick syndrome (ESS) is a common pattern of thyroid function markers seen in acutely ill and hospitalized patients.&nbsp; Initial findings include a low T3 level; however, as the underlying illness continues, T4 and TSH levels may also decrease.&nbsp; ESS may represent a mild, transient central hypothyroid state that functions to minimize catabolism in severe illness.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 10509,
            "topic": "Euthyroid sick syndrome",
            "titleId": 10509,
            "title": "Euthyroid sick syndrome",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adaptation to nonthyroidal illness",
                    "choiceNumber": 1,
                    "correctTaken": 8981,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication adverse effect",
                    "choiceNumber": 2,
                    "correctTaken": 2266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary ischemia",
                    "choiceNumber": 3,
                    "correctTaken": 2234,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid gland inflammation",
                    "choiceNumber": 4,
                    "correctTaken": 2670,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "934,1063,true,-1,1*2335,2451,true,-1,1*341,625,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "486",
                    "mediaDataId": 0,
                    "title": "Hypothyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 47,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 16151,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1677,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 4588,
            "questionIndex": 4588,
            "questionText": "<p>A 21-year-old woman comes to the office with 5 months of fatigue, excessive sweating, and palpitations.&nbsp; The patient is slightly overweight and had previously been unsuccessful in losing weight with caloric restriction and exercise.&nbsp; However, she has lost weight during the past 6 months with an over-the-counter weight loss remedy.&nbsp; The patient has had no menstrual periods for the last 3 months.&nbsp; She is not sexually active.&nbsp; Her blood pressure is 136/70 mm Hg and pulse is 100/min.&nbsp; Her BMI is 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The patient has lid lag but no proptosis.&nbsp; Examination of the thyroid shows a small gland without nodules or tenderness.&nbsp; Laboratory findings are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"225\"><tbody><tr><td width=\"50%\">TSH</td><td>low</td></tr><tr><td>Free T4</td><td>high</td></tr><tr><td>&#946;-hCG</td><td>negative</td></tr></tbody></table></blockquote><p>Radioiodine uptake by the thyroid gland is diffusely decreased.&nbsp; Which of the following would most likely be found in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"5862\" src=\"https://www.uworld.com/media/L24678.jpg\" ></p><p>This patient, with fatigue, sweating, palpitations, and weight loss, has features of <strong>hyperthyroidism</strong>.&nbsp; The first step in evaluating hyperthyroidism is to measure serum <strong>TSH</strong> and <strong>free T4</strong> levels.&nbsp; In the absence of a TSH-secreting pituitary adenoma (secondary hyperthyroidism), patients with hyperthyroidism will have an elevated T4 and suppressed TSH.&nbsp; The most common cause of hyperthyroidism is Graves&#39; disease, which is caused by an autoantibody to the TSH receptor and is characterized by a diffuse goiter and ocular abnormalities (proptosis, periorbital edema).&nbsp; Patients with clear features of Graves&#39; disease may be managed accordingly, but those without require further investigation.</p><p>Patients with undiagnosed hyperthyroidism may be evaluated further with <strong>radioactive iodine uptake</strong> (RAIU), usually with scan.&nbsp; A high RAIU suggests de novo hormone synthesis due to Graves&#39; disease (diffusely increased uptake) or toxic nodular disease (nodular uptake).&nbsp; In contrast, a low RAIU suggests either release of preformed thyroid hormone (ie, thyroiditis) or exogenous thyroid hormone intake.&nbsp; In such cases, the serum <strong>thyroglobulin</strong> level can make the distinction: elevated thyroglobulin is consistent with endogenous thyroid hormone release whereas decreased thyroglobulin suggests exogenous or factitious thyrotoxicosis.&nbsp; In this patient, it is likely that her weight loss supplement contains thyroid hormone derived from porcine or other animal sources.</p><p><strong>(Choice A)</strong>&nbsp; Antithyroid peroxidase antibodies are seen in Hashimoto thyroiditis, which usually presents with a palpable goiter and clinical hypothyroidism (rather than hyperthyroidism).&nbsp; RAIU is not typically part of the evaluation of hypothyroidism but would generally show low uptake in patients with Hashimoto thyroiditis due to autoimmune thyroid destruction.&nbsp; Rarely, patients with Hashimoto thyroiditis can present with a transient hyperthyroid state (due to inflammation) early in the course of the disease.&nbsp; Factitious thyrotoxicosis is much more likely in this patient who developed manifestations of hyperthyroidism shortly after she started taking an over-the-counter weight loss remedy.</p><p><strong>(Choice B)</strong>&nbsp; Subacute thyroiditis (de Quervain&#39;s thyroiditis) is characterized by fever, neck pain, thyroid tenderness, and an elevated erythrocyte sedimentation rate.&nbsp; In most cases, hyperthyroid symptoms fade in &lt;8 weeks as the thyroid gland becomes depleted of preformed hormone.</p><p><strong>(Choice C)</strong>&nbsp; TSH is comprised of 2 subunits, an alpha-subunit (common to TSH, FSH, LH, and hCG) and a thyroid-specific beta-subunit.&nbsp; Many TSH-secreting pituitary adenomas overproduce the alpha-subunit, and an elevated ratio of alpha-subunit to TSH suggests a pituitary adenoma.&nbsp; These patients would have an elevated TSH, elevated free T4, and normal or increased RAIU.</p><p><strong>(Choice D)</strong>&nbsp; This patient&#39;s absence of ophthalmopathy (eg, proptosis, periorbital edema) and low RAIU make Graves&#39; disease unlikely.</p><p><strong>Educational objective:</strong><br>In hyperthyroidism, increased radioactive iodine uptake (RAIU) suggests de novo thyroid hormone synthesis, whereas decreased RAIU suggests release of preformed hormone or exogenous hormone intake.&nbsp; Thyrotoxicosis due to exogenous thyroid hormone is characterized by low serum thyroglobulin levels.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Elevated antithyroid peroxidase antibody titer",
                    "choiceNumber": 1,
                    "correctTaken": 11195,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Elevated erythrocyte sedimentation rate",
                    "choiceNumber": 2,
                    "correctTaken": 4145,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Elevated serum alpha-subunit level",
                    "choiceNumber": 3,
                    "correctTaken": 10751,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Elevated TSH receptor antibody titer",
                    "choiceNumber": 4,
                    "correctTaken": 14891,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low serum thyroglobulin level",
                    "choiceNumber": 5,
                    "correctTaken": 34912,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "847,990,true,-1,1*1193,1352,true,-1,1*2514,2744,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "487",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18363120",
                    "mediaDataId": 0,
                    "title": "Factitious thyrotoxicosis and herbal dietary supplement for weight reduction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18363120",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 112,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 75894,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 46,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1809,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 3495,
            "questionIndex": 3495,
            "questionText": "<p>A 70-year-old-man is admitted to the hospital with acute retrosternal chest pain and severe shortness of breath.&nbsp; His other medical conditions include hypertension and hyperlipidemia.&nbsp; Coronary angiography reveals critical stenosis of the left main coronary artery, and the patient subsequently undergoes emergency coronary artery bypass grafting.&nbsp; On the fourth postoperative day, he develops atrial flutter with a rapid ventricular response.&nbsp; Thyroid function test results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Free thyroxine (free T4)</td><td>1.4 ng/dL (normal: 0.9-2.4 ng/dL)</td></tr><tr><td>Triiodothyronine (T3), total</td><td>70 ng/dL (normal: 115-190 ng/dL)</td></tr><tr><td>Thyroid-stimulating hormone (TSH)</td><td>0.7 mU/L (normal: 0.5-5.0 mU/L)</td></tr></tbody></table><p>Which of the following is the most likely etiology of this patient&#39;s abnormal thyroid function tests?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t61946\"><table class=\"table-default-style table-footer-only-style\" style=\"width:550px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Euthyroid sick syndrome (low T3 syndrome)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Severe acute illness</li><li>ICU admission</li><li>High-dose glucocorticoid therapy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>High circulating levels of glucocorticoids and inflammatory cytokines (eg, tumor necrosis factor, interferon alpha)</li><li>Decreased peripheral conversion of T4 to T3</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic testing</strong></p></td><td><ul><li>Early: &nbsp;Low T3, normal TSH &amp; T4</li><li>Late: &nbsp;Low T3, TSH &amp; T4</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Observe without treatment</li><li>Follow-up testing when patient has returned to baseline health</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ICU</strong> = intensive care unit.</p></td></tr></tbody></table></div><p>Thyroid function tests are often abnormal in patients with <strong>severe, acute illness</strong>.&nbsp; Severe illness is associated with decreased peripheral 5&#39;-deiodination of T4 to T3 due to caloric deprivation, increased glucocorticoid and inflammatory cytokine release, and inhibitors of 5&#39;-monodeiodinase (eg, free fatty acids).&nbsp; The most common pattern is <strong>low total and free T3 levels</strong> with <strong>normal T4 and TSH</strong>, often called <strong>euthyroid sick syndrome</strong>.&nbsp; However, many experts consider this a misnomer and believe it represents a mild transient central hypothyroid state that serves as an adaptive response to severe illness.&nbsp; If the underlying illness continues, <a href=\"7695\">T4 and TSH levels</a> may eventually decrease.</p><p>In general, thyroid function testing in hospitalized patients should be avoided; however, it may be necessary in certain circumstances (eg, to rule out hyperthyroidism in acute atrial fibrillation).&nbsp; When a euthyroid sick syndrome pattern is found, thyroid hormone supplementation does not improve clinical outcomes and is not indicated.&nbsp; During recovery, patients may experience a modest, transient increase in TSH, which may be misinterpreted as subclinical hypothyroidism.&nbsp; Therefore, <strong>follow-up testing</strong> should be delayed until the patient has returned to baseline health.</p><p><strong>(Choice A)</strong>&nbsp; Chronic lymphocytic (Hashimoto) thyroiditis is characterized by autoimmune destruction of thyroid follicles.&nbsp; It usually presents with chronic hypothyroidism (ie, low T4, high TSH), although a transient hyperthyroid phase (ie, high T4, low TSH) is sometimes seen.&nbsp; Normal TSH and T4 are not consistent with this disorder.</p><p><strong>(Choice B)</strong>&nbsp; Drug-induced hypothyroidism is a common adverse effect of amiodarone, which is occasionally given for atrial fibrillation.&nbsp; However, this results in high TSH and low T4 levels, which are not seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Overt central hypothyroidism is characterized by a low T4 level with low (or inappropriately normal) TSH.&nbsp; This patient&#39;s T4 is normal.</p><p><strong>(Choice E)</strong>&nbsp; Subclinical hypothyroidism is characterized by elevated TSH with normal T4 (and T3) levels.&nbsp; Although subclinical hyperthyroidism (ie, low TSH, normal T4) is associated with increased risk for atrial fibrillation, this patient has normal TSH.</p><p><strong>Educational objective:</strong><br>Thyroid function tests are often abnormal in patients with severe, acute illness.&nbsp; The most common pattern is low T3 with normal T4 and TSH (ie, euthyroid sick syndrome), which may represent an adaptive response to severe illness.&nbsp; Thyroid hormone supplementation is not indicated for these patients, and follow-up testing should be delayed until the patient has returned to baseline health.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 10509,
            "topic": "Euthyroid sick syndrome",
            "titleId": 10509,
            "title": "Euthyroid sick syndrome",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic lymphocytic thyroiditis (Hashimoto disease)",
                    "choiceNumber": 1,
                    "correctTaken": 82,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Drug-induced hypothyroidism",
                    "choiceNumber": 2,
                    "correctTaken": 1505,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Euthyroid sick syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 12221,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Overt central hypothyroidism",
                    "choiceNumber": 4,
                    "correctTaken": 394,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subclinical hypothyroidism",
                    "choiceNumber": 5,
                    "correctTaken": 2520,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "120,152,true,-1,1*2613,2723,true,-1,1*788,843,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "486",
                    "mediaDataId": 0,
                    "title": "Hypothyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 22,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16722,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 748,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 3487,
            "questionIndex": 3487,
            "questionText": "<p>A 35-year-old, previously healthy woman comes to the office due to palpitations, excessive sweating, weight loss, and intermittent diarrhea for the past 2 months.&nbsp; She does not use alcohol or tobacco.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 135/80 mm Hg, pulse is 100/min, and respirations are 14/min.&nbsp; Physical examination shows excessive eyelid retraction and lid lag.&nbsp; The thyroid is diffusely enlarged and nontender.&nbsp; Mild tremors of the hands are present.&nbsp; The remainder of the examination is normal.&nbsp; Laboratory results show decreased TSH and increased free T4 and T3 levels.&nbsp; Thyroid-stimulating antibodies are detected.&nbsp; The diagnosis and various treatment options are discussed, and the patient opts for long-term treatment with methimazole.&nbsp; This patient is at greatest risk for which of the following conditions due to the use of this medication?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T40707\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Complications of Graves disease treatment</strong></p></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><p align=\"center\"><strong>Adverse effects</strong></p></td></tr><tr><td><p align=\"center\"><strong>Antithyroid drugs<br>(thionamides)</strong></p></td><td><ul><li>Agranulocytosis</li><li>Methimazole: 1st-trimester teratogen, cholestasis</li><li>Propylthiouracil: hepatic failure, ANCA-associated vasculitis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Radioiodine<br>ablation</strong></p></td><td><ul><li>Permanent hypothyroidism</li><li>Worsening of ophthalmopathy</li><li>Possible radiation side effects</li></ul></td></tr><tr><td><p align=\"center\"><strong>Surgery</strong></p></td><td><ul><li>Permanent hypothyroidism</li><li>Risk for recurrent laryngeal nerve damage</li><li>Risk for hypoparathyroidism</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ANCA</strong> = antineutrophilic cytoplasmic antibodies.</p></td></tr></tbody></table></div><p>This patient has <strong>Graves disease</strong> presenting with overt hyperthyroidism and a positive assay for thyroid-stimulating immunoglobulins.&nbsp; She has opted for <strong>antithyroid drug (ATD)</strong> therapy, which can be used in short courses to achieve remission in mild cases or for chronic management in those with more significant hyperthyroidism who wish to avoid surgery or radioactive iodine therapy.&nbsp; <strong>Methimazole</strong> is preferred for most nonpregnant patients due to an increased risk for fulminant hepatic necrosis associated with propylthiouracil <strong>(Choice A)</strong>.&nbsp; However, propylthiouracil is preferred in the first trimester of pregnancy due to teratogenicity associated with methimazole.</p><p>ATDs can cause <strong>agranulocytosis</strong> (ie, severe <strong>neutropenia</strong>), a rare but life-threatening complication that can rapidly lead to overwhelming infection.&nbsp; Oropharyngeal (eg, sore throat, pharyngeal ulcers) and systemic (eg, fever) features are often the initial manifestations.&nbsp; Patients who develop symptoms should stop the drug immediately; samples for laboratory studies (eg, white blood cell count, organ-specific [throat, blood] cultures) should be drawn immediately and empiric broad-spectrum antibiotics started if neutropenia is confirmed.</p><p><strong>(Choice B)</strong>&nbsp; Uncontrolled hyperthyroidism can accelerate bone turnover and increase the risk for osteoporotic fracture.&nbsp; However, patients who take ATDs and are biochemically euthyroid and are not at increased risk for fracture.</p><p><strong>(Choice C)</strong>&nbsp; Permanent hypothyroidism may result after radioiodine treatment or thyroidectomy.&nbsp; When properly dosed, ATDs do not cause hypothyroidism.</p><p><strong>(Choice E)</strong>&nbsp; Inadvertent injury to the parathyroid glands during thyroidectomy can cause hypoparathyroidism and hypocalcemia.&nbsp; This is not seen with ATDs.</p><p><strong>(Choice F)</strong>&nbsp; Propylthiouracil has been associated with antineutrophilic cytoplasmic antibody&ndash;positive vasculitis (eg, fever, purpura, hematuria).&nbsp; The risk for vasculitis due to methimazole has not been established and is likely very rare.</p><p><strong>(Choice G)</strong>&nbsp; Radioactive iodine therapy can lead to worsening Graves ophthalmopathy, but this is not seen with ATDs.</p><p><strong>Educational objective:</strong><br>Antithyroid drugs (eg, methimazole, propylthiouracil) can cause agranulocytosis, which can lead to overwhelming infection.&nbsp; Patients who develop symptoms of infection (eg, sore throat, fever) should stop the drug immediately.&nbsp; Management includes blood- and organ-specific cultures, white blood cell count, and broad-spectrum antibiotics.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fulminant hepatic necrosis",
                    "choiceNumber": 1,
                    "correctTaken": 2112,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Osteoporotic fractures",
                    "choiceNumber": 2,
                    "correctTaken": 1125,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Permanent hypothyroidism",
                    "choiceNumber": 3,
                    "correctTaken": 934,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Severe neutropenia",
                    "choiceNumber": 4,
                    "correctTaken": 9823,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Symptomatic hypocalcemia",
                    "choiceNumber": 5,
                    "correctTaken": 464,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic vasculitis",
                    "choiceNumber": 6,
                    "correctTaken": 293,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Worsening of ophthalmopathy",
                    "choiceNumber": 7,
                    "correctTaken": 1547,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "146,257,true,-1,1*304,331,true,-1,1*698,896,true,-1,1*899,1181,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "786",
                    "mediaDataId": 0,
                    "title": "Graves disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "35129917",
                    "mediaDataId": 0,
                    "title": "Management of thyrotoxicosis: anti thyroid drugs: thyroid disease: assessment and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/35129917",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 39,
            "othersAvgTimeSpent": 47,
            "notes": null,
            "peopleTaken": 16298,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1123,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 16726,
            "questionIndex": 18171,
            "questionText": "<p>A 34-year-old man with no previous medical history comes to the clinic due to worsening headaches and dizziness.&nbsp; The headaches tend to occur during periods of stress and are sometimes associated with blurry vision and nausea.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 170/100 mm Hg supine and 150/90 mm Hg standing 2 minutes, and pulse is 90/min and regular.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Fasting laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hemoglobin</td><td>15.6 g/L</td></tr><tr><td>Sodium</td><td>144 mEq/L</td></tr><tr><td>Potassium</td><td>4.5 mEq/L</td></tr><tr><td>Creatinine</td><td>1.0 mg/dL</td></tr><tr><td>Glucose</td><td>196 mg/dL</td></tr><tr><td>Calcium</td><td>8.6 mg/dL</td></tr></tbody></table><p>Which of the following investigations should be ordered next?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t56582\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pheochromocytoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Indications for testing</strong></p></td><td><ul><li>Classic triad: episodic headache, sweating &amp; tachycardia</li><li>Resistant HTN or HTN accompanied by unexplained &uarr; glucose</li><li>Family history or familial syndrome (eg, MEN2, NF1, VHL)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic approach</strong></p></td><td><ul><li>Urine or plasma metanephrine levels</li><li>Confirmatory abdominal imaging for &uarr; metanephrines</li></ul></td></tr><tr><td><p align=\"center\"><strong>Notable features</strong></p></td><td><ul><li>10% bilateral, 10% extraadrenal, 10% malignant</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Preoperative alpha blockade prior to beta blockade</li><li>Laparoscopic or open surgical resection</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HTN</strong> = hypertension; <strong>MEN2</strong> = multiple endocrine neoplasia type 2; <strong>NF1</strong> = neurofibromatosis type 1; <strong>VHL</strong> = von Hippel-Lindau syndrome.</p></td></tr></tbody></table></div><p>This patient&#39;s hypertension, episodic headaches, and unexplained hyperglycemia should raise suspicion for <strong>pheochromocytoma</strong>.&nbsp; Pheochromocytomas are rare neuroendocrine tumors that arise from chromaffin cells and release excess <strong>catecholamines</strong> (ie, dopamine, epinephrine, norepinephrine) into the bloodstream, resulting in characteristic manifestations.&nbsp; <strong>Headaches</strong> are often episodic and present in 90% of patients.&nbsp; <strong>Paroxysmal hypertension</strong> occurs in approximately half of patients and may be associated with orthostasis (possibly reflecting low plasma volume).&nbsp; Vision changes, coinciding with episodes of headache and hypertension, can also occur.</p><p>Because catecholamines inhibit insulin secretion, hyperglycemia is also common.&nbsp; Therefore, pheochromocytoma should be considered in patients who develop&nbsp;<strong>hyperglycemia</strong> that is <strong>atypical</strong> for both type 1 (ie, usually presents with diabetic ketoacidosis) and type 2 (ie, rarely occurs in patients age &lt;35 with <strong>normal BMI</strong>, as in this patient) diabetes mellitus, especially when accompanied by other suggestive features, such as onset of <strong>hypertension </strong>(particularly&nbsp;at a young age).&nbsp; Other indications for screening include: the classic triad of headache, sweating, and tachycardia; resistant hypertension; or a familial syndrome (eg, multiple endocrine neoplasia type 2).</p><p>The initial step in evaluation for pheochromocytoma involves testing for <strong>urine or plasma levels of metanephrines</strong>, which are products of catecholamine breakdown.&nbsp; Normal levels typically rule out the disease; elevated levels are nonspecific and warrant additional testing, such as CT scan of the abdomen <strong>(Choice A)</strong>, to confirm the presence and localization of the suspected pheochromocytoma (usually on one or both adrenal glands).</p><p><strong>(Choice B)</strong>&nbsp; CT scan of the head is typically indicated for headaches only when red-flag features (eg, focal neurologic deficits, fever, new-onset headache in patient age &gt;50) are present.</p><p><strong>(Choice C)</strong>&nbsp; Dexamethasone suppression testing is indicated for suspected hypercortisolism (ie, Cushing syndrome).&nbsp; Although hypertension and hyperglycemia are common, patients are usually overweight and have characteristic findings on physical examination (eg, purple abdominal striae, fat pad on the upper back).</p><p><strong>(Choice E)</strong>&nbsp; Renal vascular imaging may help diagnose fibromuscular dysplasia, which typically presents with headaches and can cause hypertension.&nbsp; However, fibromuscular dysplasia usually occurs in women and would not explain this patient&#39;s hyperglycemia.</p><p><strong>(Choice F)</strong>&nbsp; A serum glucagon level is indicated for suspected glucagonoma.&nbsp; Although a glucagonoma would cause hyperglycemia, it would not explain hypertension, episodic headaches, and vision changes.</p><p><strong>Educational objective:</strong><br>Pheochromocytoma commonly presents with episodic headaches and hypertension and can cause unexplained hyperglycemia.&nbsp; Measurement of urine or plasma metanephrines is the initial step in diagnostic evaluation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 8195,
            "topic": "Pheochromocytoma",
            "titleId": 8195,
            "title": "Pheochromocytoma",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen",
                    "choiceNumber": 1,
                    "correctTaken": 1629,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the head",
                    "choiceNumber": 2,
                    "correctTaken": 2031,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dexamethasone suppression test",
                    "choiceNumber": 3,
                    "correctTaken": 3259,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma metanephrines",
                    "choiceNumber": 4,
                    "correctTaken": 8009,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal vascular imaging",
                    "choiceNumber": 5,
                    "correctTaken": 1411,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum glucagon level",
                    "choiceNumber": 6,
                    "correctTaken": 1088,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1135,1292,true,-1,1*1293,1373,true,-1,1*1769,1958,true,-1,1*1959,2388,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "508",
                    "mediaDataId": 0,
                    "title": "Pheochromocytoma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "6453259",
                    "mediaDataId": 0,
                    "title": "Prevalence of clinically unsuspected pheochromocytoma.  Review of a 50-year autopsy series.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/6453259",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 131,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 17427,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 46,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 830,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 12739,
            "questionIndex": 14025,
            "questionText": "<p>A 39-year-old woman, gravida 1 para 1, comes to the office with abnormal uterine bleeding.&nbsp; The patient underwent menarche at age 15 and had irregular menses that normalized with oral contraceptives.&nbsp; She used oral contraceptives until 4 years ago, when she became pregnant and had a cesarean delivery with tubal ligation.&nbsp; The patient&#39;s menstrual cycles after delivery occurred monthly with 4-5 days of moderate bleeding.&nbsp; However, over the last year, her menses have become increasingly irregular and now occur every 2-3 months, with heavier bleeding and passage of clots.&nbsp; She also has had difficulty concentrating at work due to increasing irritability and depressed mood.&nbsp; The patient has gained 6.8 kg (15 lb) over the past year despite any changes in her diet.&nbsp; She has no headaches or hot flashes.&nbsp; Vital signs are normal.&nbsp; Skin is cool and dry.&nbsp; Pelvic examination reveals a well-rugated vagina, mobile uterus, and small, nontender ovaries.&nbsp; The remainder of the physical examination is normal.&nbsp; Pregnancy test is negative.&nbsp; This patient&#39;s laboratory results would most likely reveal which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"19897\" src=\"https://www.uworld.com/media/highresdefault/L45228.jpg\"  ></p><p>This patient has <strong>hypothyroidism</strong>, a common endocrine disorder that causes abnormal uterine bleeding due to disruption of the <strong>hypothalamic-pituitary-ovarian axis</strong>.&nbsp; Patients with hypothyroidism also have cool, dry skin and metabolic slowing, which often leads to weight gain and cognitive (eg, difficulty concentrating) and psychiatric (eg, depression, increased irritability) effects.</p><p>In patients with hypothyroidism, low thyroxine levels feed back to the hypothalamus and increase the secretion of thyrotropin-releasing hormone, stimulating the anterior pituitary and <strong>increasing TSH and prolactin levels</strong>.&nbsp; The resulting hyperprolactinemia inhibits the hypothalamus and anterior pituitary, causing <strong>decreased FSH and LH levels</strong>.&nbsp; The decreased, nonpulsatile FSH and LH levels result in <strong>anovulation</strong> and <strong>abnormal uterine bleeding</strong> (eg, oligomenorrhea), as seen in this patient.</p><p>Treatment with thyroxine hormone replacement achieves symptom resolution (eg, regulation of menses) and normalizes TSH and prolactin levels.</p><p><strong>(Choice A)</strong>&nbsp; Patients undergoing menopause have an elevated FSH level due to age-related ovarian follicle depletion but normal TSH and prolactin levels.&nbsp; The median age of menopause is 51 and patients typically have hot flushes and vaginal atrophy (eg, loss of rugation), making this diagnosis unlikely in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Patients with functional hypothalamic amenorrhea have secondary amenorrhea due to low FSH levels but normal TSH and prolactin levels.&nbsp; This type of amenorrhea typically occurs due to stress and a relative caloric deficiency (eg, overexercising, undereating).&nbsp; Patients with this condition are usually underweight (ie, BMI &lt;18.5 kg/m<font size=\"2\"><sup>2</sup></font>) and have signs of estrogen deficiency (eg, vaginal atrophy).</p><p><strong>(Choice C)</strong>&nbsp; Elevated prolactin levels from prolactinomas cause low FSH levels, which result in anovulation and abnormal uterine bleeding despite normal TSH levels.&nbsp; Prolactinomas do not typically cause depressed mood, irritability, or skin changes.</p><p><strong>(Choice D)</strong>&nbsp; Polycystic ovary syndrome causes abnormal uterine bleeding due to hyperandrogenism (eg, acne, hirsutism); FSH, TSH, and prolactin levels are typically normal.&nbsp; These patients have oligomenorrhea due to chronic anovulation from enlarged, polycystic ovaries.&nbsp; This patient&#39;s ovaries are small and nontender.</p><p><strong>Educational objective:</strong><br>Hypothyroidism disrupts the hypothalamic-pituitary-ovarian axis.&nbsp; Low circulating thyroxine levels increase the excretion of hypothalamic thyrotropin-releasing hormone, which in turn stimulates anterior pituitary production of both TSH and prolactin.&nbsp; The resulting hyperprolactinemia suppresses ovulation, leading to abnormal uterine bleeding (eg, oligomenorrhea).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 12124,
            "topic": "Hypothyroidism",
            "titleId": 12124,
            "title": "Hypothyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px;\">\n\t<tbody>\n\t\t<tr style=\"text-align:center;\">\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 1,
                    "correctTaken": 1075,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px;\">\n\t<tbody>\n\t\t<tr style=\"text-align:center;\">\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 2,
                    "correctTaken": 725,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px;\">\n\t<tbody>\n\t\t<tr style=\"text-align:center;\">\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 3,
                    "correctTaken": 428,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px;\">\n\t<tbody>\n\t\t<tr style=\"text-align:center;\">\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 4,
                    "correctTaken": 259,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px;\">\n\t<tbody>\n\t\t<tr style=\"text-align:center;\">\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t\t<td style=\"width:33%;\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 5,
                    "correctTaken": 2519,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2137,2190,true,-1,1*1374,1423,true,-1,1*1676,1770,true,-1,1*1055,1158,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "486",
                    "mediaDataId": 0,
                    "title": "Hypothyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26620017",
                    "mediaDataId": 0,
                    "title": "Hypothyroidism and its effect on menstrual pattern and fertility.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26620017",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27540882",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism and hyperprolactinemia: is there any association?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27540882",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30137821",
                    "mediaDataId": 0,
                    "title": "Hypothyroidism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30137821",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 124,
            "othersAvgTimeSpent": 118,
            "notes": null,
            "peopleTaken": 5006,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%;\"><strong>FSH</strong></td><td style=\"width:33%;\"><strong>TSH</strong></td><td style=\"width:33%;\"><strong>Prolactin</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 941,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 2191,
            "questionIndex": 2191,
            "questionText": "<p>A 24-year-old woman comes to the clinic after 3 weeks of heat intolerance and increased appetite.&nbsp; Despite increased caloric intake, she has lost weight.&nbsp; The patient&#39;s medical history is insignificant, and she takes no prescription or over-the-counter medications.&nbsp; She does not use tobacco or illicit drugs, and consumes alcohol only on rare occasions.&nbsp; The patient&#39;s last menstrual period was 3 days ago and was unusually light.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 130/75 mm Hg, pulse is 110/min and regular, and respiratory rate is 14/min.&nbsp; On examination, the thyroid gland is mildly enlarged, mobile, and nontender.&nbsp; Cranial nerve examination is normal, although there is mild lid lag.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"350\"><tbody><tr><td>Free T4</td><td>Increased</td></tr><tr><td>Total T3</td><td>Increased</td></tr><tr><td>TSH</td><td>Decreased</td></tr></tbody></table></blockquote><p>Radioactive iodine uptake is &lt;5% (normal: 8%-25%).&nbsp; The thyroid gland is not visualized on thyroid scan.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t31172\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\" style=\"width:32.0%\"><p align=\"center\"><strong>Thyroiditis</strong></p></td></tr><tr><td style=\"width:33.0%\"></td><td style=\"width:35.0%\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:32.0%\"><p align=\"center\"><strong>Diagnostic testing</strong></p></td></tr><tr><td style=\"width:33.0%\"><p align=\"center\"><strong>Chronic autoimmune thyroiditis</strong><br />(Hashimoto thyroiditis)</p></td><td style=\"width:35.0%\"><ul><li>Predominant hypothyroid features</li><li>Diffuse goiter</li></ul></td><td style=\"width:32.0%\"><ul><li>Positive TPO antibody</li><li>Variable radioiodine uptake</li></ul></td></tr><tr><td style=\"width:33.0%\"><p align=\"center\"><strong>Painless thyroiditis</strong><br />(silent thyroiditis)</p></td><td style=\"width:35.0%\"><ul><li>Variant of chronic autoimmune thyroiditis</li><li>Mild, brief hyperthyroid phase</li><li>Small, nontender goiter</li><li>Spontaneous recovery</li></ul></td><td style=\"width:32.0%\"><ul><li>Positive TPO antibody</li><li>Low radioiodine uptake</li></ul></td></tr><tr><td style=\"width:33.0%\"><p align=\"center\"><strong>Subacute </strong><strong>(granulomatous) </strong><strong>thyroiditis</strong><br />(de Quervain thyroiditis)</p></td><td style=\"width:35.0%\"><ul><li>Likely postviral inflammatory process</li><li>Prominent fever &amp; hyperthyroid symptoms</li><li>Painful/tender goiter</li></ul></td><td style=\"width:32.0%\"><ul><li>Elevated ESR &amp; CRP</li><li>Low radioiodine uptake</li></ul></td></tr><tr><td colspan=\"3\" style=\"width:32.0%\"><p style=\"margin-left:.05in;\"><strong>CRP</strong> = C-reactive protein; <strong>ESR</strong> = erythrocyte sedimentation rate; <strong>TPO</strong> = thyroid peroxidase.</p></td></tr></tbody></table></div></p><p>This patient has <strong>painless thyroiditis</strong> (silent thyroiditis), characterized by acute <strong>thyrotoxicosis</strong> with mild thyroid gland enlargement and suppressed TSH.&nbsp; Painless thyroiditis is an autoimmune disorder thought to be a variant of Hashimoto thyroiditis, although the latter classically presents with chronic hypothyroidism.&nbsp; A similar disorder can also be seen within a year following pregnancy but would be properly termed postpartum thyroiditis.&nbsp; The follicular inflammatory reaction in painless thyroiditis may occasionally lead to a persistent hypothyroid phase, but most patients recover normal thyroid function.</p><p>Patients with hyperthyroidism and a suppressed TSH should undergo thyroid radioiodine scintigraphy to distinguish painless thyroiditis from Graves disease.&nbsp; With painless thyroiditis, radioiodine uptake is decreased suggesting the release of <strong>preformed thyroid hormone</strong>.&nbsp; In contrast, Graves disease causes hyperthyroidism due to increased synthesis of thyroid hormone.&nbsp; Radioiodine uptake will be diffusely increased, and extra-thyroidal manifestations (eg, <a href=\"1177\">exophthalmos</a>, pretibial myxedema) are often present <strong>(Choice A)</strong>.</p><p><strong>(Choice C)</strong>&nbsp; Struma ovarii is a very rare cause of thyrotoxicosis and is due to production of thyroid hormone by an ovarian teratoma.&nbsp; It typically presents in women over age 40 with a pelvic mass, ascites, or abdominal pain.&nbsp; The thyroid gland is not enlarged with this condition.</p><p><strong>(Choice D)</strong>&nbsp; Subacute thyroiditis (granulomatous or De Quervain thyroiditis) also causes hyperthyroidism with a suppressed TSH and decreased radioiodine uptake.&nbsp; However, it is associated with a painful, tender goiter.</p><p><strong>(Choice E)</strong>&nbsp; Nodular thyroid disease is a more common cause of hyperthyroidism in older individuals.&nbsp; A thyroid scan will show increased uptake in either a focal (<a href=\"4404\">toxic adenoma</a>) or heterogeneous (toxic multinodular goiter) pattern.</p><p><strong>Educational objective:</strong><br>Painless thyroiditis (silent thyroiditis) is characterized by acute thyrotoxicosis with mild thyroid enlargement and suppressed TSH.&nbsp; Thyroid scintigraphy shows decreased radioiodine uptake.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Graves disease",
                    "choiceNumber": 1,
                    "correctTaken": 5227,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Painless thyroiditis",
                    "choiceNumber": 2,
                    "correctTaken": 11116,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Struma ovarii",
                    "choiceNumber": 3,
                    "correctTaken": 7197,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subacute thyroiditis",
                    "choiceNumber": 4,
                    "correctTaken": 2510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Toxic nodular goiter",
                    "choiceNumber": 5,
                    "correctTaken": 1152,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1882,2096,true,-1,1*2097,2151,true,-1,1*1181,1349,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "488",
                    "mediaDataId": 0,
                    "title": "Thyroiditis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22443972",
                    "mediaDataId": 0,
                    "title": "Subacute, silent, and postpartum thyroiditis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22443972",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 27202,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 537,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 18827,
            "questionIndex": 20304,
            "questionText": "<p>A 25-year-old woman, gravida 1 para 1, comes to the office for follow-up.&nbsp; Two months ago, she gave birth at 39 weeks gestation by an uncomplicated vaginal delivery.&nbsp; The patient reports tiredness and occasional palpitations over the past 2 weeks.&nbsp; She has not felt sad or hopeless and feels well bonded with her infant.&nbsp; The patient is breastfeeding and wants to continue doing so.&nbsp; She has no chronic medical conditions and takes no medications.&nbsp; Blood pressure is 140/70 mm Hg and pulse is 102/min.&nbsp; Physical examination shows mild, diffuse enlargement of the thyroid gland without tenderness or bruit.&nbsp; No proptosis or eye redness is present.&nbsp; A fine tremor of the patient&#39;s outstretched hands is present.&nbsp; Deep tendon reflexes are brisk and symmetric.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Serum TSH</td><td style=\"vertical-align:middle;\">&lt;0.001 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">Serum free thyroxine (T4)</td><td style=\"vertical-align:middle;\">2.8 ng/dL (normal: 0.8-1.8)</td></tr><tr><td style=\"vertical-align:middle;\">Serum total triiodothyronine (T3)</td><td style=\"vertical-align:middle;\">210 ng/dL (normal: 115-190)</td></tr><tr><td style=\"vertical-align:middle;\">Thyroid peroxidase antibody</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">Thyrotropin receptor antibody</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Propranolol is prescribed, and periodic thyroid function tests are planned.&nbsp; Which of the following additional interventions is indicated?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"47580\" src=\"https://www.uworld.com/media/highresdefault/L66268.jpg\"  ></p><p>This patient has <strong>postpartum thyroiditis</strong> (PPT), an autoimmune disorder similar to painless (silent) thyroiditis but defined as occurring <strong>&lt;12 months after childbirth</strong>.&nbsp; PPT is characterized by lymphocytic infiltration of the thyroid gland with disruption of thyroid follicles and release of <strong>preformed thyroid hormone</strong>.&nbsp; Laboratory findings include the following:</p><ul><li><p>Elevated thyroid hormone (ie, thyroxine [T4], triiodothyronine [T3]) levels</p></li><li><p>Suppressed TSH level</p></li><li><p><strong>Positive thyroid peroxidase antibody assay</strong> (marker for autoimmune thyroid disease that is also commonly associated with Hashimoto thyroiditis)</p></li><li><p>Negative thyrotropin receptor antibody test (marker for Graves disease)</p></li></ul><p>Radioactive iodine uptake (RAIU) is low because thyroid metabolic activity is suppressed.&nbsp; However, RAIU testing is not always needed for diagnosis and is frequently deferred in patients who are breastfeeding.</p><p>PPT is <strong>self-limited</strong>, and specific antithyroid treatment is not recommended.&nbsp; However, a <strong>beta blocker</strong> (eg, propranolol) should be prescribed to attenuate hyperadrenergic symptoms.&nbsp; Patients should be monitored with serial laboratory tests (eg, TSH) because a <a href=\"51264\">transient hypothyroid phase</a>&nbsp;may occur due to thyroid hormone depletion; testing should continue until the patient returns to a euthyroid state.</p><p><strong>(Choices B and E)</strong>&nbsp; Radioactive iodine ablation and thyroidectomy are used to treat Graves disease, which also causes hyperthyroidism.&nbsp; Graves disease is associated with thyrotropin receptor antibodies (which stimulate increased thyroid hormone synthesis) and extrathyroidal signs (eg, proptosis), which are not seen in this patient.&nbsp; Neither ablation nor thyroidectomy is appropriate for PPT.</p><p><strong>(Choice C)</strong>&nbsp; Prednisone is appropriate for treatment of subacute (de Quervain/granulomatous) thyroiditis, which presents with neck pain and a tender goiter (not seen in this patient).&nbsp; Glucocorticoid therapy is not needed for PPT.</p><p><strong>(Choice D)</strong>&nbsp; Thionamides (eg, methimazole, propylthiouracil) inhibit thyroid hormone synthesis; propylthiouracil also inhibits peripheral conversion of T4 to T3.&nbsp; These agents are used in the treatment of Graves disease but are ineffective in PPT, in which hyperthyroidism is due to release of preformed thyroid hormone.</p><p><strong>Educational objective:</strong><br>Postpartum thyroiditis is an autoimmune disorder characterized by lymphocytic inflammation of the thyroid gland and disruption of thyroid follicles occurring &lt;12 months after childbirth.&nbsp; It causes a self-limited hyperthyroid phase due to release of preformed thyroid hormone.&nbsp; Management includes a beta blocker to attenuate adrenergic symptoms, but specific antithyroid therapy is not needed.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "No additional intervention needed",
                    "choiceNumber": 1,
                    "correctTaken": 3696,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Radioactive iodine ablation",
                    "choiceNumber": 2,
                    "correctTaken": 246,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic glucocorticoid",
                    "choiceNumber": 3,
                    "correctTaken": 404,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thionamide",
                    "choiceNumber": 4,
                    "correctTaken": 560,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroidectomy",
                    "choiceNumber": 5,
                    "correctTaken": 163,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "707,915,true,-1,1*1952,2102,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "488",
                    "mediaDataId": 0,
                    "title": "Thyroiditis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28056690",
                    "mediaDataId": 0,
                    "title": "2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28056690",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 54,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 5069,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 536,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 10177,
            "questionIndex": 10958,
            "questionText": "<p>A 28-year-old woman develops tachycardia in the postoperative recovery room.&nbsp; She was admitted for a right femur fracture following a motor vehicle collision and had an open reduction and internal fixation of the fracture.&nbsp; While in the recovery area, she began experiencing nausea and vomiting, and became anxious and agitated.&nbsp; The patient has no known medical problems.&nbsp; She drinks 1 or 2 glasses of wine on weekends.&nbsp; Her temperature is 39.4 C (103 F), blood pressure is 160/90 mm Hg, pulse is 148/min, and respirations are 24/min.&nbsp; Pulse oximetry shows 98% on room air.&nbsp; On examination, the patient is delirious and has fine tremor.&nbsp; Mild lid lag is present.&nbsp; She has no muscle rigidity and deep-tendon reflexes are 2+ in the bilateral extremities.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"300\"><tbody><tr><td>Hematocrit</td><td>30%</td></tr><tr><td>Sodium</td><td>135 mEq/L</td></tr><tr><td>Potassium</td><td>4.5 mEq/L</td></tr><tr><td>Bicarbonate</td><td>24 mEq/L</td></tr><tr><td>Blood urea nitrogen</td><td>32 mg/dL</td></tr><tr><td>Creatinine</td><td>1.2 mg/dL</td></tr><tr><td>Glucose</td><td>120 mg/dL</td></tr><tr><td>Creatine kinase, serum</td><td>176 U/L</td></tr></tbody></table></blockquote><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t80968\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of thyroid storm</strong></p></td></tr><tr><td><p align=\"center\"><strong>Precipitating factors</strong></p></td><td><ul><li>Thyroid or nonthyroidal surgery</li><li>Acute illness (eg, trauma, infection), childbirth</li><li>Acute iodine load (eg, iodine contrast)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Fever as high as 40-41.1 C (104-106 F)</li><li>Tachycardia, hypertension, congestive heart failure, cardiac arrhythmias (eg, atrial fibrillation)</li><li>Agitation, delirium, seizure, coma</li><li>Goiter, lid lag, tremor, warm &amp; moist skin</li><li>Nausea, vomiting, diarrhea, jaundice</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>&beta;&nbsp;Blocker (eg, propranolol) to &darr; adrenergic manifestations</li><li>PTU followed by iodine solution (SSKI) to &darr; hormone synthesis &amp; release</li><li>Glucocorticoids (eg, hydrocortisone) to &darr; peripheral T4 to T3 conversion &amp; improve vasomotor stability</li><li>Identify trigger &amp; treat, provide supportive care</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>PTU</strong> = propylthiouracil; <strong>SSKI</strong> = potassium iodide.</p></td></tr></tbody></table></div></p><p>This patient&#39;s presentation is concerning for <strong>thyroid storm</strong>, a life-threatening thyrotoxicosis usually triggered by a specific event (eg, thyroid or non-thyroid surgery, trauma, infection) in patients with undiagnosed or inadequately treated hyperthyroidism.&nbsp; Proposed mechanisms include a rapid increase in serum thyroid hormone levels or increased sensitivity to thyroid hormone.&nbsp; Characteristic features include tachycardia, hypertension, cardiac arrhythmias (eg, atrial fibrillation), and fever up to 40-41 C (104-106 F).&nbsp; Other findings include anxiety, altered mentation, seizure, severe nausea, vomiting, hepatic dysfunction, tremor, lid lag, and goiter.</p><p>Diagnosis is suspected clinically and confirmed by thyroid function studies documenting hyperthyroidism.&nbsp; Treatment includes beta blockers (eg, propranolol) for symptom control, thionamides (eg, propylthiouracil) to block new hormone synthesis, iodine solution to block thyroid hormone release (given at least an hour after propylthiouracil to prevent excess iodine incorporation into thyroid hormone), and glucocorticoids to decrease peripheral conversion of T4 to T3 (and treat a potential relative adrenal insufficiency).</p><p><strong>(Choice A)</strong>&nbsp; Echocardiography can identify causes of congestive heart failure or arrhythmias (eg, abnormal valves, ventricular dysfunction).&nbsp; However, this patient has no features of heart failure, and echocardiography is not needed.</p><p><strong>(Choice B)</strong>&nbsp; Fluid resuscitation and intravenous dexamethasone should be given to patients with suspected <a href=\"2366\">acute adrenal insufficiency</a>.&nbsp; These patients will have hypotension often associated with tachycardia, abdominal pain, vomiting, and weakness.</p><p><strong>(Choice C)</strong>&nbsp; Intravenous dantrolene can treat malignant hyperthermia (MH), a hypermetabolic syndrome due to volatile anesthetics leading to sustained muscle contraction and breakdown.&nbsp; MH typically presents with hypercarbia, sinus tachycardia, muscle rigidity, significantly elevated creatine kinase (can reach &gt;10,000-20,000 U/L), hyperkalemia (due to muscle breakdown), and hyperthermia.&nbsp; In this patient, the presence of lid lag, the absence of muscle rigidity, and the normokalemia are more consistent with thyroid storm than MH.&nbsp; Her moderate creatine kinase elevation likely reflects muscle injury related to trauma or surgery.</p><p><strong>(Choice D)</strong>&nbsp; Intravenous lorazepam can treat alcohol withdrawal, which usually presents with tachycardia, hypertension, and altered mental status.&nbsp; Fever is atypical with early withdrawal but can occur with delirium tremens, which develops 72-96 hours after the last drink.&nbsp; This patient&#39;s history of moderate alcohol use makes withdrawal less likely, and alcohol withdrawal would not explain her lid lag.</p><p><strong>(Choice E)</strong>&nbsp; Free plasma metanephrines are elevated in pheochromocytoma, which usually presents with episodic hypertension and the classic triad (episodic headache, diaphoresis, and tachycardia).&nbsp; Pheochromocytoma is usually not associated with high fever.</p><p><strong>Educational objective:</strong><br>Thyroid storm is a life-threatening thyrotoxicosis often triggered by thyroid or non-thyroid surgery, trauma, infection, iodine contrast, or childbirth.&nbsp; It is characterized by tachycardia, hypertension, cardiac arrhythmias, high fever, tremor, altered mentation, and lid lag.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "6",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Echocardiogram",
                    "choiceNumber": 1,
                    "correctTaken": 79,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fluid bolus and intravenous dexamethasone",
                    "choiceNumber": 2,
                    "correctTaken": 386,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous dantrolene",
                    "choiceNumber": 3,
                    "correctTaken": 1436,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous lorazepam",
                    "choiceNumber": 4,
                    "correctTaken": 485,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma free metanephrines",
                    "choiceNumber": 5,
                    "correctTaken": 167,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid function tests and propranolol",
                    "choiceNumber": 6,
                    "correctTaken": 2427,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "170,209,true,-1,1*248,270,true,-1,1*554,728,true,-1,1*1735,1894,true,-1,1*1961,2015,true,-1,1*2679,2884,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "487",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23920160",
                    "mediaDataId": 0,
                    "title": "Thyroid storm: an updated review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23920160",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 106,
            "othersAvgTimeSpent": 110,
            "notes": null,
            "peopleTaken": 5055,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2380,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 3486,
            "questionIndex": 3486,
            "questionText": "<p>A 64-year-old man comes to the emergency department due to severe community-acquired pneumonia complicated by respiratory failure.&nbsp; Medical history includes chronic obstructive pulmonary disease.&nbsp; The patient&#39;s airway is intubated, and he is admitted to the intensive care unit.&nbsp; In addition to mechanical ventilation, treatment includes intravenous antibiotics, intravenous glucocorticoids, and nebulized bronchodilators.&nbsp; During the night following admission, cardiac telemetry detects 2 episodes of atrial fibrillation, with a maximum ventricular rate of 130/min.&nbsp; Thyroid function test results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>TSH</td><td>0.6 &micro;U/mL (normal: 0.5-5.0)</td></tr><tr><td>Free T4</td><td>1 ng/dL (normal: 0.9-2.4)</td></tr><tr><td>Total T3</td><td>50 ng/dL (normal: 80-200)&nbsp;</td></tr></tbody></table><p>Which of the following is the most appropriate management in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31412\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Alterations in thyroid physiology<br>associated with acute illness</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Early/mild</strong></p></td><td><p align=\"center\"><strong>Prolonged/severe</strong></p></td></tr><tr><td><p align=\"center\"><strong>T3</strong></p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8595;</p></td></tr><tr><td><p align=\"center\"><strong>T4</strong></p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">&#8595;</p></td></tr><tr><td><p align=\"center\"><strong>TSH</strong></p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">&#8595;</p></td></tr><tr><td><p align=\"center\"><strong>Reverse T3</strong></p></td><td><p align=\"center\">&#8593;</p></td><td><p align=\"center\">&#8593;</p></td></tr></tbody></table></div><p>Severe illness often induces a <strong>catabolic state</strong> due to increased release of cortisol and inflammatory cytokines, decreased nutritional intake, and associated medications (eg, glucocorticoids).&nbsp; These factors can induce several <strong>changes in thyroid physiology</strong>, which may be initially beneficial by reducing excessive tissue catabolism.&nbsp; They include the following:</p><ul><li><p><strong>Low-normal </strong>or low <strong>TSH</strong> due to suppression of thyrotropin-releasing hormone from the hypothalamus</p></li><li><p><strong>Low total T3</strong> and elevated reverse T3 (inactive metabolite) due to reduced peripheral deiodination of T4</p></li><li><p>Low-<strong>normal </strong>or low<strong> total T4</strong> due to decreased levels of thyroid hormone&ndash;binding proteins in the plasma; <strong>free T4</strong> levels are usually <strong>normal</strong> unless the illness is prolonged.</p></li></ul><p>These thyroid physiologic changes are sometimes termed euthyroid sick syndrome.</p><p>This patient had thyroid testing due to atrial fibrillation; the results (low-normal TSH, low T3, normal free T4) are consistent with the physiologic changes of severe illness, and <strong>no treatment</strong> is required.&nbsp; However, the tests should be <strong>repeated</strong> following recovery to ensure normalization.</p><p><strong>(Choices A and B)</strong>&nbsp; Levothyroxine therapy is commonly used for primary hypothyroidism (ie, low T4, elevated TSH), whereas liothyronine (synthetic T3) is not recommended for routine use due to its short half-life.&nbsp; Neither option is appropriate for this patient with severe illness due to the risk for precipitating a relative hyperthyroid state and excessive tissue catabolism.</p><p><strong>(Choice C)</strong>&nbsp; This patient&#39;s laboratory studies are consistent with thyroid physiologic changes in the setting of acute illness; therefore, no additional testing is required.&nbsp;&nbsp;Serum free T3 and reverse T3 tests can be unreliable in severe illness due to rapidly fluctuating levels.&nbsp; Total T4 levels can be obtained if unexpected abnormalities in TSH and free T4 (eg, significantly elevated or suppressed TSH) are seen in patients with acute illness who have thyroid studies sent.</p><p><strong>(Choice D)</strong>&nbsp; Serum cortisol and ACTH stimulation tests are appropriate for evaluating for a possible pituitary lesion if central hypothyroidism is suspected (eg, overtly low TSH and free T4).&nbsp; This patient&#39;s TSH is in the expected low-normal range, and observation with repeat thyroid testing is more appropriate.</p><p><strong>Educational objective:</strong><br>In acutely ill patients, thyroid function tests are often abnormal, characterized by low T3 levels with low-normal TSH and T4.&nbsp; No treatment is required, but the tests should be repeated following recovery to ensure normalization.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 12124,
            "topic": "Hypothyroidism",
            "titleId": 12124,
            "title": "Hypothyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Begin levothyroxine therapy",
                    "choiceNumber": 1,
                    "correctTaken": 1682,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Begin liothyronine therapy",
                    "choiceNumber": 2,
                    "correctTaken": 589,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain serum free T3, reverse T3, and total T4 levels",
                    "choiceNumber": 3,
                    "correctTaken": 2776,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order serum cortisol and ACTH stimulation tests",
                    "choiceNumber": 4,
                    "correctTaken": 507,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat thyroid studies after hospital discharge",
                    "choiceNumber": 5,
                    "correctTaken": 9743,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "747,834,true,-1,1*1393,1484,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "486",
                    "mediaDataId": 0,
                    "title": "Hypothyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27065175",
                    "mediaDataId": 0,
                    "title": "Euthyroid sick syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27065175",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 63,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 15297,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 519,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 4415,
            "questionIndex": 4415,
            "questionText": "<p>A 58-year-old woman comes to the office due to tremor, palpitations, weight loss, and fatigue.&nbsp; She has no other medical conditions and takes no medications or over-the-counter supplements.&nbsp; The patient&#39;s mother had hypothyroidism and osteoporosis.&nbsp; Blood pressure is 144/80 mm Hg, pulse is 110/min, and respirations are 18/min.&nbsp; On examination, there is diffuse, nontender enlargement of the thyroid gland.&nbsp; Ocular examination shows bilateral proptosis, lid lag, and periorbital puffiness.&nbsp; The patient has diplopia and ocular discomfort on extremes of lateral gaze.&nbsp; Laboratory tests show suppressed TSH and elevated thyroid hormone levels.&nbsp; Which of the following treatment options is most likely to worsen this patient&#39;s eye disease?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T40707\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Complications of Graves disease treatment</strong></p></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><p align=\"center\"><strong>Adverse effects</strong></p></td></tr><tr><td><p align=\"center\"><strong>Antithyroid drugs<br>(thionamides)</strong></p></td><td><ul><li>Agranulocytosis</li><li>Methimazole: 1st-trimester teratogen, cholestasis</li><li>Propylthiouracil: hepatic failure, ANCA-associated vasculitis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Radioiodine<br>ablation</strong></p></td><td><ul><li>Permanent hypothyroidism</li><li>Worsening of ophthalmopathy</li><li>Possible radiation adverse effects</li></ul></td></tr><tr><td><p align=\"center\"><strong>Surgery</strong></p></td><td><ul><li>Permanent hypothyroidism</li><li>Risk for recurrent laryngeal nerve damage</li><li>Risk for hypoparathyroidism</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ANCA</strong> = antineutrophilic cytoplasmic antibody.</p></td></tr></tbody></table></div><p>This patient has <strong>Graves disease</strong> presenting with hyperthyroidism, a diffuse goiter, and <strong>thyroid eye disease</strong> (eg, proptosis, pain with extraocular movements, swelling of periorbital tissues).&nbsp; Graves disease causes hyperthyroidism due to the activation of TSH receptors on thyroid follicular cells by <strong>thyrotropin receptor antibodies</strong> (TRABs).&nbsp; Ophthalmopathy in Graves disease is due to the effects of TRAB and activated T cells on retroorbital fibroblasts and adipocytes, causing cellular expansion and orbital inflammation.</p><p>Treatment options for Graves disease include <strong>radioactive iodine (RAI) therapy</strong>, antithyroid drugs (eg, methimazole, propylthiouracil), and thyroidectomy.&nbsp; However, RAI therapy can <strong>induce or worsen thyroid eye disease</strong>, possibly due to an increase in TRAB levels caused by leakage of thyroid antigens from the irradiated thyroid.&nbsp; Therefore, RAI is <strong>contraindicated</strong> in patients with moderate or severe thyroid eye disease.</p><p><strong>(Choices A and E)</strong>&nbsp; Antithyroid drugs (eg, methimazole, propylthiouracil) and thyroidectomy do not exacerbate thyroid eye disease and would be appropriate options for this patient.&nbsp; In many cases, an antithyroid drug would be started first to achieve a euthyroid state; subsequently, the patient may have a thyroidectomy or continue the antithyroid drug for long-term management.</p><p><strong>(Choice B)</strong> Oral glucocorticoids (eg, prednisone) are often given with RAI therapy in patients who are at risk for thyroid eye disease due to high baseline TRAB levels; they lower TRAB levels and reduce, rather than worsen, the risk for eye disease.</p><p><strong>(Choice C)</strong>&nbsp; Beta blockers (eg, propranolol) are given to minimize the adrenergic effects (eg, hypertension, tachycardia, tremor) of hyperthyroidism.&nbsp; They do not worsen eye disease.</p><p><strong>Educational objective:</strong><br>Treatment options for Graves disease include radioactive iodine (RAI) therapy, antithyroid drugs (eg, methimazole, propylthiouracil), and thyroidectomy.&nbsp; RAI therapy can induce or worsen thyroid eye disease and is contraindicated in patients with moderate or severe eye disease.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Methimazole",
                    "choiceNumber": 1,
                    "correctTaken": 573,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prednisone",
                    "choiceNumber": 2,
                    "correctTaken": 943,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 3,
                    "correctTaken": 545,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Radioactive iodine",
                    "choiceNumber": 4,
                    "correctTaken": 2790,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroidectomy",
                    "choiceNumber": 5,
                    "correctTaken": 178,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "857,1038,true,-1,1*1193,1457,true,-1,1*1847,2004,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "487",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31929534",
                    "mediaDataId": 0,
                    "title": "Radioiodine therapy and Graves&#39; diseasemyths and reality.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31929534",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 31,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 5029,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 756,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 2648,
            "questionIndex": 2648,
            "questionText": "<p>A 5-year-old boy is brought to the office by his parents for evaluation of &#x22;clumsiness.&#x22;&nbsp; The patient&#39;s fine and gross motor development have been normal at prior visits, but he now frequently runs into doorways or corners of furniture while walking around the house.&nbsp; He has also begun drinking large amounts of water and urinating &#x22;all the time.&#x22;&nbsp; Temperature is 37 C (98.6 F), blood pressure is 95/65 mm Hg, and pulse is 130/min.&nbsp; Physical examination shows dry mucous membranes and loss of peripheral visual fields.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td><td></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td><td></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td style=\"vertical-align:middle;\">145 mEq/L</td><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td style=\"vertical-align:middle;\">3.9 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td style=\"vertical-align:middle;\">20 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td style=\"vertical-align:middle;\">18 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">0.6 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">88 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Urinalysis</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Specific gravity</td><td style=\"vertical-align:middle;\">1.001</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>CT scan of the brain (<a href=\"4428\">exhibit</a>) reveals an abnormality.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t54282\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Craniopharyngioma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Benign, slow growing</li><li>Derived from remnants of Rathke pouch</li><li>Bimodal age distribution (age 5-14 &amp; 50-75)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Optic chiasm compression &rarr; bitemporal hemianopsia</li><li>Pituitary stalk compression &rarr; endocrinopathies<ul style=\"list-style-type:circle;\"><li>Growth failure in children (&darr; TSH or &darr; GH)</li><li>Pubertal delay in children or sexual dysfunction in adults (&darr; LH &amp; FSH)</li><li>Diabetes insipidus (&darr; ADH)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>MRI/CT scan: calcified &amp;/or cystic suprasellar mass</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Surgical resection &plusmn; radiation therapy</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ADH</strong> = antidiuretic hormone; <strong>GH</strong> = growth hormone.</p></td></tr></tbody></table></div><p><strong>Craniopharyngioma</strong> is a <strong>benign</strong>, <strong>slow-growing</strong> tumor derived from epithelial remnants of Rathke pouch (within the pituitary stalk).&nbsp; The mass is located in the <strong>suprasellar</strong> region adjacent to the optic chiasm and can cause a variety of complications.</p><ul><li>Compression of the optic chiasm can lead to visual field deficits including <a href=\"2824\">bitemporal hemianopsia</a>.&nbsp; Due to peripheral vision loss, patients often bump into the corners of walls or furniture, as in this case.</li><li>In addition, pituitary stalk compression can cause multiple <strong>endocrinopathies</strong>.&nbsp;</li></ul><p>For example, growth hormone or thyroid-stimulating hormone deficiencies can present as <strong>growth failure</strong> and pubertal delay in children.&nbsp; The damaged pituitary is also often unable to produce or secrete adequate antidiuretic hormone, which causes <strong>diabetes insipidus</strong>.&nbsp; The classic symptoms of dehydration, polyuria, and polydipsia are seen in this patient due to inability to concentrate urine.&nbsp; Laboratory findings may include high-normal serum sodium and dilute urine.</p><p>As with most intracranial tumors, craniopharyngiomas can present with headache secondary to compression of nearby structures or obstructive hydrocephalus.&nbsp; Diagnostic imaging with MRI and CT scan of a <a href=\"28531\">craniopharyngioma</a> would show a suprasellar mass with cysts and/or <strong>calcification</strong>.&nbsp; This patient&#39;s CT scan shows these typical findings.</p><p><strong>(Choice B)</strong>&nbsp; Medulloblastomas typically arise from the cerebellar vermis and present with vomiting, headache, and signs of cerebellar dysfunction (eg, ataxia, dysmetria).&nbsp; Signs of pituitary hormone deficiency would not be seen.&nbsp; In addition, this patient&#39;s mass is in the sellar region.</p><p><strong>(Choice C)</strong>&nbsp; Meningiomas are typically extraaxial, benign tumors most commonly seen in adults.&nbsp; Although these tumors can calcify, a symptomatic parasagittal meningioma would cause hemiparesis and seizures.&nbsp; This patient&#39;s tumor is in the sellar region.</p><p><strong>(Choice D)</strong>&nbsp; Pituitary adenomas are benign neoplasms that secrete excess prolactin, resulting in galactorrhea and amenorrhea.&nbsp; They can also present with bitemporal hemianopsia.&nbsp; Unlike craniopharyngiomas, pituitary adenomas do not calcify.</p><p><strong>(Choice E)</strong>&nbsp; Similar to craniopharyngiomas, Rathke cleft cysts are derived from Rathke pouch remnants.&nbsp; If large, they can cause visual field defects and endocrinopathies, but Rathke cleft cysts are not associated with calcifications.</p><p><strong>Educational objective:</strong><br>Craniopharyngiomas are benign, slow-growing tumors found in the suprasellar region and typically appear calcified on neuroimaging.&nbsp; Presenting symptoms include bitemporal hemianopsia and signs of pituitary hormone deficiencies (eg, diabetes insipidus, growth failure).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 16697,
            "topic": "Brain tumors",
            "titleId": 16697,
            "title": "Brain tumors",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Craniopharyngioma",
                    "choiceNumber": 1,
                    "correctTaken": 5446,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medulloblastoma",
                    "choiceNumber": 2,
                    "correctTaken": 142,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parasagittal meningioma",
                    "choiceNumber": 3,
                    "correctTaken": 91,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary adenoma",
                    "choiceNumber": 4,
                    "correctTaken": 3153,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rathke cleft cyst",
                    "choiceNumber": 5,
                    "correctTaken": 670,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "82,163,true,-1,1*232,278,true,-1,1*1931,1991,true,-1,1*2315,2335,true,-1,1*2338,2411,true,-1,1*2470,2698,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24467716",
                    "mediaDataId": 0,
                    "title": "Craniopharyngioma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24467716",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21819881",
                    "mediaDataId": 0,
                    "title": "Craniopharyngioma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21819881",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 71,
            "othersAvgTimeSpent": 46,
            "notes": null,
            "peopleTaken": 9502,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1051,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 3952,
            "questionIndex": 3952,
            "questionText": "<p>A 25-year-old woman comes to the clinic due to a 3-month history of weight loss, irritability, insomnia, and palpitations.&nbsp; Medical history is insignificant.&nbsp; The patient is not currently taking any medications.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Blood pressure is 155/70 mm Hg and pulse is 110/min.&nbsp; Physical examination is significant for bilateral proptosis, lid retraction, warm skin, and fine tremor of the hands.&nbsp; Which of the following is the most likely cause of this patient&#39;s hypertension?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T60190\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Cardiovascular effects of thyrotoxicosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Rhythm</strong></p></td><td><ul><li>Sinus tachycardia</li><li>Premature atrial &amp; ventricular complexes</li><li>Atrial fibrillation/flutter</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hemodynamic effects</strong></p></td><td><ul><li>Systolic hypertension &amp; &#8593; pulse pressure</li><li>&#8593; Contractility &amp; cardiac output</li><li>&#8595; Systemic vascular resistance</li><li>&#8593; Myocardial oxygen demand</li></ul></td></tr><tr><td><p align=\"center\"><strong>Heart failure</strong></p></td><td><ul><li>High-output failure</li><li>Exacerbation of preexisting low-output failure</li></ul></td></tr><tr><td><p align=\"center\"><strong>Angina symptoms</strong></p></td><td><ul><li>Coronary vasospasm</li><li>Preexisting coronary atherosclerosis</li></ul></td></tr></tbody></table></div><p>This patient has <strong>systolic hypertension</strong> along with weight loss, tremor, and tachycardia.&nbsp; The associated proptosis (due to expansion of retroorbital tissues) is a specific finding for <strong>thyrotoxicosis</strong> due to <strong>Graves disease</strong>.</p><p>Patients with thyrotoxicosis can develop cardiovascular complications due to the direct effects of excess thyroid hormone on the myocardium and vasculature, manifesting with the following hemodynamic changes:</p><ul><li><p><strong>Reduced systemic vascular resistance</strong> (SVR) results from <strong>direct vasodilatory effects</strong> of thyroid hormone on the endothelium (ie, peripheral vasodilation).&nbsp; This decreases <a href=\"43398\">diastolic blood pressure</a>.</p></li><li><p><strong>Increased cardiac contractility and stroke volume</strong> result from both a direct effect of thyroid hormone on the myocardium and a reflexive response to peripheral vasodilation.&nbsp; This <strong>increases pulse pressure</strong> to cause systolic hypertension.</p></li><li><p><strong>Increased heart rate</strong> results from a direct effect of thyroid hormone and a reflexive response to peripheral vasodilation, and further contributes to increased cardiac output.</p></li></ul><p>Cardiovascular complications of thyrotoxicosis include <strong>high-output heart failure</strong>, angina (due to increased myocardial oxygen demand), and tachyarrhythmias (eg, atrial fibrillation, atrial flutter).</p><p><strong>(Choice A)</strong>&nbsp; Long-standing hypercalcemia, as seen in hyperparathyroidism, is associated with hypertension, possibly due to effects on cardiac contractility and large artery compliance.&nbsp; Thyrotoxicosis may cause hypercalcemia due to increased bone turnover, but this is generally mild and is not a significant contributor to hypertension.</p><p><strong>(Choice C)</strong>&nbsp; Increased synthesis of catecholamines is seen in certain neuroendocrine tumors (eg, pheochromocytoma), which manifest with systolic hypertension, tachycardia, and tremor, but not proptosis (which is specific for Graves disease).&nbsp; Thyrotoxicosis causes increased systemic sensitivity to circulating catecholamines, but does not directly increase catecholamine synthesis.</p><p><strong>(Choice D)</strong>&nbsp; SVR is decreased in thyrotoxicosis.&nbsp; In contrast, hypothyroidism (low thyroid hormone) is associated with increased SVR and elevated diastolic blood pressure.</p><p><strong>(Choice E)</strong>&nbsp; Nocturnal hypoventilation due to obstructive sleep apnea can raise blood pressure, and may be associated with symptoms including disordered sleep, irritability, and palpitations.&nbsp; However, weight loss, proptosis, and tremor are more suggestive of thyrotoxicosis.</p><p><strong>Educational objective:</strong><br>Thyrotoxicosis involves direct effects of thyroid hormone on the cardiovascular system that lead to reduced systemic vascular resistance (decreased diastolic blood pressure), increased contractility and stroke volume (increased pulse pressure causing systolic hypertension), and increased heart rate.&nbsp; Cardiovascular complications include high-output heart failure, angina (increased myocardial oxygen demand), and tachyarrhythmias (eg, atrial fibrillation).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Elevated serum calcium level",
                    "choiceNumber": 1,
                    "correctTaken": 257,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased myocardial contractility",
                    "choiceNumber": 2,
                    "correctTaken": 6840,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased synthesis of catecholamines",
                    "choiceNumber": 3,
                    "correctTaken": 4840,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased systemic vascular resistance",
                    "choiceNumber": 4,
                    "correctTaken": 4053,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nocturnal hypoventilation",
                    "choiceNumber": 5,
                    "correctTaken": 35,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "414,469,true,-1,1*351,397,true,-1,1*2285,2425,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "786",
                    "mediaDataId": 0,
                    "title": "Graves disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33012487",
                    "mediaDataId": 0,
                    "title": "Hypertension and hyperthyroidism: association and pathogenesis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33012487",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 68,
            "othersAvgTimeSpent": 41,
            "notes": null,
            "peopleTaken": 16025,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 721,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 4307,
            "questionIndex": 4307,
            "questionText": "<p>A 36-year-old woman comes to the office due to weight loss.&nbsp; She has lost 5 kg (11 lb) over the last 3 months associated with palpitations, heat intolerance, persistent tremors, and excessive sweating.&nbsp; Past medical and family histories are unremarkable, and the patient does not use tobacco, alcohol, or illicit drugs.&nbsp; She is married and has a child.&nbsp; Blood pressure is 140/70 mm Hg and pulse is 104/min and regular.&nbsp; Physical examination shows a 2x2 cm nodule in the left thyroid lobe.&nbsp; The rest of the thyroid gland is normal, and there is no associated cervical lymphadenopathy.&nbsp; Eye examination shows minimal lid lag, but no proptosis or chemosis.&nbsp; There is a fine tremor in both upper extremities.&nbsp; Thyroid function test results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"275\"><tbody><tr><td>Serum TSH</td><td>&lt;0.03 &micro;U/mL</td></tr><tr><td>Total T3</td><td>330 ng/dL</td></tr><tr><td>Total T4</td><td>14 &micro;g/dL</td></tr></tbody></table></blockquote><p>Radioactive iodine scan shows uptake only in the nodule.&nbsp; The patient wishes to have additional children and is concerned that she will not be able to get pregnant if she is treated for her current condition.&nbsp; If left untreated, this patient is at greatest risk for developing which of the following complications?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"3659\"  src=\"https://www.uworld.com/media/L23284.jpg\" draggable=\"false\" ></p><p>This patient with hyperthyroid symptoms, suppressed TSH, and a &#x22;hot&#x22; thyroid nodule has typical features of a <strong>toxic adenoma</strong> (TA).&nbsp; TA and toxic multinodular goiter (MNG) are the most common causes of <strong>hyperthyroidism</strong> after Graves disease and are most often caused by activating mutations in the TSH receptor.&nbsp; These disorders are characterized by TSH-independent thyroid hormone secretion and focal (TA) or multifocal (MNG) follicular hyperplasia.&nbsp; Initial treatment of TA and MNG includes a beta blocker to alleviate the symptoms of hyperthyroidism and a thionamide (eg, methimazole, propylthiouracil) to decrease thyroid hormone secretion.&nbsp; Options for definitive management of TA include surgery and radioiodine ablation.</p><p>If left untreated, patients with hyperthyroidism can develop rapid <strong>bone loss</strong> leading to <strong>osteoporosis</strong> and increased risk of fracture.&nbsp; Direct effects of the thyroid hormones cause increased osteoclastic bone resorption.&nbsp; Patients can also develop hypercalcemia and hypercalciuria due to increased bone turnover.</p><p><strong>(Choice B)</strong>&nbsp; Common cardiovascular effects of hyperthyroidism include tachycardia, systolic hypertension, increased pulse pressure, and tachyarrhythmias (eg, atrial fibrillation).&nbsp; Thyrotoxicosis per se is not a risk factor for coronary artery disease, although its symptoms can be unmasked or worsened with thyrotoxicosis.</p><p><strong>(Choice C)</strong>&nbsp; Fetal hyperthyroidism can be seen in patients with active Graves disease, in whom TSH receptor (TSHR) antibodies can cross the placenta and affect the fetal thyroid.&nbsp; TSHR antibodies are not seen in TA.</p><p><strong>(Choice D)</strong>&nbsp; Large hypofunctioning (&#x22;cold&#x22;) nodules carry an increased risk of malignancy and require additional evaluation.&nbsp; Hyperfunctioning nodules are rarely malignant.</p><p><strong>(Choice E)</strong>&nbsp; Infiltrative ophthalmopathy in Graves disease leads to proptosis, impaired ocular movement, ocular irritation and redness, and possible vision loss.&nbsp; However, significant ophthalmopathy is not seen in TA.</p><p><strong>Educational objective:</strong><br>Untreated hyperthyroid patients are at risk for rapid bone loss from increased osteoclastic activity in the bone cells.&nbsp; Untreated hyperthyroid patients are also at risk for cardiac tachyarrhythmias, including atrial fibrillation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bone loss",
                    "choiceNumber": 1,
                    "correctTaken": 4821,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Coronary artery disease",
                    "choiceNumber": 2,
                    "correctTaken": 1133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal hyperthyroidism",
                    "choiceNumber": 3,
                    "correctTaken": 1862,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid cancer",
                    "choiceNumber": 4,
                    "correctTaken": 2524,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vision loss",
                    "choiceNumber": 5,
                    "correctTaken": 863,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "163,202,true,-1,1*298,478,true,-1,1*889,1066,true,-1,1*1730,1776,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "487",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23970897",
                    "mediaDataId": 0,
                    "title": "Metabolic and clinical consequences of hyperthyroidism on bone density.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23970897",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 51,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 11203,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 616,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 11244,
            "questionIndex": 12399,
            "questionText": "<p>A 40-year-old, previously healthy woman comes to the office due to a 3-month history of progressive weakness, frequent insomnia, palpitations, and an unintended 4-kg (8.8-lb) weight loss.&nbsp; She also has a constant feeling of anxiety and increased sensitivity to warm temperatures.&nbsp; Blood pressure is 140/70 mm Hg and pulse is 110/min.&nbsp; Physical examination shows lid lag without exophthalmos and a fine tremor of the patient&#39;s outstretched hands.&nbsp; The thyroid gland is enlarged and nontender.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">&nbsp; 0.1 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">T4 serum</td><td style=\"vertical-align:middle;\">&nbsp; 20 &micro;g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Thyroid-stimulating immunoglobulins</td><td style=\"vertical-align:middle;\">&nbsp; 340% (normal: &lt;110%)</td></tr></tbody></table><p>After learning about treatment options, the patient elects to proceed with radioactive iodine therapy.&nbsp; Which of the following is the most likely outcome after radioiodine treatment in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T96214\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Choice of treatment in Graves disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Antithyroid drugs</strong></p></td><td><ul><li>Preferred in patients with limited life expectancy</li><li>May induce remission in mild hyperthyroidism</li><li>May be used as pretreatment prior to radioactive iodine or thyroidectomy (eg, high-risk patient, severe hyperthyroidism)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Radioactive iodine</strong></p></td><td><ul><li>Acceptable option for moderate hyperthyroidism</li><li>May initially worsen ophthalmopathy &amp; hyperthyroid symptoms (increases TRAb)</li><li>Leads to permanent hypothyroidism over time</li></ul></td></tr><tr><td><p align=\"center\"><strong>Thyroidectomy</strong></p></td><td><ul><li>Preferred in patients with very large goiter, obstructive symptoms, or ophthalmopathy</li><li>Potential complications from injury to parathyroids (eg, hypocalcemia, hypoparathyroidism) &amp;/or laryngeal or vagus nerve (eg, hoarseness)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>TRAb</strong> = thyrotropin receptor antibodies.</p></td></tr></tbody></table></div><p>This patient has symptomatic hyperthyroidism (low TSH and elevated T4) with elevated thyrotropin receptor antibodies (eg, thyroid-stimulating immunoglobulins [TSIs]), findings that are consistent with <strong>Graves disease</strong>.&nbsp; The 3 primary treatment options in Graves disease are <strong>radioactive iodine (RAI)</strong> (<font size=\"2\"><sup>131</sup></font>I) <strong>therapy</strong>, antithyroid medication, and thyroidectomy.&nbsp; The choice of treatment is based on patient preferences and characteristics, including symptom severity, degree of thyroid gland enlargement, orbital symptoms, and treatment contraindications (eg, hepatitis for antithyroid medication, pregnancy for RAI therapy).</p><p>RAI is taken up by the thyroid follicular cells (similarly to natural iodine), and the subsequent beta emission (ie, radioactive decay) induces <strong>gradual necrosis</strong> of the thyroid follicular cells.&nbsp; In Graves disease, diffuse RAI uptake leads to biochemical resolution of hyperthyroidism.&nbsp; However, the dose of radioiodine treatment needed to prevent recurrent hyperthyroidism also typically results in <strong>permanent hypothyroidism</strong>, which develops over <strong>6-18 weeks</strong> following treatment (vs rapid normalization) <strong>(Choice E)</strong>.&nbsp; In contrast, treatment of toxic nodular goiter or adenoma with RAI results in uptake by only the hyperfunctioning portion of the thyroid gland, and the remaining normal tissue functions adequately to prevent hypothyroidism.</p><p><strong>(Choice A)</strong>&nbsp; RAI therapy is associated with a transient increase (rather than decreased) level of TSIs and can therefore worsen Graves ophthalmopathy.&nbsp; For this reason, RAI therapy is generally not recommended in patients with pronounced thyroid eye disease; thyroidectomy is preferred.</p><p><strong>(Choice C)</strong>&nbsp; External beam radiation (eg, remote treatment of malignancy), rather than RAI, is a strongly established risk factor for papillary thyroid cancer.&nbsp; After RAI treatment, gradual onset of hypothyroidism is a much more likely outcome.</p><p><strong>(Choice D)</strong>&nbsp; RAI causes local thyroid tissue damage and hypothyroidism primarily through radioactive effects (ie, beta emission) rather than direct iodine-induced inhibition.&nbsp; Moreover, the actual dose of iodine in RAI is much lower than that required to biochemically block thyroid hormone synthesis (eg, in contrast to pharmacologic doses of iodine used in potassium iodide solutions).</p><p><strong>(Choice F)</strong>&nbsp; Beta blockers can be used to blunt hyperadrenergic symptoms (eg, tachycardia) without altering thyroid hormone levels.&nbsp; In contrast, RAI therapy drastically decreases thyroid hormone production by inducing necrosis of thyroid tissue.</p><p><strong>Educational objective:</strong><br>Radioactive iodine therapy for Graves disease resolves hyperthyroidism, but it also gradually leads to permanent hypothyroidism (due to diffuse uptake of treatment by thyroid follicular cells and subsequent gradual necrosis).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 25269,
            "topic": "Radioactive iodine",
            "titleId": 25269,
            "title": "Radioactive iodine",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decrease in the level of thyroid-stimulating immunoglobulins",
                    "choiceNumber": 1,
                    "correctTaken": 219,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Development of hypothyroidism over weeks to months",
                    "choiceNumber": 2,
                    "correctTaken": 3174,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased risk of papillary thyroid cancer",
                    "choiceNumber": 3,
                    "correctTaken": 207,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iodine-induced blockage of thyroid hormone synthesis",
                    "choiceNumber": 4,
                    "correctTaken": 1195,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid normalization of thyroid hormone levels",
                    "choiceNumber": 5,
                    "correctTaken": 152,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Symptom improvement without hormonal changes",
                    "choiceNumber": 6,
                    "correctTaken": 64,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "86,136,true,-1,1*369,445,true,-1,1*504,589,true,-1,1*1288,1387,true,-1,1*1388,1580,true,-1,1*1812,1888,true,-1,1*1901,2124,true,-1,1*2424,2571,true,-1,1*2667,2829,true,-1,1*2840,3042,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "786",
                    "mediaDataId": 0,
                    "title": "Graves disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27521067",
                    "mediaDataId": 0,
                    "title": "2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27521067",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 85,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 5011,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1270,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 12742,
            "questionIndex": 14028,
            "questionText": "<p>A 45-year-old woman comes to the office for preoperative evaluation.&nbsp; The patient had been having intermittent headaches and sweating for several months.&nbsp; During that time, plasma metanephrines were found to be markedly elevated, and she underwent an abdominal CT scan that showed a 4.9 cm left adrenal mass.&nbsp; She has no other medical problems and takes no medications.&nbsp; Family history is unremarkable.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 136/84 mm Hg and pulse is 92/min.&nbsp; Physical examination is normal.&nbsp; Surgical resection of the mass is scheduled in 2 weeks.&nbsp; Which of the following is the most appropriate next step in preparation for surgery?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t56582\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pheochromocytoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Indications for testing</strong></p></td><td><ul><li>Classic triad: episodic headache, sweating &amp; tachycardia</li><li>Resistant HTN or HTN accompanied by unexplained &uarr; glucose</li><li>Family history or familial syndrome (eg, MEN2, NF1, VHL)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic approach</strong></p></td><td><ul><li>Urine or plasma metanephrine levels</li><li>Confirmatory abdominal imaging for &uarr; metanephrines</li></ul></td></tr><tr><td><p align=\"center\"><strong>Notable features</strong></p></td><td><ul><li>10% bilateral, 10% extraadrenal, 10% malignant</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Preoperative alpha blockade prior to beta blockade</li><li>Laparoscopic or open surgical resection</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HTN</strong> = hypertension; <strong>MEN2</strong> = multiple endocrine neoplasia type 2; <strong>NF1</strong> = neurofibromatosis type 1; <strong>VHL</strong> = von Hippel-Lindau syndrome.</p></td></tr></tbody></table></div><p>An adrenal mass in combination with elevated plasma metanephrines is diagnostic of <strong>pheochromocytoma</strong>.&nbsp; All pheochromocytomas should undergo <strong>surgical resection</strong> due to the risk for complications caused by catecholamine surges and the potential for malignant disease (approximately 10% of pheochromocytomas are malignant).&nbsp; Surgical removal of a pheochromocytoma is a high-risk procedure because intraoperative catecholamine surges can precipitate hypertensive crisis, pheochromocytoma crisis (a condition characterized by labile blood pressures, high fever, and multiorgan failure), and fatal arrhythmias.&nbsp; To help prevent these complications, appropriate <strong>adrenergic blockade</strong> is needed prior to surgery.</p><p>The <strong>order of administration</strong> of adrenergic blockade is <strong>critical</strong>.&nbsp; Beta-blocker therapy in the absence of alpha-adrenergic blockade can lead to lethal hypertensive crisis due to unopposed alpha-1 stimulation.&nbsp; Therefore, <strong>alpha-adrenergic blockade should be administered first</strong>, usually 7-14 days prior to surgery.&nbsp; Phenoxybenzamine, an irreversible and nonselective alpha blocker, is often preferred; however, selective alpha-1 blockers (eg, terazosin) are also sometimes used.&nbsp; Patients should also be encouraged to increase sodium intake and stay well-hydrated to minimize possible side effects of alpha-adrenergic blockade (eg, orthostasis, hypotension).</p><p>Once adequate alpha-adrenergic blockade is established, beta-adrenergic blockade (eg, propranolol) can be safely initiated, usually 2-3 days prior to surgery&nbsp;<strong>(Choice D)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Octreotide is a somatostatin analogue used in carcinoid syndrome (eg, diarrhea, flushing, elevated urinary 5-hydroxyindoleacetic acid).&nbsp; It has unclear effects on slowing the growth of malignant pheochromocytomas, which are histologically identical to benign pheochromocytomas but show evidence of metastasis or localized tissue invasion.</p><p><strong>(Choice C)</strong>&nbsp; Although ACE inhibitors&nbsp;may help reduce blood pressure, they will not help prevent beta-1 receptor&ndash;mediated cardiac effects (eg, tachycardia, arrhythmias).</p><p><strong>(Choice E)</strong>&nbsp; Pharmacologic intervention is necessary as this patient will be at high risk for serious intraoperative complications without adequate preoperative adrenergic blockade.</p><p><strong>Educational objective:</strong><br>All pheochromocytomas should undergo surgical resection, which is a high-risk procedure due to the potential for intraoperative catecholamine surges and related complications.&nbsp; To reduce this risk, patients should initiate preoperative alpha-adrenergic blockade 7-14 days prior to surgery, followed by beta-adrenergic blockade 2-3 days prior to surgery.&nbsp; Beta-blocker therapy should never be given in the absence of alpha blockade due to the risk of precipitating hypertensive crisis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 8195,
            "topic": "Pheochromocytoma",
            "titleId": 8195,
            "title": "Pheochromocytoma",
            "topicAttributeId": 330593,
            "topicAttribute": "Endocrine tumors",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer a somatostatin analogue",
                    "choiceNumber": 1,
                    "correctTaken": 412,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate alpha-adrenergic blockade",
                    "choiceNumber": 2,
                    "correctTaken": 13660,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate an ACE inhibitor",
                    "choiceNumber": 3,
                    "correctTaken": 206,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate beta-adrenergic blockade",
                    "choiceNumber": 4,
                    "correctTaken": 1582,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No pharmacologic intervention necessary",
                    "choiceNumber": 5,
                    "correctTaken": 1039,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "226,242,true,-1,1*748,966,true,-1,1*1090,1247,true,-1,1*1658,1743,true,-1,1*1823,2001,true,-1,1*2182,2322,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "508",
                    "mediaDataId": 0,
                    "title": "Pheochromocytoma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24893135",
                    "mediaDataId": 0,
                    "title": "Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24893135",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 75,
            "othersAvgTimeSpent": 37,
            "notes": null,
            "peopleTaken": 16899,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 668,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 10357,
            "questionIndex": 11277,
            "questionText": "<p>A 32-year-old woman with a 13-year history of type 1 diabetes mellitus comes to the hospital with palpitations and shortness of breath.&nbsp; She has had these symptoms for the last several months, but they have worsened recently.&nbsp; The patient also has experienced anxiety, poor sleep, and unintentional weight loss that she attributes to drinking too much coffee at work.&nbsp; Her diabetes mellitus is managed with a regimen of insulin glargine and insulin lispro, and the patient has had good glycemic control in the past.&nbsp; However, in the last few months, she has had rising home glucose readings and has required increasing insulin doses to maintain control.&nbsp; D-dimer screen is positive; CT scan of the chest with contrast performed in the emergency department shows no evidence of pulmonary embolism, and the patient is admitted for additional evaluation.&nbsp; Following admission, she develops nausea and vomiting.&nbsp; Six hours later, the patient is found to be confused, diaphoretic, and agitated.&nbsp; Temperature is 38.9 C (102 F), blood pressure is 96/50 mm Hg, and pulse is 154/min.&nbsp; The chest is clear to auscultation.&nbsp; Examination of the skin and abdomen is unremarkable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Sodium</td><td style=\"vertical-align:middle;\">138 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Potassium</td><td style=\"vertical-align:middle;\">4 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Chloride</td><td style=\"vertical-align:middle;\">106 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Bicarbonate</td><td style=\"vertical-align:middle;\">22 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">28 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td style=\"vertical-align:middle;\">1.2 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Calcium</td><td style=\"vertical-align:middle;\">9.6 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Glucose</td><td style=\"vertical-align:middle;\">320 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"padding-left: 2em;\">Albumin</td><td style=\"vertical-align:middle;\">3.7 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Total bilirubin</td><td style=\"vertical-align:middle;\">2.3 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Direct bilirubin</td><td style=\"vertical-align:middle;\">1.3 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">62 U/L</td></tr><tr><td style=\"padding-left: 2em;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">74 U/L</td></tr></tbody></table><p>Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T80971\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of thyroid storm</strong></p></td></tr><tr><td><p align=\"center\"><strong>Precipitating factors</strong></p></td><td><ul><li>Thyroid or nonthyroidal surgery</li><li>Acute illness (eg, trauma, infection), childbirth</li><li>Acute iodine load (eg, iodine contrast)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>presentation</strong></p></td><td><ul><li>High fever</li><li>Tachycardia, hypotension, congestive heart failure, cardiac arrhythmias (eg, atrial fibrillation)</li><li>Agitation, delirium, seizure, coma</li><li>Goiter, lid lag, tremor</li><li>Nausea, vomiting, diarrhea, jaundice</li></ul></td></tr></tbody></table></div><p>This patient initially experienced nonspecific symptoms of <strong>hyperthyroidism</strong>, including palpitations, weight loss, and impaired glycemic control.&nbsp; After undergoing a radiologic procedure, she rapidly developed fever, tachycardia, and delirium, findings concerning for <strong>thyroid storm</strong> (ie, severe, life-threatening thyrotoxicosis).</p><p>Thyroid storm is usually seen in patients with undiagnosed or inadequately treated hyperthyroidism and is characterized by <strong>rapidly rising thyroid hormone levels</strong>.&nbsp; This patient with a preexisting autoimmune condition (eg, type 1 diabetes mellitus) likely has undiagnosed autoimmune thyroid disease (eg, Graves disease).&nbsp; As seen in this patient, the <strong>iodine load</strong> in radiologic contrast agents (eg, CT scan of the chest with contrast) is a common trigger for thyroid storm; other causes include physiologic stressors such as surgery, trauma, infection, or childbirth.</p><p>Clinical manifestations of thyroid storm include cardiac arrhythmias, congestive heart failure, seizures, hypotension, coma, and shock.&nbsp; Severe hyperglycemia may occur in patients with diabetes mellitus because excess thyroid hormone increases systemic sensitivity to circulating catecholamines, leading to suppression of insulin release and increased glycogen breakdown.</p><p><strong>(Choice A)</strong>&nbsp; Delayed hypersensitivity to iodine contrast occurs 1 hour to several days after exposure and causes a rash that resolves spontaneously without significant hemodynamic effects.&nbsp; Immediate hypersensitivity can cause hemodynamic instability (along with urticaria and angioedema) but usually occurs within an hour of exposure.</p><p><strong>(Choice B)</strong>&nbsp; Although this patient has hyperglycemia, her serum bicarbonate and <a href=\"34222\">anion gap</a> are normal, findings inconsistent with diabetic ketoacidosis.</p><p><strong>(Choice C)</strong>&nbsp; Acute hepatic injury may occur in thyroid storm due to congestive hepatopathy and/or direct hepatocyte injury from thyrotoxicosis.&nbsp; Hepatic encephalopathy, however, most often occurs in patients with stigmata of chronic liver disease (eg, palmar erythema, spider angioma, ascites), hypoalbuminemia, and hyponatremia.</p><p><strong>(Choice D)</strong>&nbsp; Subsegmental pulmonary emboli are usually hemodynamically insignificant and cause pleuritic chest pain, dyspnea, tachypnea, and tachycardia.&nbsp; Massive pulmonary embolism may cause significant hypotension but is usually visible on CT scan.</p><p><strong>Educational objective:</strong><br>Thyroid storm is a life-threatening thyrotoxicosis that can be triggered by an iodine load (eg, radiologic contrast agents) or physiologic stressors (eg, surgery, trauma, infection, childbirth) in patients with undiagnosed or inadequately treated hyperthyroidism.&nbsp; Manifestations include fever, hemodynamic instability, cardiac arrhythmias, and congestive heart failure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Delayed iodine allergy",
                    "choiceNumber": 1,
                    "correctTaken": 426,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diabetic ketoacidosis",
                    "choiceNumber": 2,
                    "correctTaken": 1089,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatic encephalopathy",
                    "choiceNumber": 3,
                    "correctTaken": 336,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subsegmental pulmonary emboli",
                    "choiceNumber": 4,
                    "correctTaken": 335,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyrotoxic crisis",
                    "choiceNumber": 5,
                    "correctTaken": 2787,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1083,1327,true,-1,1*1465,1699,true,-1,1*1711,2034,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "487",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "36118802",
                    "mediaDataId": 0,
                    "title": "Clinical review and update on the management of thyroid storm.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/36118802",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 112,
            "othersAvgTimeSpent": 149,
            "notes": null,
            "peopleTaken": 5058,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1004,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 17088,
            "questionIndex": 18539,
            "questionText": "<p>A 34-year-old woman comes to the office due to fullness in her neck after noticing a difference in how jewelry rests around her neck as compared to before.&nbsp; The patient has no other symptoms.&nbsp; She has no medical issues and takes no medications.&nbsp; Family history includes thyroid surgery for an enlarged thyroid gland in her mother.&nbsp; Examination reveals a 1.4-cm firm, nontender, mobile nodule in her left thyroid lobe.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Laboratory evaluation shows serum TSH of 0.25 &micro;U/mL, serum total thyroxine (T4) of 10 &micro;g/dL, and serum triiodothyronine (T3) of 176 ng/dL.&nbsp; A thyroid ultrasound reveals a 1.4-cm left thyroid nodule with smooth margins and no microcalcifications or internal vascularity.&nbsp; Which of the following is the most appropriate next step?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"13781\" src=\"https://www.uworld.com/media/L38357.jpg\" ></p><p><strong>Thyroid nodules</strong> are common and may be diagnosed on physical examination or noted incidentally when imaging studies are obtained for other reasons.&nbsp; Once a thyroid nodule is found, cancer risk factors (eg, family history, radiation exposure) should be assessed by history.&nbsp; Physical examination should evaluate the size, mobility, and firmness of the thyroid nodule and check for the presence of enlarged cervical lymph nodes.</p><p><strong>Serum TSH</strong> levels should be obtained, along with a <strong>thyroid ultrasound</strong>, to determine nodule size and sonographic features.&nbsp; Certain sonographic features (eg, microcalcifications, irregular margins, internal vascularity) carry a much higher risk of malignancy than others (eg, cystic or spongiform lesions).&nbsp; Thyroid nodules &gt;1 cm with these high-risk sonographic features&mdash;and all noncystic thyroid nodules &gt;2 cm&mdash;should undergo fine-needle aspiration (FNA).</p><p>If the <strong>TSH is low</strong>, as seen here,&nbsp;the patient should be evaluated with <strong>radionuclide thyroid scan</strong> using iodine-123:</p><ul><li>A hypofunctioning (&#x22;cold&#x22;) nodule (decreased isotope uptake compared to surrounding tissue) is associated with a higher risk of cancer.</li><li>A hyperfunctioning (&#x22;hot&#x22;) nodule (increased isotope uptake in the nodule with decreased surrounding uptake) is associated with a low cancer risk; therefore, FNA is not necessary <strong>(Choice B)</strong>.</li></ul><p>This patient who has a thyroid nodule with no concerning sonographic features and a low TSH should receive a radionuclide thyroid scan.</p><p><strong>(Choice A)</strong>&nbsp; A CT scan of the neck is inferior to ultrasound for characterizing thyroid nodules.&nbsp; Even if a thyroid nodule is detected on CT scan, a thyroid ultrasound is still needed.</p><p><strong>(Choice D)</strong>&nbsp; Anti-thyroperoxidase antibody testing can identify chronic autoimmune (Hashimoto) thyroiditis, but it is used for patients with high TSH levels (eg, hypothyroid).</p><p><strong>(Choice E)</strong>&nbsp; Calcitonin is an important tumor marker in medullary thyroid carcinoma (MTC).&nbsp; In patients with a thyroid nodule, testing for calcitonin should be performed if there is a family history of MTC or if cytologic examination (eg, FNA) of the nodule is consistent with MTC.</p><p><strong>(Choice F)</strong>&nbsp; Thyroid stimulating antibodies are present in patients with Graves disease, which can result in hyperthyroidism.&nbsp; However, Graves disease typically causes a diffusely enlarged goiter rather than a focal nodule.</p><p><strong>Educational objective:</strong><br>The initial evaluation of thyroid nodules includes a serum TSH assay and thyroid ultrasound.&nbsp; Patients with a suppressed TSH should undergo thyroid scintigraphy.&nbsp; Small, hyperfunctioning nodules are rarely malignant and do not usually require fine-needle aspiration.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 6741,
            "topic": "Thyroid nodules",
            "titleId": 6741,
            "title": "Thyroid nodules",
            "topicAttributeId": 330676,
            "topicAttribute": "Thyroid disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "CT scan of the neck",
                    "choiceNumber": 1,
                    "correctTaken": 217,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fine-needle aspiration",
                    "choiceNumber": 2,
                    "correctTaken": 6103,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Radionuclide thyroid scan",
                    "choiceNumber": 3,
                    "correctTaken": 8664,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum anti-thyroid peroxidase measurement",
                    "choiceNumber": 4,
                    "correctTaken": 486,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum calcitonin measurement",
                    "choiceNumber": 5,
                    "correctTaken": 229,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum thyroid stimulating antibody measurement",
                    "choiceNumber": 6,
                    "correctTaken": 1117,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "179,457,true,-1,1*579,912,true,-1,1*1586,1673,true,-1,1*1938,2129,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "485",
                    "mediaDataId": 0,
                    "title": "Thyroid nodules",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26462967",
                    "mediaDataId": 0,
                    "title": "2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26462967",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 73,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16816,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 452,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}